N-cadherin antibody | antibody review based on formal publications

This is a Validated Antibody Database (VAD) review about human N-cadherin, based on 476 published articles (read how Labome selects the articles), using N-cadherin antibody in all methods. It is aimed to help Labome visitors find the most suited N-cadherin antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.

N-cadherin synonym: CD325; CDHN; CDw325; NCAD

Knockout validation

Invitrogen mouse monoclonal (CH-19) MA1-91128	western blot knockout validation; human; loading ...; fig 3a immunohistochemistry - paraffin section; human; loading ...; fig 1a, 2g	Invitrogen N-cadherin antibody (Thermo Fisher, MA1-91128) was used in western blot knockout validation on human samples (fig 3a) and in immunohistochemistry - paraffin section on human samples (fig 1a, 2g). J Immunother Cancer (2021) ncbi
Abcam domestic rabbit polyclonal ab76057	immunohistochemistry knockout validation; mouse; 1:1000; loading ...; fig s3b	Abcam N-cadherin antibody (Abcam, ab76057) was used in immunohistochemistry knockout validation on mouse samples at 1:1000 (fig s3b). Cells (2019) ncbi
BD Biosciences mouse monoclonal (32/N-Cadherin) 610921	immunohistochemistry knockout validation; mouse; loading ...; fig 2a, 2b western blot knockout validation; mouse; loading ...; fig 2c	BD Biosciences N-cadherin antibody (BD, 610921) was used in immunohistochemistry knockout validation on mouse samples (fig 2a, 2b) and in western blot knockout validation on mouse samples (fig 2c). Dev Biol (2017) ncbi

Invitrogen

mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 3	Invitrogen N-cadherin antibody (ThermoFisher, 33-3900) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 3). Nat Commun (2021) ncbi
mouse monoclonal (CH-19) MA1-91128	western blot knockout validation; human; loading ...; fig 3a immunohistochemistry - paraffin section; human; loading ...; fig 1a, 2g	Invitrogen N-cadherin antibody (Thermo Fisher, MA1-91128) was used in western blot knockout validation on human samples (fig 3a) and in immunohistochemistry - paraffin section on human samples (fig 1a, 2g). J Immunother Cancer (2021) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry; human; 1:100; loading ...; tbl 2	Invitrogen N-cadherin antibody (Thermo Fisher Scientific, 3B9) was used in immunohistochemistry on human samples at 1:100 (tbl 2). Mod Pathol (2020) ncbi
mouse monoclonal (3B9) 33-3900	western blot; mouse; 1:500; loading ...; fig 4h	Invitrogen N-cadherin antibody (Thermo, 33-3900) was used in western blot on mouse samples at 1:500 (fig 4h). elife (2020) ncbi
domestic rabbit polyclonal PA5-29570	immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig 5e western blot; mouse; 1:1000; loading ...; fig s5c	Invitrogen N-cadherin antibody (Thermo Fisher, PA5-29570) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 5e) and in western blot on mouse samples at 1:1000 (fig s5c). Nat Commun (2019) ncbi
mouse monoclonal (8C11) 17-3259-42	flow cytometry; human; 1:50; fig 3a, 3b	Invitrogen N-cadherin antibody (eBioscience/Thermo, 17-3259-42) was used in flow cytometry on human samples at 1:50 (fig 3a, 3b). Stem Cells (2019) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - frozen section; mouse; loading ...; fig 6d	Invitrogen N-cadherin antibody (ThermoFisher, 33-3900) was used in immunohistochemistry - frozen section on mouse samples (fig 6d). J Biol Chem (2019) ncbi
domestic rabbit monoclonal (SP90) MA5-16324	immunohistochemistry - paraffin section; mouse; loading ...; fig s4c	Invitrogen N-cadherin antibody (Invitrogen, MA5-16324) was used in immunohistochemistry - paraffin section on mouse samples (fig s4c). Cell (2019) ncbi
mouse monoclonal (3B9) 33-3900	immunocytochemistry; mouse; 1:250; loading ...; fig 1a	Invitrogen N-cadherin antibody (Thermo Fisher, 33-3900) was used in immunocytochemistry on mouse samples at 1:250 (fig 1a). J Cell Sci (2019) ncbi
mouse monoclonal (8C11) 46-3259-41 46-3259-42	immunohistochemistry - paraffin section; mouse; loading ...; fig 5c	Invitrogen N-cadherin antibody (eBioscience, 46-3259) was used in immunohistochemistry - paraffin section on mouse samples (fig 5c). Mol Cancer Res (2018) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry; mouse; 1:200; loading ...; fig 3a	In order to examine connexin40 and connexin43 expression in mouse models of hypoxia and sleep apnea, Invitrogen N-cadherin antibody (Life Technologies, 33-3900) was used in immunohistochemistry on mouse samples at 1:200 (fig 3a). BMC Cell Biol (2017) ncbi
domestic rabbit polyclonal PA5-19486	immunohistochemistry - paraffin section; human; 1:300 immunocytochemistry; human; 1:200; loading ...; fig 1c western blot; human; 1:1000; loading ...; fig 1e	In order to test if chemotherapy affects the epithelial-mesenchymal transition of osteosarcoma cells, Invitrogen N-cadherin antibody (Thermo Fisher, PA5-19486) was used in immunohistochemistry - paraffin section on human samples at 1:300, in immunocytochemistry on human samples at 1:200 (fig 1c) and in western blot on human samples at 1:1000 (fig 1e). Oncol Lett (2016) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry; rat; loading ...; fig 7b	In order to describe a cardiovascular progenitor population derived during embryonic stem cell differentiation, Invitrogen N-cadherin antibody (Invitrogen, 3B9) was used in immunohistochemistry on rat samples (fig 7b). Stem Cells Int (2016) ncbi
mouse monoclonal (3B9) 33-3900	immunocytochemistry; mouse; loading ...; fig 3b	In order to show that decreased WNT/beta-catenin contributes to the pathophysiology of lamin A/C gene cardiomyopathy, Invitrogen N-cadherin antibody (Invitrogen, 33-3900) was used in immunocytochemistry on mouse samples (fig 3b). Hum Mol Genet (2017) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry; mouse; loading ...	In order to discuss methods to generate induced cardiomyocytes in vitro and in vivo, Invitrogen N-cadherin antibody (Thermo Fisher, 33-3900) was used in immunohistochemistry on mouse samples . Methods Mol Biol (2017) ncbi
mouse monoclonal (3B9) 33-3900	immunocytochemistry; rat; 1:200; loading ...; fig 3a western blot; rat; 1:200; loading ...; fig 3a	In order to explore how laminin2 in the basement membrane modulates the blood testis barrier dynamics during spermatogenesis, Invitrogen N-cadherin antibody (ThermoFisher Scientific, 33-3900) was used in immunocytochemistry on rat samples at 1:200 (fig 3a) and in western blot on rat samples at 1:200 (fig 3a). FASEB J (2017) ncbi
mouse monoclonal (3B9) 33-3900	western blot; human; loading ...; fig 4b	In order to investigate the role of Cx26 to cell mobility, Invitrogen N-cadherin antibody (Thermo, 33-3900) was used in western blot on human samples (fig 4b). J Cell Sci (2016) ncbi
mouse monoclonal (3B9) 33-3900	immunocytochemistry; human; loading ...; fig 3c	In order to show that apical polarization of the sodium, potassium-ATPase in retinal pigment epithelium cells depends on the expression of the beta2 subunit, Invitrogen N-cadherin antibody (ZYMED, 333900) was used in immunocytochemistry on human samples (fig 3c). Front Physiol (2016) ncbi
domestic rabbit polyclonal PA5-17526	western blot; human; 1:1000; loading ...; fig 2c	In order to study the the protein levels and biophysical properties of CaV3.3 channel and its implication in schizophrenia., Invitrogen N-cadherin antibody (Life Technology, PA5-17526) was used in western blot on human samples at 1:1000 (fig 2c). Sci Rep (2016) ncbi
mouse monoclonal (3B9) 33-3900	immunocytochemistry; human; loading ...; fig 5c western blot; human; loading ...; fig 5c	In order to investigate the alternative splicing of E-cadherin mRNA, Invitrogen N-cadherin antibody (Zymed, 3-B9) was used in immunocytochemistry on human samples (fig 5c) and in western blot on human samples (fig 5c). J Cell Physiol (2017) ncbi
mouse monoclonal (3B9) 33-3900	immunocytochemistry; rat; 1:100; loading ...; tbl 1 western blot; rat; 1:500; loading ...; tbl 1	In order to examine the organization of actin microfilaments in Sertoli cell at the blood testis barrier, Invitrogen N-cadherin antibody (Invitrogen, 33-3900) was used in immunocytochemistry on rat samples at 1:100 (tbl 1) and in western blot on rat samples at 1:500 (tbl 1). Spermatogenesis (2016) ncbi
mouse monoclonal (CH-19) MA1-91128	western blot; mouse; loading ...; fig 1a	In order to explore how ST8SIA2-mediated polysialylation influences oligodendrocyte differentiation and schizophrenia, Invitrogen N-cadherin antibody (Thermo Scientific, MA1-91128) was used in western blot on mouse samples (fig 1a). Glia (2017) ncbi
mouse monoclonal (3B9) 33-3900	immunocytochemistry; rat; 1:100; fig 1 western blot; rat; 1:500; fig 1	In order to characterize overexpression of gap junction protein connexin 43 by rescue of perfluorooctanesulfonate (PFOS)-mediated sertoli cell injury, Invitrogen N-cadherin antibody (Invitrogen, 33-3900) was used in immunocytochemistry on rat samples at 1:100 (fig 1) and in western blot on rat samples at 1:500 (fig 1). Sci Rep (2016) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry; human; loading ...	In order to identify signaling pathways that mediate the EGF-induced epithelial to mesenchymal transition, Invitrogen N-cadherin antibody (Thermo Fisher, 33-3900) was used in immunohistochemistry on human samples . J Proteomics (2017) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - frozen section; rat; 1:100; fig 2 immunocytochemistry; rat; 1:100; fig 5 western blot; rat; 1:200; fig 5	In order to report that crumbs homolog 3 is an actin microfilament regulator, Invitrogen N-cadherin antibody (Invitrogen, Life Technologies, 33-3900) was used in immunohistochemistry - frozen section on rat samples at 1:100 (fig 2), in immunocytochemistry on rat samples at 1:100 (fig 5) and in western blot on rat samples at 1:200 (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - frozen section; mouse; 1:200; fig s3	In order to study induction of granulosa cell fate and defects and cancers in mouse adult ovary by amplification of R-spondin1 signaling, Invitrogen N-cadherin antibody (Invitrogen, 33-3900) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig s3). Oncogene (2017) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; human; 1:50; fig 3	In order to determine mediation of differentiation and cisplatin chemotherapy resistance by biased expression of the FOXP3delta3 isoform in aggressive bladder cancer, Invitrogen N-cadherin antibody (Invitrogen, 33-3900) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 3). Clin Cancer Res (2016) ncbi
mouse monoclonal (3B9) 33-3900	immunoprecipitation; rat; 1:60; fig 2 immunocytochemistry; rat; 1:100; fig 1 western blot; rat; 1:200; fig 3	In order to determine regulation of ectoplasmic specialization dynamics via its effects on actin microfilaments in the testes of male rats by planar cell polarity (PCP) protein Vangl2, Invitrogen N-cadherin antibody (Invitrogen, 33-3900) was used in immunoprecipitation on rat samples at 1:60 (fig 2), in immunocytochemistry on rat samples at 1:100 (fig 1) and in western blot on rat samples at 1:200 (fig 3). Endocrinology (2016) ncbi
mouse monoclonal (8C11) MA1-2002 14-3259-82	flow cytometry; human; fig st1	In order to find cell-surface markers specific to human neutrophils, Invitrogen N-cadherin antibody (e- Bioscienc e, 12-3259-73) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (3B9) 33-3900	immunocytochemistry; rat; 1:100; fig 1	In order to characterize disruption of the sertolic cell cytoskeleton by interleukin 1alpha and its affect on gap junctional communication, Invitrogen N-cadherin antibody (Invitrogen, 33-3900) was used in immunocytochemistry on rat samples at 1:100 (fig 1). Cell Signal (2016) ncbi
mouse monoclonal (3B9) 33-3900	western blot; mouse; 1:100; tbl 1	In order to elucidate a deletion of AMP-activated protein kinase in mouse Sertoli cells that modify germ cell quality, Invitrogen N-cadherin antibody (Invitrogen, 3B9) was used in western blot on mouse samples at 1:100 (tbl 1). Mol Cell Endocrinol (2016) ncbi
mouse monoclonal (3B9) 33-3900	western blot; human; fig 5	In order to investigate how CaSm promotes pancreatic cancer, Invitrogen N-cadherin antibody (Invitrogen, 33-3900) was used in western blot on human samples (fig 5). Oncogenesis (2016) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - frozen section; rat; 1:100; tbl 2	In order to test if overexpression of Connexin 43 in adjudin-treated rats reseals the disrupted blood-testis barrier and reinitiates spermatogenesis, Invitrogen N-cadherin antibody (Invitrogen, 33-3900) was used in immunohistochemistry - frozen section on rat samples at 1:100 (tbl 2). FASEB J (2016) ncbi
mouse monoclonal (3B9) 33-3900	western blot; mouse; fig 7	In order to study postnatal liver maturation and its support by ESRP2 and adult splicing program in hepatocytes, Invitrogen N-cadherin antibody (Life Technologies, 33?C3900) was used in western blot on mouse samples (fig 7). Nat Commun (2015) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; human; 1:150; fig 1b	In order to study markers of the epithelial to mesenchymal transition using invasive lobular carcinoma samples, Invitrogen N-cadherin antibody (Invitrogen, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:150 (fig 1b). J Pathol (2016) ncbi
mouse monoclonal (3B9) 33-3900	western blot; African green monkey western blot; rat; 1:1000	In order to determine the functional effects of S368 phosphorylation of connexin 43, Invitrogen N-cadherin antibody (Invitrogen, 33?C3900) was used in western blot on African green monkey samples and in western blot on rat samples at 1:1000. J Cardiovasc Electrophysiol (2016) ncbi
mouse monoclonal (3B9) 33-3900	western blot; human; 1:500; fig 2a	In order to characterize two clones from triple negative breast MDA-MB-231 cancer cells, Invitrogen N-cadherin antibody (Invitrogene, 33-3900) was used in western blot on human samples at 1:500 (fig 2a). Exp Cell Res (2015) ncbi
mouse monoclonal (3B9) 33-3900	western blot; human; 1:500; fig 3	In order to identify the role of defective autophagy in cerebral cavernous malformations, Invitrogen N-cadherin antibody (Invitrogen, 33-3900) was used in western blot on human samples at 1:500 (fig 3). EMBO Mol Med (2015) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - frozen section; mouse; 1:500	In order to test if Wwp1 regulates connexin 43, Invitrogen N-cadherin antibody (Invitrogen, 3B9) was used in immunohistochemistry - frozen section on mouse samples at 1:500. J Mol Cell Cardiol (2015) ncbi
domestic rabbit polyclonal PA5-29570		In order to study the role of autophagy factors in cancer progression and treatment response, Invitrogen N-cadherin antibody (Pierce, PA5-29570) was used . Nat Commun (2015) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; mouse; 1:100; tbl 3	In order to characterize a conditional knock out of ataxia telangiectasia-mutated as a mouse model of pancreatic ductal adenocarcinoma, Invitrogen N-cadherin antibody (Zymed, 33-3900) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (tbl 3). Nat Commun (2015) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; domestic horse; 1:500 western blot; domestic horse; 1:500	In order to characterize the equine blood-testis barrier during tubular development in normal and cryptorchid stallions, Invitrogen N-cadherin antibody (Invitrogen, 33-3900) was used in immunohistochemistry - paraffin section on domestic horse samples at 1:500 and in western blot on domestic horse samples at 1:500. Theriogenology (2015) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry; rat; 1:100	In order to study the role of plastin 3 in ectoplasmic specialization dynamics during spermatogenesis in the rat testis, Invitrogen N-cadherin antibody (Invitrogen, 33-3900) was used in immunohistochemistry on rat samples at 1:100. FASEB J (2015) ncbi
mouse monoclonal (3B9) 33-3900	western blot; human; 1:1000	In order to elucidate the contribution of microRNAs in resistance to BRAF inhibitor treatment, Invitrogen N-cadherin antibody (Life Technologies, 3B9) was used in western blot on human samples at 1:1000. Pigment Cell Melanoma Res (2015) ncbi
mouse monoclonal (3B9) 33-3900	western blot; human; 1:500	In order to study the tissue factor protein and metastasis initiating cell markers during thrombocytosis, Invitrogen N-cadherin antibody (Invitrogen, 33-3900) was used in western blot on human samples at 1:500. BMC Cancer (2015) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; rat; 1:100 immunoprecipitation; rat western blot; rat; 1:1000	In order to study the effect of flutamide on the distribution of c-Src and the N-cadherin-beta-catenin complex in the seminiferous epithelium of adult rat, Invitrogen N-cadherin antibody (Invitrogen, 33-3900) was used in immunohistochemistry - paraffin section on rat samples at 1:100, in immunoprecipitation on rat samples and in western blot on rat samples at 1:1000. Andrology (2015) ncbi
mouse monoclonal (8C11) MA1-2002	immunohistochemistry; human; fig 3	In order to elucidate the contributions of cell-cell adhesion proteins to intercellular force and epithelial tissue dynamics, Invitrogen N-cadherin antibody (Thermo, MA1-2002) was used in immunohistochemistry on human samples (fig 3). Nat Cell Biol (2015) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry; rat; 1:200	Invitrogen N-cadherin antibody (Invitrogen, 3B9) was used in immunohistochemistry on rat samples at 1:200. Exp Mol Pathol (2015) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry; domestic rabbit; fig 4 western blot; domestic rabbit; fig 3	In order to generate and characterize a novel rabbit corneal endothelial cell line, Invitrogen N-cadherin antibody (Invitrogen, 3B9) was used in immunohistochemistry on domestic rabbit samples (fig 4) and in western blot on domestic rabbit samples (fig 3). J Tissue Eng Regen Med (2017) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry; mouse	In order to investigate the role of fibroblast growth factor receptor 2 in corneal epithelial cell proliferation and differentiation during embryonic development, Invitrogen N-cadherin antibody (Zymed, 33-3900) was used in immunohistochemistry on mouse samples . PLoS ONE (2015) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; human; 1:300	Invitrogen N-cadherin antibody (Invitrogen, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:300. Hum Pathol (2015) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; human; 1:100	Invitrogen N-cadherin antibody (Invitrogen, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:100. J Pathol (2015) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; rat; 1:100 western blot; rat; 1:125	In order to investigate the role of rpS6 in blood-testis barrier function, Invitrogen N-cadherin antibody (Invitrogen, 33-3900) was used in immunohistochemistry - paraffin section on rat samples at 1:100 and in western blot on rat samples at 1:125. J Cell Sci (2014) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - frozen section; mouse; 1:200; fig s9a	In order to study the initiation and regulation of radial migration, Invitrogen N-cadherin antibody (Invitrogen, 333900) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig s9a). Nat Commun (2014) ncbi
mouse monoclonal (5D5) MA5-15633	western blot; human; 1:1000	In order to demonstrate that baicalein inhibits metastasis of cancer cells via inactivation of TGF-beta/Smad4 signaling, Invitrogen N-cadherin antibody (Pierce, MA5-15633) was used in western blot on human samples at 1:1000. Mol Med Rep (2014) ncbi
mouse monoclonal (3B9) 33-3900	western blot; rat; fig 6b	In order to study the role of calpain activation in hearts subjected to myocardial infarction, Invitrogen N-cadherin antibody (Invitrogen, 3B9) was used in western blot on rat samples (fig 6b). J Biol Chem (2014) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - frozen section; mouse; 1:100; fig 8a	In order to elucidate the critical role of TRPV2 in maintenance of cardiac function and structure in mice, Invitrogen N-cadherin antibody (life technologies, 3B9) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 8a). Nat Commun (2014) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry; human; 1:500; fig 8	In order to study the contribution of 14-3-3gamma to testis organization and spermatogenesis, Invitrogen N-cadherin antibody (Life Technologies, 33-3900) was used in immunohistochemistry on human samples at 1:500 (fig 8). J Cell Sci (2014) ncbi
mouse monoclonal (3B9) 33-3900	western blot; human; 1:1000	In order to develop and characterize a novel three-dimensional cell culture model of ovarian endometriosis, Invitrogen N-cadherin antibody (Invitrogen, 3B9) was used in western blot on human samples at 1:1000. J Ovarian Res (2014) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; human	In order to evaluate the role of VEGF-mediated angiogenesis in EMT-induced cancer stemness and tumorigenesis, Invitrogen N-cadherin antibody (Zymed, 33-3900) was used in immunohistochemistry - paraffin section on human samples . Cancer Res (2014) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry; human; 1:100; fig 9	In order to describe the magnetic levitation method of 3D cell culturing, Invitrogen N-cadherin antibody (Invitrogen, 33-3900) was used in immunohistochemistry on human samples at 1:100 (fig 9). Nat Protoc (2013) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; human; 1:100; tbl 1	In order to describe the molecular pathologic characteristics of urothelial carcinomas subtypes, Invitrogen N-cadherin antibody (Invitrogen, 33-3900) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 1). Am J Pathol (2013) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry; rat; 1:100	In order to report that Rai14 regulates actin filaments organization in Sertoli cells during the epithelial cycle, Invitrogen N-cadherin antibody (Invitrogen, 33-3900) was used in immunohistochemistry on rat samples at 1:100. PLoS ONE (2013) ncbi
mouse monoclonal (3B9) 33-3900	western blot; human; fig 4	In order to compare the histological, biological, and molecular features of 2D and 3D epithelial ovarian cancer cultures, Invitrogen N-cadherin antibody (Invitrogen, 33-3900) was used in western blot on human samples (fig 4). Lab Invest (2013) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry; human; 1:150; fig 1	In order to examine E-cadherin-negative ductal carcinoma, Invitrogen N-cadherin antibody (Zymed, 33-3900) was used in immunohistochemistry on human samples at 1:150 (fig 1). Histopathology (2013) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; mouse	In order to study the development of fatal cardiac hypertrophy and arrrhythmia in mice overexpressing miRNA-17-92 in heart and smooth muscle, Invitrogen N-cadherin antibody (Invitrogen, 3B9) was used in immunohistochemistry - paraffin section on mouse samples . FASEB J (2013) ncbi
mouse monoclonal (3B9) 33-3900	western blot; human; fig 3	In order to study the intercalated disc of the heart, Invitrogen N-cadherin antibody (Invitrogen, clone 3B9) was used in western blot on human samples (fig 3). Dev Biol (2013) ncbi
mouse monoclonal (3B9) 33-3900	western blot; human; fig 3	In order to investigate the role of miR-205 in human bladder cancers, Invitrogen N-cadherin antibody (Invitrogen, 33-3900) was used in western blot on human samples (fig 3). J Biol Chem (2013) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - frozen section; rat; 1:100	In order to examine the role of actin and tubulin in ectoplasmic specialization, Invitrogen N-cadherin antibody (Invitrogen, 33-3900) was used in immunohistochemistry - frozen section on rat samples at 1:100. Spermatogenesis (2012) ncbi
mouse monoclonal (3B9) 33-3900	western blot; mouse; fig 4	In order to study plakoglobin using hypomorphic mice, Invitrogen N-cadherin antibody (Invitrogen, 3B9) was used in western blot on mouse samples (fig 4). Genesis (2012) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; human; fig 3	In order to assess the incidence and prognostic significance of the epithelial to mesenchymal transition in cancer of unknown primary, Invitrogen N-cadherin antibody (Invitrogen, 3B9) was used in immunohistochemistry - paraffin section on human samples (fig 3). Anticancer Res (2012) ncbi
mouse monoclonal (3B9) 33-3900	western blot; mouse; fig 1	In order to test if beta-catenin is required to maintain cardiac conduction in the absence of plakoglobin, Invitrogen N-cadherin antibody (Invitrogen, 3B9) was used in western blot on mouse samples (fig 1). Mol Cell Biol (2012) ncbi
mouse monoclonal (3B9) 33-3900	immunocytochemistry; mouse; fig 5	In order to test if CDH11 is increased in pulmonary fibrosis and contributes its development, Invitrogen N-cadherin antibody (Invitrogen, 3B9) was used in immunocytochemistry on mouse samples (fig 5). FASEB J (2012) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; mouse; 1:200 western blot; mouse	In order to study the role of the Rac1 GTPase the shaping of the ocular lens, Invitrogen N-cadherin antibody (Invitrogen, 3b9) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 and in western blot on mouse samples . Dev Biol (2011) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry; human; 1:20	In order to test is c-met normalizes altered limbal stem cell marker patterns in diabetic corneas, Invitrogen N-cadherin antibody (Invitrogen, 3B9) was used in immunohistochemistry on human samples at 1:20. Mol Vis (2011) ncbi
mouse monoclonal (3B9) 33-3900	immunocytochemistry; human; 1:100; fig 4	In order to describe a method to cultivate corneal endothelial cells for transplantation, Invitrogen N-cadherin antibody (Invitrogen, 3B9) was used in immunocytochemistry on human samples at 1:100 (fig 4). Tissue Eng Part A (2011) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; human; 1:40; fig 5	In order to use adipose tissue-derived stem cells to generate dental buds, Invitrogen N-cadherin antibody (Zymed, 33-3900) was used in immunohistochemistry - paraffin section on human samples at 1:40 (fig 5). Am J Pathol (2011) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry; mouse; fig 6	In order to investigate how plakoglobin affects beta-catenin activity in the heart, Invitrogen N-cadherin antibody (Invitrogen, 3B9) was used in immunohistochemistry on mouse samples (fig 6). Mol Cell Biol (2011) ncbi
mouse monoclonal (3B9) 33-3900	western blot; human	In order to determine the role of mammary epithelial cell NF-kapaB signaling in tumor progression in vivo, Invitrogen N-cadherin antibody (Zymed, 3B9) was used in western blot on human samples . Cancer Res (2010) ncbi
mouse monoclonal (3B9) 33-3900	immunoprecipitation; rat; fig 2	In order to study the contribution of ZO-1 to cell-cell junction localization, Invitrogen N-cadherin antibody (Zymed, 33-3900) was used in immunoprecipitation on rat samples (fig 2). Am J Physiol Heart Circ Physiol (2011) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry; mouse; fig 5	In order to study M-band alterations in heart disease, Invitrogen N-cadherin antibody (Invitrogen, 33-3900) was used in immunohistochemistry on mouse samples (fig 5). Basic Res Cardiol (2011) ncbi
mouse monoclonal (3B9) 33-3900	immunocytochemistry; rat; 1:50; tbl 1	In order to test if the function of the blood-testis barrier in affected by adjudin, Invitrogen N-cadherin antibody (Zymed, 33-3900) was used in immunocytochemistry on rat samples at 1:50 (tbl 1). Int J Biochem Cell Biol (2010) ncbi
mouse monoclonal (3B9) 33-3900	immunocytochemistry; rat; 1:50; tbl 1 western blot; rat; 1:250; tbl 1	In order to study protein trafficking in Sertoli cells, Invitrogen N-cadherin antibody (Invitrogen, 33-3900) was used in immunocytochemistry on rat samples at 1:50 (tbl 1) and in western blot on rat samples at 1:250 (tbl 1). Exp Cell Res (2010) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry; human; 1:100; tbl 1	In order to characterize the expression of a number of proteins in tissues from pseudomyxoma peritonei patients, Invitrogen N-cadherin antibody (Zymed, 3B9) was used in immunohistochemistry on human samples at 1:100 (tbl 1). Hum Pathol (2010) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; human; 1:200; tbl 2	In order to measure the expression of tenascin-C, osteopontin, and fibronectin in inflammatory myofibroblastic tumor of the lung, Invitrogen N-cadherin antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 2). APMIS (2010) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry; human; fig 3b	In order to examine granzyme B and perforin expression in bladder cancer cell lines and in urothelial carcinoma tissues, Invitrogen N-cadherin antibody (Zymed, 3B9) was used in immunohistochemistry on human samples (fig 3b). Int J Cancer (2010) ncbi
mouse monoclonal (3B9) 33-3900	western blot; human; 1:500; fig 6	In order to examine the effects of Slit2 expression on the migration and invasion of invasive glioma cells, Invitrogen N-cadherin antibody (Invitrogen, 33-3900) was used in western blot on human samples at 1:500 (fig 6). Neuro Oncol (2009) ncbi
mouse monoclonal (3B9) 33-3900	western blot; human; fig 4	In order to measure expression of E-cadherin and related proteins in breast cancer cell lines, Invitrogen N-cadherin antibody (Zymed, 3-B9) was used in western blot on human samples (fig 4). J Cell Physiol (2010) ncbi
mouse monoclonal (3B9) 33-3900	western blot; human; fig 1	In order to determine the localization and function of N-cadherin in human spermatozoa and oocytes, Invitrogen N-cadherin antibody (Zymed, 33-3900) was used in western blot on human samples (fig 1). Int J Androl (2010) ncbi
mouse monoclonal (3B9) 33-3900	western blot; mouse; fig 7	In order to observe the spatial expression of the mu-opioid receptor, Invitrogen N-cadherin antibody (Zymed, 33-3900) was used in western blot on mouse samples (fig 7). J Cell Mol Med (2009) ncbi
mouse monoclonal (3B9) 33-3900	western blot; human; fig 3	In order to examine the effects of connexin-43 expression in breast cancer cells, Invitrogen N-cadherin antibody (Zymed, 33-3900) was used in western blot on human samples (fig 3). Clin Exp Metastasis (2008) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; human; 1:50; fig 3b western blot; human; 1:250; fig 5b	In order to assess if E- and N-cadherin expression has diagnostic value for intrahepatic cholangiocarcinoma, Invitrogen N-cadherin antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 3b) and in western blot on human samples at 1:250 (fig 5b). Mod Pathol (2009) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; human; 1:200	In order to measure Twist and E- and N-cadherin expression in human primary bladder tumor from tobacco and non-tobacco users and evaluate their prognostic value, Invitrogen N-cadherin antibody (Zymed Laboratories, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:200. Urol Oncol (2009) ncbi
mouse monoclonal (3B9) 33-3900	western blot; human; fig 3c immunocytochemistry; mouse; fig 6	In order to examine cadherin expression in mouse fibroblast-like synoviocytes, Invitrogen N-cadherin antibody (Zymed, 3B9) was used in western blot on human samples (fig 3c) and in immunocytochemistry on mouse samples (fig 6). Arthritis Rheum (2008) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry; mouse; fig 3	In order to explore the relationship between N-cadherin and connexin43 in the heart, Invitrogen N-cadherin antibody (Zymed, 3B9) was used in immunohistochemistry on mouse samples (fig 3). J Mol Cell Cardiol (2008) ncbi
mouse monoclonal (3B9) 33-3900	immunocytochemistry; rat; fig 2	In order to examine the distribution of nectin-1 and afadin during hippocampal synapse formation, Invitrogen N-cadherin antibody (Zymed, 3B9) was used in immunocytochemistry on rat samples (fig 2). J Comp Neurol (2008) ncbi
mouse monoclonal (3B9) 33-3900	western blot; human; fig 6	In order to find that basic fibroblast growth factor downregulates typical cadherin expression on the surface of human umbilical vein endothelial cells via FGF receptor 1 signaling, Invitrogen N-cadherin antibody (Zymed, 3B9) was used in western blot on human samples (fig 6). Exp Cell Res (2008) ncbi
mouse monoclonal (3B9) 33-3900	western blot; human; fig 10	In order to propose that a paucity of pericytes in the germinal matrix vasculature contributes to its propensity to hemorrhage, Invitrogen N-cadherin antibody (Zymed Laboratories, 33-3900) was used in western blot on human samples (fig 10). J Neurosci (2007) ncbi
mouse monoclonal (3B9) 33-3900	western blot; rat; 0.1 ug/ml	In order to test if aconitine affects connexin43 phosphorylation and intracellular calcium oscillation patterns in cultured ventricular myocytes of neonatal rats, Invitrogen N-cadherin antibody (Zymed, 33-3900) was used in western blot on rat samples at 0.1 ug/ml. Toxicol In Vitro (2007) ncbi
mouse monoclonal (3B9) 33-3900	western blot; mouse	In order to study epigenetic silencing and activation of the MOR gene, Invitrogen N-cadherin antibody (Zymed, 33-3900) was used in western blot on mouse samples . Mol Cell Biol (2007) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - frozen section; rat; 1:50	In order to determine the distribution pattern and physiological function of coxsackie and adenovirus receptor in the testis, Invitrogen N-cadherin antibody (Zymed Laboratories, 33-3900) was used in immunohistochemistry - frozen section on rat samples at 1:50. Exp Cell Res (2007) ncbi
mouse monoclonal (3B9) 33-3900	immunocytochemistry; mouse; 1:100; fig 2	In order to identify the membrane ruffle-targeting region of beta-catenin, Invitrogen N-cadherin antibody (Zymed, 33-3900) was used in immunocytochemistry on mouse samples at 1:100 (fig 2). J Biol Chem (2007) ncbi
mouse monoclonal (3B9) 33-3900	western blot; mouse; 1:1000	In order to examine the effects of mammary gland-specific deletion of Bin1 on initiation and progression of breast cancer in mice, Invitrogen N-cadherin antibody (Zymed, 3B9) was used in western blot on mouse samples at 1:1000. Cancer Res (2007) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry; mouse	In order to compare the eye defects of dyl and Foxe3 mutant mice, Invitrogen N-cadherin antibody (Zymed, 33-3900) was used in immunohistochemistry on mouse samples . Dev Biol (2007) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry; dogs; 1:25; fig 5	In order to investigate genes regulated by Snail, Slug, and E47 transcription factors, Invitrogen N-cadherin antibody (Zymed, 3B9) was used in immunohistochemistry on dogs samples at 1:25 (fig 5). Cancer Res (2006) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; human; 1:200	In order to discover if N-cadherin expression is associated with the bladder tumor progression, Invitrogen N-cadherin antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:200. Clin Cancer Res (2006) ncbi
mouse monoclonal (3B9) 33-3900	western blot; human; fig 6	In order to report that Notch1 signaling drives the vertical growth phase of primary melanoma, Invitrogen N-cadherin antibody (Zymed, 33-3900) was used in western blot on human samples (fig 6). Cancer Res (2006) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; rat; tbl 1 immunoprecipitation; rat; tbl 1 western blot; rat; tbl 1	In order to determine the role of soluble guanylate cyclase in junction restructuring of the seminiferous epithelium of rat testis, Invitrogen N-cadherin antibody (Invitrogen, 33-3900) was used in immunohistochemistry - paraffin section on rat samples (tbl 1), in immunoprecipitation on rat samples (tbl 1) and in western blot on rat samples (tbl 1). J Cell Physiol (2006) ncbi
mouse monoclonal (3B9) 33-3900	immunocytochemistry; mouse; fig 4 western blot; mouse; fig 1	In order to identify and characterize a novel classical cadherin adhesion system, Invitrogen N-cadherin antibody (Zymed, 3B9) was used in immunocytochemistry on mouse samples (fig 4) and in western blot on mouse samples (fig 1). J Cell Sci (2005) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry; human; fig 5 western blot; human; fig 4	In order to study the intrinsic molecular programs that determine tumor differentiation, Invitrogen N-cadherin antibody (Zymed Laboratories, 33-3900) was used in immunohistochemistry on human samples (fig 5) and in western blot on human samples (fig 4). J Pathol (2005) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; human	In order to compare clinicopathological characteristics and immunohistochemical profiles of simultaneous bilateral breast cancer and corresponding lymph node metastases, Invitrogen N-cadherin antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on human samples . Histol Histopathol (2005) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - frozen section; rat; 1:100; tbl 1	In order to test if TGF-beta3 regulates anchoring junction dynamics in the blood-testis barrier, Invitrogen N-cadherin antibody (Zymed, 33-3900) was used in immunohistochemistry - frozen section on rat samples at 1:100 (tbl 1). Dev Biol (2005) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - frozen section; rat; 1:100; tbl 1	In order to study regulation of the blood-testis barrier, Invitrogen N-cadherin antibody (Zymed, 33-3900) was used in immunohistochemistry - frozen section on rat samples at 1:100 (tbl 1). J Cell Physiol (2005) ncbi
mouse monoclonal (13A9) MA1-159	immunohistochemistry - paraffin section; mouse	In order to investigate the effect of N-cadherin misexpression in mice, Invitrogen N-cadherin antibody (Zymed, 13A9) was used in immunohistochemistry - paraffin section on mouse samples . J Cell Biochem (2005) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; mouse	In order to investigate the effect of N-cadherin misexpression in mice, Invitrogen N-cadherin antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on mouse samples . J Cell Biochem (2005) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; human; 1:200; tbl 1	In order to measure the E- and N-cadherin and beta- and alpha-catenin expression in benign and malignant epithelial neoplasms of the ovary and correlate expression with tumor staging, histological grade, and presence of metastases during evolution, Invitrogen N-cadherin antibody (ZYMED, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 1). Gynecol Oncol (2004) ncbi
mouse monoclonal (3B9) 33-3900	western blot; human; fig 4	In order to test if carcinoma cells form gap junctions with bone cells and assess the function of this interaction, Invitrogen N-cadherin antibody (Zymed, 33-3900) was used in western blot on human samples (fig 4). Int J Cancer (2004) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry; human; 1:125; tbl 2	In order to report on a case of pilomatrix carcinoma with lymph node metastases, Invitrogen N-cadherin antibody (ZYMED, 3B9) was used in immunohistochemistry on human samples at 1:125 (tbl 2). J Cutan Pathol (2004) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; rat; 1:100; fig 6	In order to investigate zyxin, axin, and Wiskott-Aldrich syndrome protein in the seminiferous epithelium, Invitrogen N-cadherin antibody (Zymed, 33-3900) was used in immunohistochemistry - paraffin section on rat samples at 1:100 (fig 6). J Androl (2004) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; human; tbl 1	In order to present three cases of primary peritoneal malignant mixed mullerian tumors, Invitrogen N-cadherin antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on human samples (tbl 1). Int J Gynecol Cancer (2003) ncbi
mouse monoclonal (3B9) 33-3900	western blot; rat	In order to investigate the beta1-integrin/laminin gamma3 complex, MMP-2, MT1-MMP and TIMP-2 at the apical ectoplasmic specialization, Invitrogen N-cadherin antibody (Zymed, 33-3900) was used in western blot on rat samples . Biol Reprod (2004) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry; human; 1:20; fig 3	In order to study expression of E- and N-cadherin in mesotheliomas and adenocarcinomas, Invitrogen N-cadherin antibody (Zymed, 3B9) was used in immunohistochemistry on human samples at 1:20 (fig 3). Hum Pathol (2003) ncbi
mouse monoclonal (3B9) 33-3900	immunocytochemistry; mouse; 1:100	In order to test if N-cadherin is required for normal myocyte structure and function, Invitrogen N-cadherin antibody (Zymed, 3B9) was used in immunocytochemistry on mouse samples at 1:100. J Cell Sci (2003) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - frozen section; rat	In order to show that the cadherin/catenin complex is present between Sertoli and germ cells and is used for the assembly of functional adheren junctions, Invitrogen N-cadherin antibody (Zymed, 33-3900,) was used in immunohistochemistry - frozen section on rat samples . Biol Reprod (2003) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; human; 1:400; fig 1	In order to investigate the relationship between primary mucoepidermoid carcinoma of the thyroid and papillary thyroid carcinoma, Invitrogen N-cadherin antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 1). Virchows Arch (2002) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; mouse; 1:100; fig 2 western blot; mouse; 1:1000; fig 1	In order to explore the effect of cadherin specificity on cardiac structure and function, Invitrogen N-cadherin antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 2) and in western blot on mouse samples at 1:1000 (fig 1). J Cell Sci (2002) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; human; 1:400; tbl 2	In order to investigate the expression of E-, N-, and P-cadherin in ductal carcinoma in situ of the breast, Invitrogen N-cadherin antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:400 (tbl 2). Virchows Arch (2002) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; human; 1:200	In order to examine epithelial-type cadherin and neural-type cadherin as diagnostic markers of malignant noncarcinomatous neoplasms, Invitrogen N-cadherin antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:200. Arch Pathol Lab Med (2002) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; human; tbl 1	In order to discuss using expression of cadherins and catenins as prognosis markers for cancer, Invitrogen N-cadherin antibody (Zymed, clone 3B9) was used in immunohistochemistry - paraffin section on human samples (tbl 1). J Mammary Gland Biol Neoplasia (2001) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry; human; 1:400; fig 1	In order to describe the clinicopathological features of papillary thyroid carcinoma, Invitrogen N-cadherin antibody (Zymed, clone 3B9) was used in immunohistochemistry on human samples at 1:400 (fig 1). J Pathol (2001) ncbi
mouse monoclonal (3B9) 33-3900	western blot; human	In order to examine adhesion- versus a beta-catenin signaling-dependent mechanisms of E-cadherin tumor suppressor activity, Invitrogen N-cadherin antibody (Zymed, 3B9) was used in western blot on human samples . J Cell Biol (2001) ncbi
mouse monoclonal (3B9) 33-3900	immunoprecipitation; human western blot; human	In order to assess the functional significance of N-cadherin in melanoma cells, Invitrogen N-cadherin antibody (Zymed, 33-3900) was used in immunoprecipitation on human samples and in western blot on human samples . Cancer Res (2001) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; mouse; 1:100	In order to investigate the role of N-cadherin in cardiogenesis, Invitrogen N-cadherin antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on mouse samples at 1:100. Development (2001) ncbi
mouse monoclonal (3B9) 33-3900	immunohistochemistry - paraffin section; mouse; 1:500	In order to study lens development in Pax6(Sey)(-1Neu)/+ mouse embryos, Invitrogen N-cadherin antibody (Zymed, 33-3900) was used in immunohistochemistry - paraffin section on mouse samples at 1:500. Development (2000) ncbi
mouse monoclonal (13A9) MA1-159	immunohistochemistry - paraffin section; human; fig 3	In order to discuss the role of cadherins in tumor development, Invitrogen N-cadherin antibody (Zymed, 13A9 and 3B9) was used in immunohistochemistry - paraffin section on human samples (fig 3). Cancer (1999) ncbi

Abcam

domestic rabbit monoclonal (EPR1791-4) ab76011	western blot; human; loading ...; fig 5b	Abcam N-cadherin antibody (Abcam, ab76011) was used in western blot on human samples (fig 5b). Int J Mol Sci (2022) ncbi
domestic rabbit monoclonal (EPR1791-4) ab76011	western blot; human; loading ...; fig 5i western blot; mouse; loading ...; fig 5j	Abcam N-cadherin antibody (Abcam, ab76011) was used in western blot on human samples (fig 5i) and in western blot on mouse samples (fig 5j). Cell Death Dis (2022) ncbi
domestic rabbit monoclonal (EPR1791-4) ab76011	immunocytochemistry; mouse; 1:200; fig s4	Abcam N-cadherin antibody (Abcam, ab76011) was used in immunocytochemistry on mouse samples at 1:200 (fig s4). iScience (2022) ncbi
domestic rabbit polyclonal ab18203	immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig e5a	Abcam N-cadherin antibody (Abcam, ab18203) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig e5a). Nat Immunol (2022) ncbi
domestic rabbit monoclonal (EPR1791-4) ab76011	western blot; human; loading ...; fig 6f	Abcam N-cadherin antibody (Abcam, ab76011) was used in western blot on human samples (fig 6f). J Cancer (2021) ncbi
domestic rabbit polyclonal ab18203	western blot; rat; 1:1000; loading ...; fig 2a	Abcam N-cadherin antibody (Abcam, ab18203) was used in western blot on rat samples at 1:1000 (fig 2a). Open Life Sci (2021) ncbi
domestic rabbit polyclonal ab18203	western blot; mouse; 1:1000; loading ...; fig 3c	Abcam N-cadherin antibody (Abcam, ab18203) was used in western blot on mouse samples at 1:1000 (fig 3c). Oncol Lett (2021) ncbi
domestic rabbit polyclonal ab18203	western blot; human; 1:1000; loading ...; fig 2c	Abcam N-cadherin antibody (Abcam, ab18203) was used in western blot on human samples at 1:1000 (fig 2c). Cancer Cell Int (2021) ncbi
domestic rabbit polyclonal ab18203	immunohistochemistry - paraffin section; mouse; 1:400; loading ...; fig 5d western blot; human; 1:500; fig 3i	Abcam N-cadherin antibody (Abcam, ab18203) was used in immunohistochemistry - paraffin section on mouse samples at 1:400 (fig 5d) and in western blot on human samples at 1:500 (fig 3i). elife (2021) ncbi
domestic rabbit polyclonal ab76057	immunohistochemistry; human; loading ...; fig 2k western blot; human; loading ...; fig 2g, 3g	Abcam N-cadherin antibody (Abcam, ab76057) was used in immunohistochemistry on human samples (fig 2k) and in western blot on human samples (fig 2g, 3g). Cell Death Dis (2021) ncbi
mouse monoclonal (5D5) ab98952	western blot; human; 1:1000; loading ...; fig 2b	Abcam N-cadherin antibody (abcam, ab98952) was used in western blot on human samples at 1:1000 (fig 2b). Cell Death Dis (2021) ncbi
domestic rabbit polyclonal ab18203	western blot; human; 1:1000; loading ...; fig 2e	Abcam N-cadherin antibody (Abcam, ab18203) was used in western blot on human samples at 1:1000 (fig 2e). Aging (Albany NY) (2021) ncbi
domestic rabbit polyclonal ab18203	western blot; human; loading ...; fig 2	Abcam N-cadherin antibody (abcam, ab18203) was used in western blot on human samples (fig 2). Front Cell Dev Biol (2021) ncbi
domestic rabbit polyclonal ab18203	immunocytochemistry; human; 1:400; loading ...	Abcam N-cadherin antibody (Abcam, ab18203) was used in immunocytochemistry on human samples at 1:400. Cells (2021) ncbi
domestic rabbit polyclonal ab76057	western blot; mouse; 1:1000; loading ...; fig s6b	Abcam N-cadherin antibody (Abcam, ab76057) was used in western blot on mouse samples at 1:1000 (fig s6b). Nat Commun (2021) ncbi
domestic rabbit polyclonal ab18203	immunocytochemistry; mouse; fig s4a western blot; mouse; fig s4c	Abcam N-cadherin antibody (Abcam, ab18203) was used in immunocytochemistry on mouse samples (fig s4a) and in western blot on mouse samples (fig s4c). Mol Metab (2021) ncbi
domestic rabbit monoclonal (EPR1791-4) ab76011	western blot; human; loading ...; fig s4a	Abcam N-cadherin antibody (Abcam, ab76011) was used in western blot on human samples (fig s4a). Cell Death Differ (2021) ncbi
mouse monoclonal (5D5) ab98952	immunocytochemistry; human; 1:200; loading ...; fig 3e	Abcam N-cadherin antibody (Abcam, ab98952) was used in immunocytochemistry on human samples at 1:200 (fig 3e). PLoS ONE (2020) ncbi
domestic rabbit polyclonal ab18203	western blot; human; 1:250; loading ...; fig 5d	Abcam N-cadherin antibody (Abcam, ab18203) was used in western blot on human samples at 1:250 (fig 5d). Cancer Res Treat (2021) ncbi
domestic rabbit polyclonal ab18203	western blot; human; 1:1000; loading ...; fig 5a	Abcam N-cadherin antibody (Abcam, ab18203) was used in western blot on human samples at 1:1000 (fig 5a). Int J Mol Med (2020) ncbi
domestic rabbit polyclonal ab18203	immunocytochemistry; domestic rabbit; 1:100; loading ...; fig 7c	Abcam N-cadherin antibody (Abcam, ab18203) was used in immunocytochemistry on domestic rabbit samples at 1:100 (fig 7c). Invest Ophthalmol Vis Sci (2020) ncbi
domestic rabbit monoclonal (EPR1791-4) ab76011	western blot; mouse; 1:5000; loading ...; fig 4a	Abcam N-cadherin antibody (Abcam, ab76011) was used in western blot on mouse samples at 1:5000 (fig 4a). Front Immunol (2020) ncbi
domestic rabbit monoclonal (EPR1791-4) ab76011	western blot; human; 1:400; loading ...; fig 4a	Abcam N-cadherin antibody (Abcam, ab76011) was used in western blot on human samples at 1:400 (fig 4a). Cancer Manag Res (2020) ncbi
domestic rabbit polyclonal ab18203	immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig 8a	Abcam N-cadherin antibody (Abcam, ab18203) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 8a). elife (2020) ncbi
domestic rabbit polyclonal ab18203	western blot; human; 1:1000; loading ...; fig 2h	Abcam N-cadherin antibody (Abcam, ab18203) was used in western blot on human samples at 1:1000 (fig 2h). Aging (Albany NY) (2020) ncbi
domestic rabbit monoclonal ab202030	western blot; human; loading ...; fig 1g	Abcam N-cadherin antibody (Abcam, ab202030) was used in western blot on human samples (fig 1g). BMC Cancer (2020) ncbi
domestic rabbit polyclonal ab76057	western blot; human; 1:1000; loading ...; fig 1e, 3b, 4d	Abcam N-cadherin antibody (Abcam, ab76057) was used in western blot on human samples at 1:1000 (fig 1e, 3b, 4d). Sci Rep (2020) ncbi
domestic rabbit polyclonal ab18203	western blot; human; 1:500; loading ...; fig 3e	Abcam N-cadherin antibody (Abcam, ab18203) was used in western blot on human samples at 1:500 (fig 3e). Front Oncol (2020) ncbi
domestic rabbit polyclonal ab18203	western blot; human; 1:1000; loading ...; fig 3d	Abcam N-cadherin antibody (Abcam, ab18203) was used in western blot on human samples at 1:1000 (fig 3d). Cancer Cell Int (2020) ncbi
domestic rabbit polyclonal ab76057	western blot; human; 1:1000; loading ...; fig 1f,	Abcam N-cadherin antibody (Abcam, Cambridge, England, ab76057) was used in western blot on human samples at 1:1000 (fig 1f, ). Integr Cancer Ther (2020) ncbi
domestic rabbit polyclonal ab18203	immunocytochemistry; human; loading ...; fig 8c	Abcam N-cadherin antibody (Abcam, Ab18203) was used in immunocytochemistry on human samples (fig 8c). Aging (Albany NY) (2020) ncbi
domestic rabbit monoclonal ab202030	western blot; human; 1:1000; loading ...; fig 3a	Abcam N-cadherin antibody (Abcam, ab202030) was used in western blot on human samples at 1:1000 (fig 3a). Biosci Rep (2020) ncbi
domestic rabbit polyclonal ab18203	western blot; human; 1:1000; loading ...; fig 7a, 7b	Abcam N-cadherin antibody (Abcam, ab18203) was used in western blot on human samples at 1:1000 (fig 7a, 7b). Oncol Rep (2020) ncbi
domestic rabbit polyclonal ab18203	western blot; human; 1:5000; loading ...; fig 8d	Abcam N-cadherin antibody (Abcam, ab18203) was used in western blot on human samples at 1:5000 (fig 8d). Aging (Albany NY) (2020) ncbi
domestic rabbit polyclonal ab18203	immunocytochemistry; human; loading ...; fig 1b, 7a western blot; human; loading ...; fig 1a	Abcam N-cadherin antibody (Abcam, ab18203) was used in immunocytochemistry on human samples (fig 1b, 7a) and in western blot on human samples (fig 1a). Nat Commun (2020) ncbi
domestic rabbit polyclonal ab76057	immunohistochemistry knockout validation; mouse; 1:1000; loading ...; fig s3b	Abcam N-cadherin antibody (Abcam, ab76057) was used in immunohistochemistry knockout validation on mouse samples at 1:1000 (fig s3b). Cells (2019) ncbi
domestic rabbit polyclonal ab18203	western blot; human; 1:500; loading ...; fig 6b, 6d	Abcam N-cadherin antibody (Abcam, ab18203) was used in western blot on human samples at 1:500 (fig 6b, 6d). Eur Rev Med Pharmacol Sci (2019) ncbi
domestic rabbit monoclonal ab202030	western blot; human; loading ...; fig s1d	Abcam N-cadherin antibody (Abcam, ab202030) was used in western blot on human samples (fig s1d). BMC Cancer (2019) ncbi
domestic rabbit polyclonal ab18203	western blot; human; fig 6b	Abcam N-cadherin antibody (Abcam, ab18203) was used in western blot on human samples (fig 6b). Sci Rep (2019) ncbi
domestic rabbit polyclonal ab18203	immunocytochemistry; human; 5 ug/ml; loading ...; fig 6a	Abcam N-cadherin antibody (Abcam, ab18203) was used in immunocytochemistry on human samples at 5 ug/ml (fig 6a). Cancer Cell Int (2019) ncbi
mouse monoclonal (5D5) ab98952	western blot; human; 1:1000; loading ...; fig 3b	Abcam N-cadherin antibody (Abcam, ab98952) was used in western blot on human samples at 1:1000 (fig 3b). Cancer Cell Int (2019) ncbi
domestic rabbit polyclonal ab76057	western blot; human; loading ...; fig 3c	Abcam N-cadherin antibody (Abcam, ab76057) was used in western blot on human samples (fig 3c). J Exp Clin Cancer Res (2018) ncbi
domestic rabbit polyclonal ab18203	immunocytochemistry; human; 1:400; fig 2c	Abcam N-cadherin antibody (Abcam, Ab18203) was used in immunocytochemistry on human samples at 1:400 (fig 2c). PLoS ONE (2018) ncbi
domestic rabbit polyclonal ab18203	western blot; pigs ; 1:1000; fig 2b	Abcam N-cadherin antibody (Abcam, ab18203) was used in western blot on pigs samples at 1:1000 (fig 2b). Biosci Rep (2017) ncbi
domestic rabbit polyclonal ab76057	immunocytochemistry; human; loading ...; fig 4b western blot; human; loading ...; fig 4a	Abcam N-cadherin antibody (Abcam, ab76057) was used in immunocytochemistry on human samples (fig 4b) and in western blot on human samples (fig 4a). PLoS ONE (2017) ncbi
domestic rabbit polyclonal ab18203	western blot; human; 1:250; loading ...; fig 1e	Abcam N-cadherin antibody (Abcam, ab18203) was used in western blot on human samples at 1:250 (fig 1e). Int J Mol Med (2017) ncbi
domestic rabbit polyclonal ab76057	western blot; mouse; 1:1000; fig 6d	Abcam N-cadherin antibody (Abcam, ab76057) was used in western blot on mouse samples at 1:1000 (fig 6d). J Cell Biol (2017) ncbi
domestic rabbit polyclonal ab18203	western blot; human; loading ...; fig 1h	Abcam N-cadherin antibody (Abcam, ab18203) was used in western blot on human samples (fig 1h). Biochem Biophys Res Commun (2016) ncbi
domestic rabbit polyclonal ab76057	immunocytochemistry; rat; loading ...; fig 1a	In order to visualize the interaction of claudin, ZO-1 and actin in epithelial tight juntions., Abcam N-cadherin antibody (Abcam, Ab76057) was used in immunocytochemistry on rat samples (fig 1a). Mol Biol Cell (2017) ncbi
domestic rabbit monoclonal (EPR1791-4) ab76011	western blot; human; loading ...; fig 4a	Abcam N-cadherin antibody (Abcam, ab76011) was used in western blot on human samples (fig 4a). Oncotarget (2016) ncbi
domestic rabbit polyclonal ab76057	western blot; mouse; loading ...; fig 4b immunohistochemistry; human; loading ...; fig 1e western blot; human; loading ...; fig 2h	Abcam N-cadherin antibody (Abcam, ab76057) was used in western blot on mouse samples (fig 4b), in immunohistochemistry on human samples (fig 1e) and in western blot on human samples (fig 2h). Oncotarget (2016) ncbi
domestic rabbit polyclonal ab76057	immunocytochemistry; mouse; 1:50; fig 3	In order to describe a new technique based on resin-embedded multicycle imaging to study proteins in-situ, Abcam N-cadherin antibody (Abcam, ab76057) was used in immunocytochemistry on mouse samples at 1:50 (fig 3). Sci Rep (2016) ncbi
domestic rabbit polyclonal ab18203	western blot; human; 1:1000; loading ...; fig 3a	Abcam N-cadherin antibody (Abcam, ab18203) was used in western blot on human samples at 1:1000 (fig 3a). Oncol Lett (2016) ncbi
mouse monoclonal (5D5) ab98952	immunohistochemistry - paraffin section; human; fig s1	Abcam N-cadherin antibody (abcam, ab98952) was used in immunohistochemistry - paraffin section on human samples (fig s1). Sci Rep (2016) ncbi
mouse monoclonal (5D5) ab98952	immunohistochemistry; mouse; 1:200; fig 1	Abcam N-cadherin antibody (Abcam, ab98952) was used in immunohistochemistry on mouse samples at 1:200 (fig 1). PLoS ONE (2016) ncbi
domestic rabbit polyclonal ab18203	immunohistochemistry - paraffin section; mouse; 1:50; fig 5 western blot; mouse; fig 5	In order to characterize the association with pancreatic islet redistribution of cell adhesion molecules (CAMS) and reduced insulin secretion function in diabetic mice after prolonged high-fat diet, Abcam N-cadherin antibody (Abcam, ab18203) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 5) and in western blot on mouse samples (fig 5). Histochem Cell Biol (2016) ncbi
domestic rabbit polyclonal ab18203	immunohistochemistry - paraffin section; mouse; 1:400; fig 2 western blot; mouse; 1:400; fig 2	In order to elucidate the favor of Smad-independent TGF-beta signaling that drives EMT in pancreatic ductal adenocarcinoma due to TAp73 loss, Abcam N-cadherin antibody (Abcam, Ab18203) was used in immunohistochemistry - paraffin section on mouse samples at 1:400 (fig 2) and in western blot on mouse samples at 1:400 (fig 2). Cell Death Differ (2016) ncbi
mouse monoclonal (5D5) ab98952	western blot; human; loading ...; fig 3d	Abcam N-cadherin antibody (Abcam, ab98952) was used in western blot on human samples (fig 3d). Sci Rep (2016) ncbi
domestic rabbit monoclonal (EPR1791-4) ab76011	western blot; human; 1:1000; fig 3	Abcam N-cadherin antibody (Epitomics, 2447-1) was used in western blot on human samples at 1:1000 (fig 3). Oncotarget (2016) ncbi
domestic rabbit polyclonal ab18203	western blot; human; fig 4	Abcam N-cadherin antibody (Abcam, ab18203) was used in western blot on human samples (fig 4). Oncogene (2016) ncbi
mouse monoclonal (5D5) ab98952	western blot; human; fig 3	Abcam N-cadherin antibody (Abcam, AB98952) was used in western blot on human samples (fig 3). Sci Rep (2015) ncbi
domestic rabbit monoclonal (EPR1791-4) ab76011	western blot; human; 1:500	Abcam N-cadherin antibody (Epitomics, 2447) was used in western blot on human samples at 1:500. Oncotarget (2014) ncbi
mouse monoclonal (5D5) ab98952	immunocytochemistry; human western blot; human; 1:1000	Abcam N-cadherin antibody (Abcam, ab98952) was used in immunocytochemistry on human samples and in western blot on human samples at 1:1000. BMC Cancer (2014) ncbi

Santa Cruz Biotechnology

mouse monoclonal sc-393933	immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 5c western blot; human; 1:1000; loading ...; fig 5f	Santa Cruz Biotechnology N-cadherin antibody (Santa Cruz, sc-393933) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 5c) and in western blot on human samples at 1:1000 (fig 5f). Front Oncol (2022) ncbi
mouse monoclonal (CH-19) sc-59876	immunohistochemistry; mouse; loading ...; fig 3a	Santa Cruz Biotechnology N-cadherin antibody (Santa Cruz, sc-59876) was used in immunohistochemistry on mouse samples (fig 3a). EMBO J (2021) ncbi
mouse monoclonal (13A9) sc-59987	western blot; human; 1:100; loading ...; fig 5a	Santa Cruz Biotechnology N-cadherin antibody (Santa Cruz Biotechnology, sc-59987) was used in western blot on human samples at 1:100 (fig 5a). Cancers (Basel) (2021) ncbi
mouse monoclonal (8C11) sc-53488	western blot; human; 1:500; loading ...; fig 3d, 3f	Santa Cruz Biotechnology N-cadherin antibody (Santa Cruz Biotechnology, sc-53488) was used in western blot on human samples at 1:500 (fig 3d, 3f). Am J Pathol (2021) ncbi
mouse monoclonal (13A9) sc-59987	western blot; human; 1:1000; loading ...; fig 5c	Santa Cruz Biotechnology N-cadherin antibody (Santa Cruz, sc-59987) was used in western blot on human samples at 1:1000 (fig 5c). Front Cell Dev Biol (2021) ncbi
mouse monoclonal (H-4) sc-271386	flow cytometry; human; loading ...; fig s3	Santa Cruz Biotechnology N-cadherin antibody (Santa Cruz, sc-271386) was used in flow cytometry on human samples (fig s3). Stem Cell Reports (2020) ncbi
mouse monoclonal (13A9) sc-59987	western blot; human; 1:500; loading ...; fig 1c	Santa Cruz Biotechnology N-cadherin antibody (Santa Cruz, 13A9) was used in western blot on human samples at 1:500 (fig 1c). Nat Commun (2019) ncbi
mouse monoclonal (CH-19) sc-59876	western blot; mouse; loading ...; fig 4a	Santa Cruz Biotechnology N-cadherin antibody (Santa Cruz, sc-59876) was used in western blot on mouse samples (fig 4a). J Clin Invest (2017) ncbi
mouse monoclonal sc-393933	western blot; human; 1:500; loading ...; fig 6a	Santa Cruz Biotechnology N-cadherin antibody (Santa Cruz, sc-393933) was used in western blot on human samples at 1:500 (fig 6a). Exp Ther Med (2017) ncbi
mouse monoclonal (8C11) sc-53488	immunocytochemistry; human; 1:1000; loading ...; fig 4B western blot; human; loading ...; fig 4A	Santa Cruz Biotechnology N-cadherin antibody (Santa Cruz, sc-53488) was used in immunocytochemistry on human samples at 1:1000 (fig 4B) and in western blot on human samples (fig 4A). Oncol Lett (2017) ncbi
mouse monoclonal (13A9) sc-59987	western blot; human; 1:200; loading ...; fig 5a	Santa Cruz Biotechnology N-cadherin antibody (Santa Cruz Biotechnology, Inc., sc-59987) was used in western blot on human samples at 1:200 (fig 5a). Mol Med Rep (2017) ncbi
mouse monoclonal (13A9) sc-59987	western blot; human; 1:200; loading ...; fig 1b	Santa Cruz Biotechnology N-cadherin antibody (Santa Cruz, sc-59987) was used in western blot on human samples at 1:200 (fig 1b). Cancer Sci (2017) ncbi
mouse monoclonal (H-4) sc-271386	immunocytochemistry; rat; 1:50; loading ...; fig 4	In order to propose using an integrated insert in a dynamic microfluidic platform for toxicological testing, Santa Cruz Biotechnology N-cadherin antibody (Santa Cruz, SC271386) was used in immunocytochemistry on rat samples at 1:50 (fig 4). J Appl Toxicol (2017) ncbi
mouse monoclonal (8C11) sc-53488	western blot; human; 1:1000; loading ...; fig 1d	Santa Cruz Biotechnology N-cadherin antibody (Santa Cruz Biotechnology, sc-53488) was used in western blot on human samples at 1:1000 (fig 1d). Oncotarget (2016) ncbi
mouse monoclonal (13A9) sc-59987	western blot; human; 1:1000; fig 3	Santa Cruz Biotechnology N-cadherin antibody (santa Cruz, sc-59987) was used in western blot on human samples at 1:1000 (fig 3). PLoS ONE (2016) ncbi
mouse monoclonal (H-4) sc-271386	immunocytochemistry; human; loading ...; fig 2b western blot; human; 1:100; loading ...; fig 2a	Santa Cruz Biotechnology N-cadherin antibody (SantaCruz, sc-271386) was used in immunocytochemistry on human samples (fig 2b) and in western blot on human samples at 1:100 (fig 2a). Oncotarget (2016) ncbi
mouse monoclonal sc-393933	western blot; human; 1:500; fig 4	Santa Cruz Biotechnology N-cadherin antibody (Santa Cruz, sc-393933) was used in western blot on human samples at 1:500 (fig 4). PLoS ONE (2016) ncbi
mouse monoclonal (8C11) sc-53488	western blot; human; fig 2	Santa Cruz Biotechnology N-cadherin antibody (Santa Cruz, sc-53488) was used in western blot on human samples (fig 2). Oncotarget (2016) ncbi
mouse monoclonal (H-4) sc-271386	western blot; human; loading ...; fig 2b	Santa Cruz Biotechnology N-cadherin antibody (SantaCruz, sc-271386) was used in western blot on human samples (fig 2b). Oncol Lett (2016) ncbi
mouse monoclonal sc-393933	western blot; human; 1:2000; loading ...; fig 1c	In order to study leukemia inhibitory factor, EMT, and STAT3-dependent miR-21 induction, Santa Cruz Biotechnology N-cadherin antibody (Santa Cruz, sc-393933) was used in western blot on human samples at 1:2000 (fig 1c). Oncotarget (2016) ncbi
mouse monoclonal (13A9) sc-59987	western blot; human; 1:1000; fig 3	Santa Cruz Biotechnology N-cadherin antibody (Santa Cruz Biotechnology, sc-59987) was used in western blot on human samples at 1:1000 (fig 3). Mol Med Rep (2015) ncbi
mouse monoclonal (D-4) sc-8424	western blot; human; fig 5	Santa Cruz Biotechnology N-cadherin antibody (Santa Cruz, sc-8424) was used in western blot on human samples (fig 5). Mar Drugs (2015) ncbi
mouse monoclonal (D-4) sc-8424	immunohistochemistry - paraffin section; human; fig 4c	Santa Cruz Biotechnology N-cadherin antibody (Santa Cruz, sc-8424) was used in immunohistochemistry - paraffin section on human samples (fig 4c). BMC Genomics (2015) ncbi
mouse monoclonal (H-4) sc-271386	western blot; mouse; 1:1000; fig s1	Santa Cruz Biotechnology N-cadherin antibody (Santa Cruz, sc-271386) was used in western blot on mouse samples at 1:1000 (fig s1). Front Cell Neurosci (2015) ncbi
mouse monoclonal (D-4) sc-8424	immunohistochemistry - paraffin section; human; 1:30	In order to describe a mouse model to study primitive neuroectodermal tumors, Santa Cruz Biotechnology N-cadherin antibody (Santa Cruz, sc-8424) was used in immunohistochemistry - paraffin section on human samples at 1:30. PLoS ONE (2015) ncbi
mouse monoclonal (D-4) sc-8424	western blot; human; 1:1500	Santa Cruz Biotechnology N-cadherin antibody (Santa Cruz Biotech, sc-8424) was used in western blot on human samples at 1:1500. Biochem Biophys Res Commun (2015) ncbi
mouse monoclonal (D-4) sc-8424	immunocytochemistry; human	Santa Cruz Biotechnology N-cadherin antibody (Santa Cruz Biotechnology, 8424) was used in immunocytochemistry on human samples . Cancer Biol Ther (2015) ncbi
mouse monoclonal (D-4) sc-8424	western blot; human; fig 5	Santa Cruz Biotechnology N-cadherin antibody (Santa Cruz, SC-8424) was used in western blot on human samples (fig 5). Oncotarget (2015) ncbi
mouse monoclonal (CH-19) sc-59876	western blot; mouse; 1:4000; loading ...; fig 5c	Santa Cruz Biotechnology N-cadherin antibody (Santa Cruz Biotechnology, sc-59876) was used in western blot on mouse samples at 1:4000 (fig 5c). Nat Neurosci (2014) ncbi
mouse monoclonal (H-4) sc-271386	western blot; human	In order to investigate the role of lipolysis stimulated lipoprotein receptor in aggressive breast cancer behavior, Santa Cruz Biotechnology N-cadherin antibody (Santa Cruz Biotechnology, SC271386) was used in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (D-4) sc-8424	western blot; human; 1:200	In order to study the role of Frizzled-7 in keeping human limbal stem/progenitor cells in an undifferentiated state, Santa Cruz Biotechnology N-cadherin antibody (Santa Cruz Biotechnology, Sc-8424) was used in western blot on human samples at 1:200. Stem Cells (2014) ncbi
mouse monoclonal (13A9) sc-59987	immunocytochemistry; human; 1:100	In order to evaluate a cell culture system for long-term passaging of human pluripotent stem cells, Santa Cruz Biotechnology N-cadherin antibody (Santa Cruz Biotechnology, sc-59987) was used in immunocytochemistry on human samples at 1:100. J Neurosci Res (2013) ncbi

BioLegend

mouse monoclonal (8C11) 350816 350810 350809 350806 350802 350805	flow cytometry; human; fig 3a	BioLegend N-cadherin antibody (BioLegend, 8C11) was used in flow cytometry on human samples (fig 3a). Sci Rep (2018) ncbi
mouse monoclonal (8C11) 350806	flow cytometry; human	BioLegend N-cadherin antibody (BioLegend, 350806) was used in flow cytometry on human samples . Oncol Rep (2015) ncbi
mouse monoclonal (8C11) 350805	flow cytometry; human; fig 5	In order to determine the differential regulation of the inflammatory phenotype of brain microvascular endothelial cells by pro-inflammatory TNFalpha and IL-1beta, BioLegend N-cadherin antibody (Biolegend, 350805) was used in flow cytometry on human samples (fig 5). J Neuroinflammation (2015) ncbi
mouse monoclonal (8C11) 350806 350802 350805	flow cytometry; human; fig 3	BioLegend N-cadherin antibody (Biolegend, 8C11) was used in flow cytometry on human samples (fig 3). PLoS ONE (2015) ncbi
mouse monoclonal (8C11) 350806 350805	flow cytometry; human; fig 4	In order to analyze cancer cell plasticity autonomous stimulation by human NKG2D lymphocyte receptor coexpressed with its ligands on cancer cells, BioLegend N-cadherin antibody (Biolegend, 8C11) was used in flow cytometry on human samples (fig 4). PLoS ONE (2014) ncbi

R&D Systems

domestic sheep polyclonal AF6426	immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 6d	R&D Systems N-cadherin antibody (R&D Systems, AF6426) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 6d). iScience (2022) ncbi
mouse monoclonal (691723) MAB13881	western blot; human; 1:1000; loading ...; fig 3h	R&D Systems N-cadherin antibody (R&D Systems, MAB13881) was used in western blot on human samples at 1:1000 (fig 3h). Commun Biol (2021) ncbi

Novus Biologicals

mouse monoclonal (13A9)

NBP1-48309

western blot; rat; loading ...; fig s1

Novus Biologicals N-cadherin antibody (Novus, NBP1-48309) was used in western blot on rat samples (fig s1). Front Neurol (2019) ncbi

Cell Signaling Technology

domestic rabbit monoclonal (D4R1H) 13116	western blot; mouse; 1:100; loading ...; fig 6g	Cell Signaling Technology N-cadherin antibody (CST, 13116) was used in western blot on mouse samples at 1:100 (fig 6g). Front Oncol (2022) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; loading ...; fig 2g, 8d	Cell Signaling Technology N-cadherin antibody (Cell Signaling, 13,116) was used in western blot on human samples (fig 2g, 8d). Bioengineered (2022) ncbi
domestic rabbit polyclonal 4061	western blot; human; 1:1000; loading ...; fig 6d	Cell Signaling Technology N-cadherin antibody (CST, 4061) was used in western blot on human samples at 1:1000 (fig 6d). Cell Death Dis (2022) ncbi
mouse monoclonal (RMdO 20) 2836	immunohistochemistry - paraffin section; mouse; loading ...; fig 2e	Cell Signaling Technology N-cadherin antibody (Cell Signaling, RMdO 20) was used in immunohistochemistry - paraffin section on mouse samples (fig 2e). Front Immunol (2021) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; loading ...; fig 4b	Cell Signaling Technology N-cadherin antibody (Cell Signaling, D4R1H) was used in western blot on human samples (fig 4b). Biology (Basel) (2021) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; loading ...; fig 6a, 6b	Cell Signaling Technology N-cadherin antibody (Cell Signaling Technology, 13116S) was used in western blot on human samples (fig 6a, 6b). Clin Transl Med (2021) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; 1:1000; loading ...; fig 2f	Cell Signaling Technology N-cadherin antibody (CST, 13116S) was used in western blot on human samples at 1:1000 (fig 2f). Int J Biol Sci (2021) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; 1:1000; loading ...; fig 4c, 4d	Cell Signaling Technology N-cadherin antibody (Cell Signaling, 13116) was used in western blot on human samples at 1:1000 (fig 4c, 4d). Acta Pharm Sin B (2021) ncbi
mouse monoclonal (13A9) 14215	western blot; human; loading ...; fig s3e	Cell Signaling Technology N-cadherin antibody (CST, 14215) was used in western blot on human samples (fig s3e). Adv Sci (Weinh) (2021) ncbi
domestic rabbit polyclonal 4061	western blot; human; loading ...; fig 6d	Cell Signaling Technology N-cadherin antibody (Cell Signaling Technology, 4061,) was used in western blot on human samples (fig 6d). J Exp Clin Cancer Res (2021) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; 1:1000; loading ...; fig 3e	Cell Signaling Technology N-cadherin antibody (Cell Signaling Technology, 13116) was used in western blot on human samples at 1:1000 (fig 3e). Oncogene (2021) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; 1:1000; loading ...; fig 2i	Cell Signaling Technology N-cadherin antibody (CST, 13116) was used in western blot on human samples at 1:1000 (fig 2i). Front Oncol (2021) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; 1:1000; loading ...; fig 1b	Cell Signaling Technology N-cadherin antibody (Cell Signaling, 13116) was used in western blot on human samples at 1:1000 (fig 1b). Biology (Basel) (2021) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; loading ...; fig 3e	Cell Signaling Technology N-cadherin antibody (CST (Cell Signaling Technology), 13116) was used in western blot on human samples (fig 3e). Front Cell Dev Biol (2021) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; loading ...; fig 4b	Cell Signaling Technology N-cadherin antibody (CST, 13116) was used in western blot on human samples (fig 4b). J Exp Clin Cancer Res (2021) ncbi
domestic rabbit monoclonal (D4R1H) 13116	immunohistochemistry - paraffin section; human; loading ...; fig 2l western blot; human; loading ...; fig 2k	Cell Signaling Technology N-cadherin antibody (Cell Signaling, 13116) was used in immunohistochemistry - paraffin section on human samples (fig 2l) and in western blot on human samples (fig 2k). Theranostics (2021) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; fig s3a	Cell Signaling Technology N-cadherin antibody (CST, 13116) was used in western blot on human samples (fig s3a). Oncogene (2021) ncbi
domestic rabbit polyclonal 4061	western blot; mouse; 1:3000; loading ...; fig 5	Cell Signaling Technology N-cadherin antibody (Cell Signaling, 4061) was used in western blot on mouse samples at 1:3000 (fig 5). J Immunother Cancer (2021) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; loading ...; fig s2f	Cell Signaling Technology N-cadherin antibody (Cell Signaling, 13116) was used in western blot on human samples (fig s2f). Mol Oncol (2021) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; loading ...; fig ev1c	Cell Signaling Technology N-cadherin antibody (Cell Signaling Technology, 13116) was used in western blot on human samples (fig ev1c). EMBO Mol Med (2021) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; loading ...; fig 3c	Cell Signaling Technology N-cadherin antibody (Cell Signaling, 13116) was used in western blot on human samples (fig 3c). J Cell Mol Med (2021) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; mouse; 1:1000; loading ...; fig 3f	Cell Signaling Technology N-cadherin antibody (Cell Signaling, 13116) was used in western blot on mouse samples at 1:1000 (fig 3f). Mol Cell Biol (2021) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; 1:1000; loading ...; fig 3a, 3b	Cell Signaling Technology N-cadherin antibody (Cell Signaling, 13116T) was used in western blot on human samples at 1:1000 (fig 3a, 3b). Oncol Rep (2021) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; loading ...; fig 4f	Cell Signaling Technology N-cadherin antibody (Cell Signaling, 13116) was used in western blot on human samples (fig 4f). Aging (Albany NY) (2021) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; 1:1000; loading ...; fig 3a	Cell Signaling Technology N-cadherin antibody (Cell Signaling, 13116) was used in western blot on human samples at 1:1000 (fig 3a). J Exp Clin Cancer Res (2021) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; 1:1000; loading ...; fig 3e	Cell Signaling Technology N-cadherin antibody (CST, 13116S) was used in western blot on human samples at 1:1000 (fig 3e). J Cancer (2021) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; 1:1000; loading ...	Cell Signaling Technology N-cadherin antibody (Cell Signaling Technology, 13116 s) was used in western blot on human samples at 1:1000. Cell Biosci (2020) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; loading ...; fig s1b	Cell Signaling Technology N-cadherin antibody (Cell Signaling, 13116) was used in western blot on human samples (fig s1b). Adv Sci (Weinh) (2020) ncbi
domestic rabbit monoclonal (D4R1H) 13116	immunocytochemistry; human; 1:200; loading ...; fig s1-3a	Cell Signaling Technology N-cadherin antibody (CST, 13116S) was used in immunocytochemistry on human samples at 1:200 (fig s1-3a). elife (2020) ncbi
domestic rabbit monoclonal (D4R1H) 13116	immunocytochemistry; human; 1:50; loading ...; fig 1g western blot; human; 1:1000; loading ...; fig 1h	Cell Signaling Technology N-cadherin antibody (Cell Signaling, 13116) was used in immunocytochemistry on human samples at 1:50 (fig 1g) and in western blot on human samples at 1:1000 (fig 1h). elife (2020) ncbi
domestic rabbit monoclonal (D4R1H) 13116	immunohistochemistry - paraffin section; human; 1:1000; loading ...; fig 3e	Cell Signaling Technology N-cadherin antibody (CST, 13116S) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 3e). Cancer Cell Int (2020) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; 1:500; loading ...; fig s1	Cell Signaling Technology N-cadherin antibody (CST, 13116) was used in western blot on human samples at 1:500 (fig s1). Cancers (Basel) (2020) ncbi
domestic rabbit monoclonal (D4R1H) 13116	immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 6e	Cell Signaling Technology N-cadherin antibody (Cell Signaling Technology, 13116) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 6e). Oncol Rep (2020) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; 1:1000; loading ...; fig 6a	Cell Signaling Technology N-cadherin antibody (Cell Signaling Technology, 13116) was used in western blot on human samples at 1:1000 (fig 6a). Cell Prolif (2020) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; 1:1000; loading ...; fig 3e	Cell Signaling Technology N-cadherin antibody (CST, 13116) was used in western blot on human samples at 1:1000 (fig 3e). Cancer Cell Int (2020) ncbi
domestic rabbit monoclonal (D4R1H) 13116	immunocytochemistry; human; 1:200; loading ...; fig 3h western blot; human; 1:1000; loading ...; fig 3g	Cell Signaling Technology N-cadherin antibody (CST, 13116S) was used in immunocytochemistry on human samples at 1:200 (fig 3h) and in western blot on human samples at 1:1000 (fig 3g). Signal Transduct Target Ther (2020) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; 1:500; loading ...; fig 2g	Cell Signaling Technology N-cadherin antibody (Cell Signaling Technology, 3116) was used in western blot on human samples at 1:500 (fig 2g). Oncogene (2020) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; loading ...; fig 5i	Cell Signaling Technology N-cadherin antibody (CST, 13116) was used in western blot on human samples (fig 5i). CNS Neurosci Ther (2020) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; 1:1000; loading ...; fig 2c	Cell Signaling Technology N-cadherin antibody (Cell Signaling, 13116) was used in western blot on human samples at 1:1000 (fig 2c). Biosci Rep (2020) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; 1:1000; loading ...; fig 3b, 3d	Cell Signaling Technology N-cadherin antibody (Cell Signaling, 13116) was used in western blot on human samples at 1:1000 (fig 3b, 3d). Cell Div (2020) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; loading ...; fig 2f, 2g	Cell Signaling Technology N-cadherin antibody (Cell Signaling, 13116) was used in western blot on human samples (fig 2f, 2g). Cell Death Dis (2020) ncbi
domestic rabbit monoclonal (D4R1H) 13116	immunohistochemistry - paraffin section; mouse; loading ...; fig 6a western blot; mouse; 1:500; loading ...; fig 2f	Cell Signaling Technology N-cadherin antibody (CST, D4R1H) was used in immunohistochemistry - paraffin section on mouse samples (fig 6a) and in western blot on mouse samples at 1:500 (fig 2f). Cancer Manag Res (2020) ncbi
domestic rabbit polyclonal 4061	western blot; human; loading ...; fig 8a	Cell Signaling Technology N-cadherin antibody (CST, 4061) was used in western blot on human samples (fig 8a). Aging (Albany NY) (2020) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; loading ...; fig 3c	Cell Signaling Technology N-cadherin antibody (CST, 13116) was used in western blot on human samples (fig 3c). Int J Biol Sci (2020) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; fig 3c	Cell Signaling Technology N-cadherin antibody (Cell signaling, 13116) was used in western blot on human samples (fig 3c). Oncogenesis (2020) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; loading ...; fig 7d	Cell Signaling Technology N-cadherin antibody (CST, 13116) was used in western blot on human samples (fig 7d). Am J Cancer Res (2020) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; loading ...; fig 3f	Cell Signaling Technology N-cadherin antibody (CST, 13116) was used in western blot on human samples (fig 3f). Int J Biol Sci (2020) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; loading ...; fig 2f	Cell Signaling Technology N-cadherin antibody (Cell Signaling Technology, 13116) was used in western blot on human samples (fig 2f). Aging (Albany NY) (2020) ncbi
mouse monoclonal (RMdO 20) 2836	immunohistochemistry; rat; 1:400; loading ...; fig 7c	Cell Signaling Technology N-cadherin antibody (CST, RMdo20) was used in immunohistochemistry on rat samples at 1:400 (fig 7c). Cell Prolif (2020) ncbi
mouse monoclonal (13A9) 14215	western blot; human; loading ...; fig 3b	Cell Signaling Technology N-cadherin antibody (CST, 13A9) was used in western blot on human samples (fig 3b). EBioMedicine (2020) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; 1:1000; loading ...; fig 2g immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig 2i	Cell Signaling Technology N-cadherin antibody (Cell Signaling Technology, D4R1H) was used in western blot on human samples at 1:1000 (fig 2g) and in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 2i). Front Oncol (2019) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; loading ...; fig 3i	Cell Signaling Technology N-cadherin antibody (Cell Signaling, 13116) was used in western blot on human samples (fig 3i). Mol Oncol (2020) ncbi
mouse monoclonal (13A9) 14215	western blot; human; 1:2000; fig 3b	Cell Signaling Technology N-cadherin antibody (Cell Signaling Technology, 14215) was used in western blot on human samples at 1:2000 (fig 3b). Int J Mol Med (2019) ncbi
mouse monoclonal (13A9) 14215	western blot; human; 1:1000; loading ...; fig 2f	Cell Signaling Technology N-cadherin antibody (CST, 14215) was used in western blot on human samples at 1:1000 (fig 2f). Biosci Rep (2019) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; loading ...; fig 4e	Cell Signaling Technology N-cadherin antibody (Cell Signaling Technology, 13116) was used in western blot on human samples (fig 4e). Oncogene (2020) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; loading ...; fig 2a	Cell Signaling Technology N-cadherin antibody (CST, 13116) was used in western blot on human samples (fig 2a). Cell Commun Signal (2019) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; loading ...; fig 2d	Cell Signaling Technology N-cadherin antibody (Cell Signaling, 13116) was used in western blot on human samples (fig 2d). Aging (Albany NY) (2019) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; loading ...; fig 3d	Cell Signaling Technology N-cadherin antibody (CST, 13116) was used in western blot on human samples (fig 3d). J Exp Clin Cancer Res (2019) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; 1:2000; loading ...; fig 3c	Cell Signaling Technology N-cadherin antibody (Cell Signaling Technology, 13116) was used in western blot on human samples at 1:2000 (fig 3c). Nature (2019) ncbi
domestic rabbit polyclonal 4061	western blot; human; loading ...; fig 2a	Cell Signaling Technology N-cadherin antibody (Cell Signaling Technology, 4061) was used in western blot on human samples (fig 2a). elife (2019) ncbi
mouse monoclonal (13A9) 14215	western blot; human; 1:1000; loading ...; fig 1b, 4d	Cell Signaling Technology N-cadherin antibody (Cell Signaling, 14215s) was used in western blot on human samples at 1:1000 (fig 1b, 4d). Nat Commun (2019) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; fig 5a	Cell Signaling Technology N-cadherin antibody (Cell Signaling Technology, D4R1H) was used in western blot on human samples (fig 5a). Biomed Res Int (2019) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; 1:1000; loading ...; fig 3a	Cell Signaling Technology N-cadherin antibody (Cell Signaling Technology, 13116) was used in western blot on human samples at 1:1000 (fig 3a). J Cell Mol Med (2019) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; 1:1000; loading ...; fig 2i	Cell Signaling Technology N-cadherin antibody (Cell Signaling Technologies, 13116S) was used in western blot on human samples at 1:1000 (fig 2i). J Biol Chem (2019) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; loading ...; fig 6b	Cell Signaling Technology N-cadherin antibody (Cell Signaling, D4R1H) was used in western blot on human samples (fig 6b). Mol Oncol (2019) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; loading ...; fig 1f western blot; mouse; loading ...; fig 5f	Cell Signaling Technology N-cadherin antibody (Cell Signaling Technology, 13116) was used in western blot on human samples (fig 1f) and in western blot on mouse samples (fig 5f). Cancer Lett (2019) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; 1:1000; loading ...; fig 3a	Cell Signaling Technology N-cadherin antibody (Cell Signaling, 13116) was used in western blot on human samples at 1:1000 (fig 3a). Biosci Rep (2018) ncbi
mouse monoclonal (RMdO 20) 2836	immunohistochemistry; rat; 1:200; loading ...; fig 3a western blot; rat; 1:1000; loading ...; fig 3e	Cell Signaling Technology N-cadherin antibody (Cell Signaling, 2836) was used in immunohistochemistry on rat samples at 1:200 (fig 3a) and in western blot on rat samples at 1:1000 (fig 3e). Sci Rep (2018) ncbi
domestic rabbit polyclonal 4061	other; human; loading ...; fig 4c	Cell Signaling Technology N-cadherin antibody (Cell Signaling, 4061) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; loading ...; fig 3b	Cell Signaling Technology N-cadherin antibody (Cell Signaling, 13116) was used in western blot on human samples (fig 3b). J Cell Mol Med (2018) ncbi
domestic rabbit monoclonal (D4R1H) 13116	immunohistochemistry - paraffin section; human; 1:100; fig 9d western blot; human; 1:1000; loading ...; fig 3a	Cell Signaling Technology N-cadherin antibody (Cell Signaling, 13116) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 9d) and in western blot on human samples at 1:1000 (fig 3a). Oncotarget (2017) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; 1:1000; fig 1c	In order to evaluate the regulation of Epstein-Barr virus-infected ARPE19 cell migration as a model of choroidal neovascularization, Cell Signaling Technology N-cadherin antibody (Cell Signaling Technology, 13116) was used in western blot on human samples at 1:1000 (fig 1c). Exp Ther Med (2017) ncbi
domestic rabbit polyclonal 4061	western blot; human; 1:500; loading ...; fig 4C	Cell Signaling Technology N-cadherin antibody (Cell Signaling, 4061S) was used in western blot on human samples at 1:500 (fig 4C). Oncol Lett (2017) ncbi
mouse monoclonal (RMdO 20) 2836	immunohistochemistry - paraffin section; rat; 1:200; loading ...; fig 1b	In order to identify FK506 as a potent therapeutic for inhibiting nerve injury and promoting nerve regeneration following diffuse axonal injury, Cell Signaling Technology N-cadherin antibody (Cell Signaling, 2836) was used in immunohistochemistry - paraffin section on rat samples at 1:200 (fig 1b). Mol Med Rep (2017) ncbi
domestic rabbit polyclonal 4061	western blot; mouse; 1:500; loading ...; fig s5b	In order to determine the impact of smooth muscle cell beta-catenin to vascular homeostasis and arterial injury, Cell Signaling Technology N-cadherin antibody (Cell signaling, 4061) was used in western blot on mouse samples at 1:500 (fig s5b). Arterioscler Thromb Vasc Biol (2017) ncbi
domestic rabbit polyclonal 4061	reverse phase protein lysate microarray; human; loading ...; fig st6	In order to characterize the molecular identity of uterine carcinosarcomas., Cell Signaling Technology N-cadherin antibody (CST, 4061) was used in reverse phase protein lysate microarray on human samples (fig st6). Cancer Cell (2017) ncbi
domestic rabbit polyclonal 4061	western blot; human; loading ...; fig 2c	In order to find RE1 silencing transcription factor regulates epithelial-mesenchymal transition and neuroendecrin cell stemness acquisition in hormone-refractory prostate cancer, Cell Signaling Technology N-cadherin antibody (Cell signaling, 4061) was used in western blot on human samples (fig 2c). Sci Rep (2017) ncbi
domestic rabbit monoclonal (D4R1H) 13116	flow cytometry; human; loading ...; fig S3a	Cell Signaling Technology N-cadherin antibody (Cell Signaling Technology, 13116) was used in flow cytometry on human samples (fig S3a). Neoplasia (2017) ncbi
mouse monoclonal (RMdO 20) 2836	immunohistochemistry; mouse; 1:400; loading ...; fig 1b	Cell Signaling Technology N-cadherin antibody (cell signalling, 2836) was used in immunohistochemistry on mouse samples at 1:400 (fig 1b). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (RMdO 20) 2836	immunohistochemistry - frozen section; mouse; 1:1000; loading ...; fig 5a	In order to find that complex 1 -deficient Ndufs4-/- mice present with acute vision loss around p30, and this vision loss is coincident with an 'inflammatory wave', Cell Signaling Technology N-cadherin antibody (Cell signaling, 2836) was used in immunohistochemistry - frozen section on mouse samples at 1:1000 (fig 5a). Brain Res (2017) ncbi
domestic rabbit polyclonal 4061	western blot; human; loading ...	In order to analyze the context specificity of signaling networks within a causal conceptual framework using reverse-phase protein array time-course assays and network analysis approaches, Cell Signaling Technology N-cadherin antibody (Cell Signaling Technology, 4061) was used in western blot on human samples . Cell Syst (2017) ncbi
domestic rabbit polyclonal 4061	western blot; human; 1:1000; loading ...; fig s3a	In order to elucidate how CELF1 governs the epithelial-to-mesenchymal transition, Cell Signaling Technology N-cadherin antibody (Cell Signaling, 4061) was used in western blot on human samples at 1:1000 (fig s3a). Nat Commun (2016) ncbi
domestic rabbit polyclonal 4061	western blot; human; loading ...; fig 1e	Cell Signaling Technology N-cadherin antibody (cell signalling, 4061S) was used in western blot on human samples (fig 1e). Oncotarget (2017) ncbi
domestic rabbit monoclonal (D4R1H) 13116	immunocytochemistry; human; 1:200; fig s3a	In order to study the regulation of ADAMTS6 and show that ADAMTS6 reduces heparan sulphate-rich interfaces, Cell Signaling Technology N-cadherin antibody (Cell signaling, 13116) was used in immunocytochemistry on human samples at 1:200 (fig s3a). Sci Rep (2016) ncbi
domestic rabbit monoclonal (D4R1H) 13116	immunohistochemistry; human; loading ...; fig 3b	Cell Signaling Technology N-cadherin antibody (Cell Signaling Technology, 13116) was used in immunohistochemistry on human samples (fig 3b). J Clin Invest (2016) ncbi
domestic rabbit monoclonal (D4R1H) 13116	immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 2e immunocytochemistry; human; 1:200; loading ...; fig 3f western blot; human; 1:1000; loading ...; fig 3d	Cell Signaling Technology N-cadherin antibody (Cell Signaling, 13116) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2e), in immunocytochemistry on human samples at 1:200 (fig 3f) and in western blot on human samples at 1:1000 (fig 3d). Oncotarget (2016) ncbi
domestic rabbit polyclonal 4061	western blot; human; 1:200; fig st1	In order to identify and characterize alterations in signal transduction that occur during the development Lapatinib resistance, Cell Signaling Technology N-cadherin antibody (Cell Signaling, 4061) was used in western blot on human samples at 1:200 (fig st1). Nat Commun (2016) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; loading ...; fig 2b	Cell Signaling Technology N-cadherin antibody (Cell Signaling Technology, 13116P) was used in western blot on human samples (fig 2b). J Biol Chem (2016) ncbi
mouse monoclonal (RMdO 20) 2836	immunohistochemistry; mouse; loading ...; fig st1	In order to develop a method for super-resolution imaging of the multiscale organization of intact tissues and use it to image the mouse brain, Cell Signaling Technology N-cadherin antibody (Cell Signalling, 2836) was used in immunohistochemistry on mouse samples (fig st1). Nat Biotechnol (2016) ncbi
mouse monoclonal (13A9) 14215	western blot; human; loading ...; fig 1a	In order to determine the effects of histone deacetylase inhibitors on the epithelial-mesenchymal transition and the extracellular matrix, Cell Signaling Technology N-cadherin antibody (Cell Signaling, 14215) was used in western blot on human samples (fig 1a). J Cell Mol Med (2016) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; 1:1000; loading ...; fig 4a	Cell Signaling Technology N-cadherin antibody (Cell Signaling, 13116) was used in western blot on human samples at 1:1000 (fig 4a). Drug Des Devel Ther (2016) ncbi
domestic rabbit monoclonal (D4R1H) 13116	immunohistochemistry; human; fig 4	In order to study the human corneal endothelial cell via a 3D map, Cell Signaling Technology N-cadherin antibody (Cell Signaling, 13116) was used in immunohistochemistry on human samples (fig 4). Sci Rep (2016) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; loading ...; fig 4d	In order to elucidate how E-cadherin, tight junctions, and the epithelial-to-mesenchymal transition regulates hepatitis C virus entry, Cell Signaling Technology N-cadherin antibody (Cell Signaling, 13116) was used in western blot on human samples (fig 4d). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (13A9) 14215	western blot; human; loading ...; fig 3g	Cell Signaling Technology N-cadherin antibody (Cell Signaling Technology, 14215) was used in western blot on human samples (fig 3g). FEBS Open Bio (2016) ncbi
domestic rabbit polyclonal 4061	western blot; human; fig 3D	Cell Signaling Technology N-cadherin antibody (Cell Signaling, 4061) was used in western blot on human samples (fig 3D). Onco Targets Ther (2016) ncbi
domestic rabbit polyclonal 4061	western blot; human; fig 7a	In order to investigate the role of growth hormone in colon cancer, Cell Signaling Technology N-cadherin antibody (Cell Signaling, 4061) was used in western blot on human samples (fig 7a). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit polyclonal 4061	western blot; human; loading ...; fig 3b	In order to study the contribution of CCL7-induced epithelial-mesenchymal transition signaling to the progression and metastasis of colon cancer, Cell Signaling Technology N-cadherin antibody (Cell Signaling, 4061) was used in western blot on human samples (fig 3b). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; fig 6	Cell Signaling Technology N-cadherin antibody (Cell Signalling, 13116) was used in western blot on human samples (fig 6). Sci Rep (2016) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; 1:1000; fig 4	In order to characterize attenuation of triple negative breast cancer cells metastatic potential by the vitamin D analog, MART-10, Cell Signaling Technology N-cadherin antibody (Cell Signaling Technology, 13116) was used in western blot on human samples at 1:1000 (fig 4). Int J Mol Sci (2016) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; 1:1000; loading ...; fig 1a	Cell Signaling Technology N-cadherin antibody (Cell Signaling Technology, 13116) was used in western blot on human samples at 1:1000 (fig 1a). J Clin Invest (2016) ncbi
domestic rabbit monoclonal (D4R1H) 13116	immunohistochemistry - paraffin section; human; 1:125; fig 2	Cell Signaling Technology N-cadherin antibody (Cell signaling, 13116) was used in immunohistochemistry - paraffin section on human samples at 1:125 (fig 2). Endocrinology (2016) ncbi
mouse monoclonal (13A9) 14215	western blot; human; fig 4d	Cell Signaling Technology N-cadherin antibody (Cell signalling technology, 14215S) was used in western blot on human samples (fig 4d). Nucleic Acids Res (2016) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; mouse; fig 5	Cell Signaling Technology N-cadherin antibody (Cell Signaling, 13116) was used in western blot on mouse samples (fig 5). J Cell Mol Med (2016) ncbi
domestic rabbit polyclonal 4061	western blot; human; fig 3	Cell Signaling Technology N-cadherin antibody (Cell Signaling Tech, 4061) was used in western blot on human samples (fig 3). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; fig 6	Cell Signaling Technology N-cadherin antibody (Cell signaling, 13116) was used in western blot on human samples (fig 6). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; 1:1000; loading ...; fig 4h	Cell Signaling Technology N-cadherin antibody (Cell Signaling, 13116) was used in western blot on human samples at 1:1000 (fig 4h). Int J Oncol (2016) ncbi
domestic rabbit polyclonal 4061	western blot; mouse; fig 1d	In order to test if ZO-1-mediated diminution of polarity results in an epithelial-to-mesenchyme transition and increased metastatic potential, Cell Signaling Technology N-cadherin antibody (Cell Signaling, 4061) was used in western blot on mouse samples (fig 1d). Oncogene (2016) ncbi
domestic rabbit monoclonal (D4R1H) 13116	western blot; human; fig 7a	In order to demonstrate that LRIG1 functions as a growth suppressor in breast cancer cells, Cell Signaling Technology N-cadherin antibody (Cell Signaling Technology, 13116) was used in western blot on human samples (fig 7a). Oncogene (2016) ncbi
domestic rabbit polyclonal 4061	western blot; human; loading ...; fig 8	In order to report the effect of c-Met inhibition using neuroendocrine tumor cells, Cell Signaling Technology N-cadherin antibody (Cell Signaling, 4061) was used in western blot on human samples (fig 8). Neuroendocrinology (2016) ncbi

Dako

mouse monoclonal (6G11) M3613	immunohistochemistry - paraffin section; human; tbl 2	Dako N-cadherin antibody (DAKO, 6-G11) was used in immunohistochemistry - paraffin section on human samples (tbl 2). Cancers (Basel) (2019) ncbi
mouse monoclonal (6G11) M3613	immunohistochemistry - paraffin section; human; loading ...; fig 1c	Dako N-cadherin antibody (Dako, 6G11) was used in immunohistochemistry - paraffin section on human samples (fig 1c). BMC Cancer (2018) ncbi
mouse monoclonal (6G11) M3613	western blot; human; loading ...; fig 5b, 5e	In order to determine the effects of resveratrol treatment on the senescence-associated secretory phenotype, Dako N-cadherin antibody (Dako, 6G11) was used in western blot on human samples (fig 5b, 5e). J Gerontol A Biol Sci Med Sci (2017) ncbi
mouse monoclonal (6G11) M3613	immunohistochemistry - paraffin section; human; 1:25	Dako N-cadherin antibody (Dako, 6G11) was used in immunohistochemistry - paraffin section on human samples at 1:25. Res Vet Sci (2015) ncbi
mouse monoclonal (6G11) M3613	immunocytochemistry; human; 1:50	Dako N-cadherin antibody (Dako, M3613) was used in immunocytochemistry on human samples at 1:50. J Mol Endocrinol (2014) ncbi
mouse monoclonal (6G11) M3613	immunohistochemistry - paraffin section; human; 1:50	Dako N-cadherin antibody (Dako, M3613) was used in immunohistochemistry - paraffin section on human samples at 1:50. PLoS ONE (2012) ncbi

Bioworld

domestic rabbit polyclonal

BS2224

western blot; human; fig 1

Bioworld N-cadherin antibody (Bioworld Technology, BS-2224) was used in western blot on human samples (fig 1). Oncotarget (2016) ncbi

BD Biosciences

mouse monoclonal (32/N-Cadherin) 610920	western blot; human; 1:2000; loading ...; fig 4f	BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in western blot on human samples at 1:2000 (fig 4f). iScience (2022) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human; loading ...	BD Biosciences N-cadherin antibody (BD Bioscience, 610920) was used in western blot on human samples . Nat Commun (2022) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; mouse; loading ...; fig 1f, 4d	BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in western blot on mouse samples (fig 1f, 4d). Sci Adv (2022) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunohistochemistry; mouse; 1:100; fig 4k	BD Biosciences N-cadherin antibody (BD, 610920) was used in immunohistochemistry on mouse samples at 1:100 (fig 4k). Commun Biol (2022) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human; 1:100; fig 3e	BD Biosciences N-cadherin antibody (BD Bioscience, 610920) was used in western blot on human samples at 1:100 (fig 3e). Am J Cancer Res (2022) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunohistochemistry - frozen section; human; 1:500; fig 2j	BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in immunohistochemistry - frozen section on human samples at 1:500 (fig 2j). Nat Commun (2021) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human; loading ...; fig 1e	BD Biosciences N-cadherin antibody (BD Bioscience, 640920) was used in western blot on human samples (fig 1e). Cancers (Basel) (2021) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunohistochemistry - frozen section; mouse; 1:1000; loading ...; fig s1e immunocytochemistry; mouse; loading ...; fig 1c	BD Biosciences N-cadherin antibody (BD, 610920) was used in immunohistochemistry - frozen section on mouse samples at 1:1000 (fig s1e) and in immunocytochemistry on mouse samples (fig 1c). Front Cell Dev Biol (2021) ncbi
mouse monoclonal (32/N-Cadherin) 610921	western blot; human; fig 1d	BD Biosciences N-cadherin antibody (BD Biosciences, 610921) was used in western blot on human samples (fig 1d). Cancers (Basel) (2021) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human; 1:1000; loading ...; fig 2f	BD Biosciences N-cadherin antibody (BD Transduction Laboratories, 610920) was used in western blot on human samples at 1:1000 (fig 2f). Commun Biol (2021) ncbi
mouse monoclonal (32/N-Cadherin) 610921	immunohistochemistry; mouse; 1:250; loading ...; fig s3-1e	BD Biosciences N-cadherin antibody (BD Biosciences, 610921) was used in immunohistochemistry on mouse samples at 1:250 (fig s3-1e). elife (2021) ncbi
mouse monoclonal (32/N-Cadherin) 610921	western blot; human; 1:500; loading ...; fig 5a	BD Biosciences N-cadherin antibody (BD Biosciences, 610921) was used in western blot on human samples at 1:500 (fig 5a). Nat Commun (2021) ncbi
mouse monoclonal (32/N-Cadherin) 610921	western blot; human; 1:5000; loading ...; fig 5f	BD Biosciences N-cadherin antibody (BD, 610921) was used in western blot on human samples at 1:5000 (fig 5f). elife (2021) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunocytochemistry; mouse; 1:200; loading ...; fig 4a	BD Biosciences N-cadherin antibody (Transduction Laboratories, 610920) was used in immunocytochemistry on mouse samples at 1:200 (fig 4a). J Neurochem (2021) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunohistochemistry; human; loading ...; fig 3b	BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in immunohistochemistry on human samples (fig 3b). elife (2020) ncbi
mouse monoclonal (8C11) 561553	western blot; human; 1:1000; loading ...; fig 3h	BD Biosciences N-cadherin antibody (BD Biosciences, 561553) was used in western blot on human samples at 1:1000 (fig 3h). elife (2020) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human; 1:2500; loading ...; fig 5	BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in western blot on human samples at 1:2500 (fig 5). Oncol Lett (2020) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 3a	BD Biosciences N-cadherin antibody (BD bioscience, 610920) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 3a). elife (2020) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human; 1:500; loading ...; fig 1g	BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in western blot on human samples at 1:500 (fig 1g). Proc Natl Acad Sci U S A (2020) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunohistochemistry; mouse; loading ...; fig 2c	BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in immunohistochemistry on mouse samples (fig 2c). Cell Rep (2020) ncbi
mouse monoclonal (32/N-Cadherin) 610921 610920	western blot; mouse; 1:2000; loading ...; fig 5s1a	BD Biosciences N-cadherin antibody (BD Biosciences, 32) was used in western blot on mouse samples at 1:2000 (fig 5s1a). elife (2020) ncbi
mouse monoclonal (32/N-Cadherin) 610921 610920	immunocytochemistry; human; 1:250; loading ...; fig 4e	BD Biosciences N-cadherin antibody (BD Biosciences, clone 32) was used in immunocytochemistry on human samples at 1:250 (fig 4e). PLoS Biol (2019) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunohistochemistry; mouse; 1:100; fig 7h	BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in immunohistochemistry on mouse samples at 1:100 (fig 7h). Nat Commun (2019) ncbi
mouse monoclonal (32/N-Cadherin) 610921	immunohistochemistry; mouse; 1:150; loading ...; fig 4e	BD Biosciences N-cadherin antibody (BD Biosciences, 610921) was used in immunohistochemistry on mouse samples at 1:150 (fig 4e). elife (2019) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunocytochemistry; human; loading ...; fig 1e	BD Biosciences N-cadherin antibody (BD Bioscience, 610920) was used in immunocytochemistry on human samples (fig 1e). Cell Death Dis (2019) ncbi
mouse monoclonal (32/N-Cadherin) 610921	immunoprecipitation; human; 1:1000; loading ...; fig 7a	BD Biosciences N-cadherin antibody (BD, 610921) was used in immunoprecipitation on human samples at 1:1000 (fig 7a). Nat Commun (2019) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunohistochemistry - paraffin section; mouse; 1:300; loading ...; fig 6a western blot; mouse; 1:200; loading ...; fig 6c	BD Biosciences N-cadherin antibody (BD, 610920) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 6a) and in western blot on mouse samples at 1:200 (fig 6c). Biosci Rep (2019) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human; loading ...; fig 4d	BD Biosciences N-cadherin antibody (BD Transduction Laboratories, 610920) was used in western blot on human samples (fig 4d). Sci Rep (2018) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunohistochemistry - paraffin section; human; 1:150; loading ...; fig 7s2g	BD Biosciences N-cadherin antibody (BD Transduction Laboratories, 610920) was used in immunohistochemistry - paraffin section on human samples at 1:150 (fig 7s2g). elife (2018) ncbi
mouse monoclonal (32/N-Cadherin) 610921	western blot; human; 1:5000; loading ...; fig 1a	BD Biosciences N-cadherin antibody (BD Biosciences, 610921) was used in western blot on human samples at 1:5000 (fig 1a). Nat Commun (2018) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human; loading ...; fig 2b	BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in western blot on human samples (fig 2b). Cell Death Dis (2018) ncbi
mouse monoclonal (32/N-Cadherin) 610921	western blot; human; loading ...; fig 4e	BD Biosciences N-cadherin antibody (BD BioScience, 610921) was used in western blot on human samples (fig 4e). EMBO J (2018) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunohistochemistry; mouse; loading ...; fig 8a	BD Biosciences N-cadherin antibody (BD Biosciences, 610,920) was used in immunohistochemistry on mouse samples (fig 8a). Acta Neuropathol Commun (2017) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human; 1:2500; loading ...; fig 4a	BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in western blot on human samples at 1:2500 (fig 4a). Oncotarget (2017) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunohistochemistry - frozen section; rat; loading ...; fig 6c western blot; rat; loading ...; fig 6i	BD Biosciences N-cadherin antibody (Becton-Dickinson, 610920) was used in immunohistochemistry - frozen section on rat samples (fig 6c) and in western blot on rat samples (fig 6i). Development (2017) ncbi
mouse monoclonal (32/N-Cadherin) 610921	immunohistochemistry knockout validation; mouse; loading ...; fig 2a, 2b western blot knockout validation; mouse; loading ...; fig 2c	BD Biosciences N-cadherin antibody (BD, 610921) was used in immunohistochemistry knockout validation on mouse samples (fig 2a, 2b) and in western blot knockout validation on mouse samples (fig 2c). Dev Biol (2017) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; mouse; loading ...; fig 7b	BD Biosciences N-cadherin antibody (BD, 610920) was used in western blot on mouse samples (fig 7b). Cancer Res (2017) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunohistochemistry; mouse; 1:1000; loading ...; tbl 1	BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in immunohistochemistry on mouse samples at 1:1000 (tbl 1). J Comp Neurol (2017) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunocytochemistry; human; loading ...; fig 4c western blot; human; loading ...; fig 4a	In order to investigate Rac1 activity and inhibition in gastric adenocarcinoma cells and mouse xenograft models for epithelial-to-mesenchymal transition and cancer stem-like cell phenotypes, BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in immunocytochemistry on human samples (fig 4c) and in western blot on human samples (fig 4a). Mol Cancer Res (2017) ncbi
mouse monoclonal (8C11) 561553	immunocytochemistry; human; 2 ug/ml; loading ...; fig s1	In order to research the involvement of protein IQGAP1 in the regulation of actin networks, BD Biosciences N-cadherin antibody (BD Pharmigen, 561553) was used in immunocytochemistry on human samples at 2 ug/ml (fig s1). Biol Open (2017) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human; 1:1000; fig 5b	In order to elucidate the mechanism by which 15d-PGJ2 suppresses human thyroid carcinoma cell migration, BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in western blot on human samples at 1:1000 (fig 5b). Oncol Lett (2017) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human; loading ...; fig 4c	In order to investigate the role of CRB3 downregulation in maintaining breast cancer stem cells, BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in western blot on human samples (fig 4c). Oncogenesis (2017) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunocytochemistry; human; fig 2b	BD Biosciences N-cadherin antibody (BD Bioscience, 610920) was used in immunocytochemistry on human samples (fig 2b). Cell Stem Cell (2017) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunocytochemistry; human; 1:2000; fig 4b western blot; human; 1:2000; loading ...; fig 1b	BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in immunocytochemistry on human samples at 1:2000 (fig 4b) and in western blot on human samples at 1:2000 (fig 1b). Nat Commun (2016) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunohistochemistry - frozen section; mouse; 1:500; loading ...; fig 8a	BD Biosciences N-cadherin antibody (BD Transduction Labs, 610920) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig 8a). Neural Dev (2016) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; mouse; 1:1000; loading ...; fig 5a	In order to propose a role for KIDLIA in neurodevelopment and autism, BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in western blot on mouse samples at 1:1000 (fig 5a). Eneuro (2016) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunoprecipitation; mouse; loading ...; fig 5b immunocytochemistry; human; loading ...; fig s6i	In order to demonstrate that actin-binding protein filamin A interacts with actin-nucleating protein formin 2, BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in immunoprecipitation on mouse samples (fig 5b) and in immunocytochemistry on human samples (fig s6i). Development (2016) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunocytochemistry; human; fig 1b western blot; human; fig 1a	In order to determine the effects of high glucose on the epithelial-mesenchymal transition in retinal pigment epithelial cells, BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in immunocytochemistry on human samples (fig 1b) and in western blot on human samples (fig 1a). Int J Mol Med (2016) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; rat; 1:2000; fig 3b	BD Biosciences N-cadherin antibody (BD Bioscience, 610920) was used in western blot on rat samples at 1:2000 (fig 3b). PLoS ONE (2016) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; mouse; fig s2a western blot; human; loading ...; fig s2a	BD Biosciences N-cadherin antibody (BD-Transduction Laboratories, 610920) was used in western blot on mouse samples (fig s2a) and in western blot on human samples (fig s2a). J Clin Invest (2016) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human; loading ...; fig 4e	BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in western blot on human samples (fig 4e). Oncogenesis (2016) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunohistochemistry - paraffin section; mouse; 1:100; fig 3	In order to describe a role for ADAMTS9 in ocular morphogenesis, BD Biosciences N-cadherin antibody (BD Transduction Laboratories, 610920) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 3). Sci Rep (2016) ncbi
mouse monoclonal (32/N-Cadherin) 610921	immunocytochemistry; human; 1:25; fig 1 immunohistochemistry; human; 1:25; fig 7 western blot; human; 1:1000; fig 1	In order to investigate the contribution of DNA methyltransferase 1 to the epithelial-mesenchymal transition and cancer stem cells, BD Biosciences N-cadherin antibody (BD Biosciences, 610921) was used in immunocytochemistry on human samples at 1:25 (fig 1), in immunohistochemistry on human samples at 1:25 (fig 7) and in western blot on human samples at 1:1000 (fig 1). Neoplasia (2016) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunocytochemistry; dogs; fig 6d western blot; dogs; fig 6a western blot; human; fig 6a	In order to report that TrkC contributes to tumorigenicity, metastasis, and self-renewal traits of metastatic breast cancer, BD Biosciences N-cadherin antibody (BD Transduction, 610920) was used in immunocytochemistry on dogs samples (fig 6d), in western blot on dogs samples (fig 6a) and in western blot on human samples (fig 6a). Sci Rep (2016) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; mouse; loading ...; fig 2c western blot; human; loading ...; fig 3b, 4c	BD Biosciences N-cadherin antibody (BD BIOSCIENCES, 610920) was used in western blot on mouse samples (fig 2c) and in western blot on human samples (fig 3b, 4c). Oncotarget (2016) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunocytochemistry; human; loading ...; fig 5d western blot; human; loading ...; fig 5c immunohistochemistry - paraffin section; mouse; 1:100; fig 6c	BD Biosciences N-cadherin antibody (BD Transduction Laboratories, 610920) was used in immunocytochemistry on human samples (fig 5d), in western blot on human samples (fig 5c) and in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 6c). Oncotarget (2016) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunohistochemistry; mouse; loading ...; fig st1	In order to develop a method for super-resolution imaging of the multiscale organization of intact tissues and use it to image the mouse brain, BD Biosciences N-cadherin antibody (BD, 610920) was used in immunohistochemistry on mouse samples (fig st1). Nat Biotechnol (2016) ncbi
mouse monoclonal (32/N-Cadherin) 610921 610920	immunocytochemistry; human; fig 2a	BD Biosciences N-cadherin antibody (BD Biosciences, 32) was used in immunocytochemistry on human samples (fig 2a). BMC Cancer (2016) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunocytochemistry; human; 1:100; fig 1	BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in immunocytochemistry on human samples at 1:100 (fig 1). Nat Commun (2016) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunohistochemistry - paraffin section; mouse; fig 7	In order to use a blinded study to examine the effects of ANGPTL8 upon beta-cell proliferation, BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in immunohistochemistry - paraffin section on mouse samples (fig 7). PLoS ONE (2016) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunohistochemistry - paraffin section; mouse; fig 4 western blot; mouse; fig 6	In order to learn of the restriction in brain cell types and possible connection to autism by alphaT-catenin, BD Biosciences N-cadherin antibody (BD Transduction Laboratories, 610920) was used in immunohistochemistry - paraffin section on mouse samples (fig 4) and in western blot on mouse samples (fig 6). J Mol Psychiatry (2016) ncbi
mouse monoclonal (32/N-Cadherin) 610921	western blot; human; fig 4	BD Biosciences N-cadherin antibody (BD, 610921) was used in western blot on human samples (fig 4). Nat Commun (2016) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human; 1:10,000; fig 1	BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in western blot on human samples at 1:10,000 (fig 1). Schizophr Res (2016) ncbi
mouse monoclonal (32/N-Cadherin) 610921	immunocytochemistry; African green monkey; 1:200; fig 1 western blot; African green monkey; fig 6 western blot; human; fig 7	BD Biosciences N-cadherin antibody (BD Transduction Laboratories, 610921) was used in immunocytochemistry on African green monkey samples at 1:200 (fig 1), in western blot on African green monkey samples (fig 6) and in western blot on human samples (fig 7). Traffic (2016) ncbi
mouse monoclonal (32/N-Cadherin) 610921	western blot; human; 1:2000; fig 4	BD Biosciences N-cadherin antibody (BD, 610921) was used in western blot on human samples at 1:2000 (fig 4). PLoS ONE (2016) ncbi
mouse monoclonal (32/N-Cadherin) 610921	immunohistochemistry; mouse; 1:500; fig 5 western blot; mouse; fig 4a	BD Biosciences N-cadherin antibody (BD, 610921) was used in immunohistochemistry on mouse samples at 1:500 (fig 5) and in western blot on mouse samples (fig 4a). Invest Ophthalmol Vis Sci (2016) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunocytochemistry; mouse; 1:500; fig 2	BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in immunocytochemistry on mouse samples at 1:500 (fig 2). Stem Cell Reports (2016) ncbi
mouse monoclonal (32/N-Cadherin) 610921	immunohistochemistry - paraffin section; human; 1:200; fig 3	In order to study an in vitro model for tumor progression modeling and drug screening by using a reductionist metastasis-on-a-chip platform, BD Biosciences N-cadherin antibody (BD Biosciences, 610921) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 3). Biotechnol Bioeng (2016) ncbi
mouse monoclonal (32/N-Cadherin) 610921 610920	western blot; human; 1:2000; fig 2f	BD Biosciences N-cadherin antibody (BD, 32) was used in western blot on human samples at 1:2000 (fig 2f). Nat Commun (2016) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human; fig 3	BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in western blot on human samples (fig 3). Oncogene (2016) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human; fig 3	BD Biosciences N-cadherin antibody (BD Transduction Lab., 610920) was used in western blot on human samples (fig 3). Mol Cancer (2015) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human; 1:2500; loading ...; fig 2a	BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in western blot on human samples at 1:2500 (fig 2a). Vascul Pharmacol (2016) ncbi
mouse monoclonal (32/N-Cadherin) 610921	western blot; human; fig 2	In order to characterize the interaction of TRPC6 with APP to inhibit its cleavage by gamma-secretase and reduce A-beta production, BD Biosciences N-cadherin antibody (BD, 610921) was used in western blot on human samples (fig 2). Nat Commun (2015) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunohistochemistry; human; 1:25; fig s2	In order to analyze propagation of oestrogen-responsive and oestrogen receptor-positive normal human breast cells in culture, BD Biosciences N-cadherin antibody (BD Transduction Laboratories, 610920) was used in immunohistochemistry on human samples at 1:25 (fig s2). Nat Commun (2015) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunocytochemistry; mouse; 1:100; fig 1d	In order to characterize the role of p19ARF depletion and cell escape in regards to liver sinusoidal endothelial cells, BD Biosciences N-cadherin antibody (BD Transduction Laboratories, 610920) was used in immunocytochemistry on mouse samples at 1:100 (fig 1d). PLoS ONE (2015) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunohistochemistry - frozen section; mouse; 1:200; fig 8	In order to investigate the developmental processes that regulate the formation of unique inner ear cell types, BD Biosciences N-cadherin antibody (BD Bioscience, 610920) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 8). Nat Commun (2015) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunohistochemistry; mouse	In order to determine the functions of EHD1, BD Biosciences N-cadherin antibody (BD-Transduction laboratories, 610920) was used in immunohistochemistry on mouse samples . Dev Biol (2015) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; rat; 1:500; fig 4b	In order to identify novel molecules in peripheral myelination by spatial mapping of juxtacrine axo-glial interactions, BD Biosciences N-cadherin antibody (BD Bioscience, 610920) was used in western blot on rat samples at 1:500 (fig 4b). Nat Commun (2015) ncbi
mouse monoclonal (32/N-Cadherin) 610921	western blot; rat; 1:500; fig 3	In order to study how cellular localization affects DHHC5 activity, BD Biosciences N-cadherin antibody (BD Transduction Laboratories, 610921) was used in western blot on rat samples at 1:500 (fig 3). Nat Commun (2015) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; mouse	In order to investigate junctional intercellular communication, mechanotransduction through cytoskeletal organization, and the hippo-YAP pathway in cardiac damage caused by direct exposure to ethanol, BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in western blot on mouse samples . PLoS ONE (2015) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunohistochemistry - paraffin section; mouse; 1:200; fig 6	BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 6). Cell Death Dis (2015) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunohistochemistry; mouse; 1:100; fig 4	In order to determine tissue specific functions of DLL1 or DLL4 using transgenic mice, BD Biosciences N-cadherin antibody (BD Transduction Lab, 610920) was used in immunohistochemistry on mouse samples at 1:100 (fig 4). PLoS Genet (2015) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunohistochemistry; human; loading ...; fig 2c western blot; human; 1:1000; loading ...; fig 6b	BD Biosciences N-cadherin antibody (BD Bioscience, 610920) was used in immunohistochemistry on human samples (fig 2c) and in western blot on human samples at 1:1000 (fig 6b). PLoS ONE (2015) ncbi
mouse monoclonal (32/N-Cadherin) 610921 610920	western blot; human; 1:500; fig 3	BD Biosciences N-cadherin antibody (BD Biosciences, 32/N-Cadherin) was used in western blot on human samples at 1:500 (fig 3). PLoS ONE (2015) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human; fig 4d	In order to study how pre-transformation MTH1 levels in immortalized cells influence HRASV12-induced oncogenic transformation, BD Biosciences N-cadherin antibody (BD Transduction laboratories, 610920) was used in western blot on human samples (fig 4d). Oncotarget (2015) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human; fig 3b	BD Biosciences N-cadherin antibody (BD, 610920) was used in western blot on human samples (fig 3b). Breast Cancer Res (2015) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunohistochemistry; mouse; loading ...; fig 5b	BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in immunohistochemistry on mouse samples (fig 5b). Sci Rep (2015) ncbi
mouse monoclonal (32/N-Cadherin) 610921	immunocytochemistry; human; 1:200 immunohistochemistry; human; 1:200	In order to investigate using liver-tumor organoids for in vitro modeling of liver metastasis, BD Biosciences N-cadherin antibody (BD Biosciences, 610921) was used in immunocytochemistry on human samples at 1:200 and in immunohistochemistry on human samples at 1:200. Ann Biomed Eng (2015) ncbi
mouse monoclonal (32/N-Cadherin) 610921	western blot; mouse; 1:500-1:2000; fig s2	In order to describe and use a method to visualize newly synthesized proteins specifically, BD Biosciences N-cadherin antibody (BD, 610921) was used in western blot on mouse samples at 1:500-1:2000 (fig s2). Nat Methods (2015) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human; loading ...; fig 1a	BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in western blot on human samples (fig 1a). Oncotarget (2015) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human; 1:5000	BD Biosciences N-cadherin antibody (BD Transduction Laboratories, 610920) was used in western blot on human samples at 1:5000. J Biol Chem (2015) ncbi
mouse monoclonal (32/N-Cadherin) 610921	western blot; mouse; 1:500	In order to investigate the role of Cdh2 in the meiotic progression of Sertoli cells and fertility of mice, BD Biosciences N-cadherin antibody (BD, 610921) was used in western blot on mouse samples at 1:500. Biol Reprod (2015) ncbi
mouse monoclonal (32/N-Cadherin) 610921 610920	western blot; mouse	BD Biosciences N-cadherin antibody (BD Bioscience, 32/N-Cadherin) was used in western blot on mouse samples . Neoplasia (2015) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human; fig 4	In order to investigate the roles and mechanisms of the RSPO-LGR system in oncogenesis, BD Biosciences N-cadherin antibody (BD Transduction Laboratories, 610920) was used in western blot on human samples (fig 4). Oncogene (2015) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunocytochemistry; human	In order to describe a method to rapidly generate neurons from human-induced pluripotent stem cells to elucidate the underlying regulatory programs, BD Biosciences N-cadherin antibody (BD, 610920) was used in immunocytochemistry on human samples . Mol Syst Biol (2014) ncbi
mouse monoclonal (32/N-Cadherin) 610921	western blot; mouse; 1:2000	BD Biosciences N-cadherin antibody (BD Transduction Laboratories, 610921) was used in western blot on mouse samples at 1:2000. PLoS ONE (2014) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human; fig 4	In order to elucidate the role of COMMD1 in copper homeostasis, BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in western blot on human samples (fig 4). Mol Biol Cell (2015) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human; 1:1000	In order to study the effect of epithelial cadherin expression on the induction of entosis, BD Biosciences N-cadherin antibody (BD Biosciences, BD610920) was used in western blot on human samples at 1:1000. Cell Res (2014) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human	BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in western blot on human samples . PLoS Genet (2014) ncbi
mouse monoclonal (32/N-Cadherin) 610921 610920	immunocytochemistry; human; fig 1 western blot; human; fig 1	In order to analyze cancer cell plasticity autonomous stimulation by human NKG2D lymphocyte receptor coexpressed with its ligands on cancer cells, BD Biosciences N-cadherin antibody (BD Transduction Laboratories, 32) was used in immunocytochemistry on human samples (fig 1) and in western blot on human samples (fig 1). PLoS ONE (2014) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human; 1:1000; fig s1	In order to study juxtacrine signaling from macrophages and monocytes and a breast cancer stem cell niche, BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in western blot on human samples at 1:1000 (fig s1). Nat Cell Biol (2014) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human	BD Biosciences N-cadherin antibody (BD, 610920) was used in western blot on human samples . J Exp Clin Cancer Res (2014) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunohistochemistry; rat	In order to examine the progression of functional corticostriatal interactions, BD Biosciences N-cadherin antibody (BD Transduction Labs, 610920) was used in immunohistochemistry on rat samples . J Comp Neurol (2015) ncbi
mouse monoclonal (32/N-Cadherin) 610921	western blot; human	In order to study the role of autoantibodies against the GABA(A) receptor to encephalitis, BD Biosciences N-cadherin antibody (BD Biosciences, 610921) was used in western blot on human samples . J Neurosci (2014) ncbi
mouse monoclonal (8C11) 561553	western blot; mouse; 1:1000; fig e4	BD Biosciences N-cadherin antibody (BD Pharmingen, 561553) was used in western blot on mouse samples at 1:1000 (fig e4). Nature (2014) ncbi
mouse monoclonal (32/N-Cadherin) 610921	western blot; human	BD Biosciences N-cadherin antibody (BD Biosciences, 610921) was used in western blot on human samples . Int J Oncol (2014) ncbi
mouse monoclonal (32/N-Cadherin) 610921	immunohistochemistry; mouse; 1:400 western blot; mouse; 1:2000	In order to study the organization of adult hippocampal excitatory and inhibitory circuits and the role played by the N-cadherin/beta-catenin complex, BD Biosciences N-cadherin antibody (BD Transduction Labs, 610921) was used in immunohistochemistry on mouse samples at 1:400 and in western blot on mouse samples at 1:2000. Hippocampus (2014) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; rat; 1:1000	BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in western blot on rat samples at 1:1000. PLoS ONE (2014) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunohistochemistry - frozen section; mouse; 1:100 western blot; mouse; 1:100	In order to study Notch signaling in the differentiation of neural progenitors, BD Biosciences N-cadherin antibody (BD Transduction Laboratories, 610920) was used in immunohistochemistry - frozen section on mouse samples at 1:100 and in western blot on mouse samples at 1:100. Development (2014) ncbi
mouse monoclonal (32/N-Cadherin) 610921 610920	western blot; mouse	BD Biosciences N-cadherin antibody (BD Biosciences, 32) was used in western blot on mouse samples . PLoS ONE (2014) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human	BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in western blot on human samples . Br J Cancer (2014) ncbi
mouse monoclonal (32/N-Cadherin) 610921 610920	immunocytochemistry; human western blot; human	In order to determine the role of desmoglein 2 in melanoma cells, BD Biosciences N-cadherin antibody (BD Biosciences Pharmingen, clone 32) was used in immunocytochemistry on human samples and in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunohistochemistry - paraffin section; mouse; fig 2 western blot; mouse; fig 1	BD Biosciences N-cadherin antibody (BD Transduction Labs, 610920) was used in immunohistochemistry - paraffin section on mouse samples (fig 2) and in western blot on mouse samples (fig 1). Biol Open (2014) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human	BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in western blot on human samples . Exp Cell Res (2014) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human	BD Biosciences N-cadherin antibody (BD, 610920) was used in western blot on human samples . Oncogene (2014) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human	In order to study the role of CREB in the mechanism by which neurotrypsin expression and agarin proteolysis is modulated by presenilins, BD Biosciences N-cadherin antibody (BD, 610920) was used in western blot on human samples . J Biol Chem (2013) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human	BD Biosciences N-cadherin antibody (BD Pharmingen, 610920) was used in western blot on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; mouse	BD Biosciences N-cadherin antibody (BD Transduction Laboratories, 610920) was used in western blot on mouse samples . J Neurosci (2013) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunohistochemistry - frozen section; mouse	In order to study the role of endothelial-to-mesenchymal transition in the onset and progression of cerebral cavernous malformations, BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in immunohistochemistry - frozen section on mouse samples . Nature (2013) ncbi
mouse monoclonal (32/N-Cadherin) 610921	immunohistochemistry - frozen section; mouse immunohistochemistry - paraffin section; human	BD Biosciences N-cadherin antibody (BD Biosciences, 610921) was used in immunohistochemistry - frozen section on mouse samples and in immunohistochemistry - paraffin section on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (32/N-Cadherin) 610921	immunocytochemistry; rat; 1:250 western blot; rat; 1:1000	In order to examine the role of UTP on N-cadherin expression in schwannoma cells, BD Biosciences N-cadherin antibody (BD, 610921) was used in immunocytochemistry on rat samples at 1:250 and in western blot on rat samples at 1:1000. Purinergic Signal (2013) ncbi
mouse monoclonal (32/N-Cadherin) 610920	western blot; human	In order to study the role of TWIST1 activation by the MMSET histone methyltransferase in driving epithelial-to-mesenchymal transition and invasiveness in prostate cancer, BD Biosciences N-cadherin antibody (BD Transduction Laboratories, 610920) was used in western blot on human samples . Oncogene (2013) ncbi
mouse monoclonal (32/N-Cadherin) 610921	immunohistochemistry - frozen section; mouse; 1:5000	BD Biosciences N-cadherin antibody (BD Biosciences, 610921) was used in immunohistochemistry - frozen section on mouse samples at 1:5000. J Comp Neurol (2012) ncbi
mouse monoclonal (32/N-Cadherin) 610921	immunohistochemistry - frozen section; domestic sheep western blot; domestic sheep	In order to study the role of desmosomes and adherens junctions in gap junction formation by cx43, BD Biosciences N-cadherin antibody (BD, 610921) was used in immunohistochemistry - frozen section on domestic sheep samples and in western blot on domestic sheep samples . Heart Rhythm (2012) ncbi
mouse monoclonal (32/N-Cadherin) 610921	western blot; mouse; fig 4e	BD Biosciences N-cadherin antibody (BD, 610921) was used in western blot on mouse samples (fig 4e). J Clin Invest (2011) ncbi
mouse monoclonal (32/N-Cadherin) 610921 610920	western blot; human; fig 5	In order to report that mesenchymal stromal cells support proliferation and self-renewal of hematopoietic stem and progenitor cells with primitive immunophenotype, BD Biosciences N-cadherin antibody (BD, 32) was used in western blot on human samples (fig 5). J Cell Mol Med (2010) ncbi
mouse monoclonal (32/N-Cadherin) 610920	immunohistochemistry - frozen section; mouse; 1:1000	In order to examine the involvement of catenin-cadherin mediated adhesion in the axonal projection of olfactory sensory neuron (OSN) axons, BD Biosciences N-cadherin antibody (BD Biosciences, 610920) was used in immunohistochemistry - frozen section on mouse samples at 1:1000. J Comp Neurol (2006) ncbi

MilliporeSigma

mouse monoclonal (CH-19)

C1821

immunohistochemistry; rat; 1:500; fig 1d

MilliporeSigma N-cadherin antibody (Sigma-Aldrich, C1821) was used in immunohistochemistry on rat samples at 1:500 (fig 1d). Sci Rep (2021) ncbi

Developmental Studies Hybridoma Bank

rat monoclonal (MNCD2) MNCD2	immunohistochemistry - frozen section; mouse; fig 6	Developmental Studies Hybridoma Bank N-cadherin antibody (DSHB, MNCD2) was used in immunohistochemistry - frozen section on mouse samples (fig 6). Dev Biol (2016) ncbi
rat monoclonal (MNCD2) MNCD2	immunohistochemistry - frozen section; mouse; 1:20; fig 1	Developmental Studies Hybridoma Bank N-cadherin antibody (DSHB, MNCD2) was used in immunohistochemistry - frozen section on mouse samples at 1:20 (fig 1). Sci Rep (2015) ncbi

Articles Reviewed

Pan R, Yu Y, Zhu H, Zhang W, Qin Y, Ye L, et al. RSPO2 promotes progression of ovarian cancer through dual receptor-mediated FAK/Src signaling activation. iScience. 2022;25:105184 pubmed publisher
Pandey S, Shteinfer Kuzmine A, Chalifa Caspi V, Shoshan Barmatz V. Non-apoptotic activity of the mitochondrial protein SMAC/Diablo in lung cancer: Novel target to disrupt survival, inflammation, and immunosuppression. Front Oncol. 2022;12:992260 pubmed publisher
Chen F, Xiao M, Feng J, Wufur R, Liu K, Hu S, et al. Different Inhibition of Nrf2 by Two Keap1 Isoforms α and β to Shape Malignant Behaviour of Human Hepatocellular Carcinoma. Int J Mol Sci. 2022;23: pubmed publisher
Xie F, Zhou X, Su P, Li H, Tu Y, Du J, et al. Breast cancer cell-derived extracellular vesicles promote CD8+ T cell exhaustion via TGF-β type II receptor signaling. Nat Commun. 2022;13:4461 pubmed publisher
Wu T, Wang W, Shi G, Hao M, Wang Y, Yao M, et al. Targeting HIC1/TGF-β axis-shaped prostate cancer microenvironment restrains its progression. Cell Death Dis. 2022;13:624 pubmed publisher
Chi R, Yao C, Chen S, Liu Y, He Y, Zhang J, et al. Elevated BCAA Suppresses the Development and Metastasis of Breast Cancer. Front Oncol. 2022;12:887257 pubmed publisher
Azarnia Tehran D, Kochlamazashvili G, Pampaloni N, Sposini S, Shergill J, Lehmann M, et al. Selective endocytosis of Ca2+-permeable AMPARs by the Alzheimer's disease risk factor CALM bidirectionally controls synaptic plasticity. Sci Adv. 2022;8:eabl5032 pubmed publisher
Fleming Martinez A, D xf6 ppler H, Bastea L, Edenfield B, Liou G, Storz P. Ym1+ macrophages orchestrate fibrosis, lesion growth, and progression during development of murine pancreatic cancer. iScience. 2022;25:104327 pubmed publisher
Kimura Yoshida C, Mochida K, Kanno S, Matsuo I. USP39 is essential for mammalian epithelial morphogenesis through upregulation of planar cell polarity components. Commun Biol. 2022;5:378 pubmed publisher
Fischer A, Wannemacher J, Christ S, Koopmans T, Kadri S, Zhao J, et al. Neutrophils direct preexisting matrix to initiate repair in damaged tissues. Nat Immunol. 2022;23:518-531 pubmed publisher
Yi B, Dai K, Yan Z, Yin Z. Circular RNA PLCE1 promotes epithelial mesenchymal transformation, glycolysis in colorectal cancer and M2 polarization of tumor-associated macrophages. Bioengineered. 2022;13:6243-6256 pubmed publisher
Zhong L, Yang B, Zhang Z, Wang J, Wang X, Guo Y, et al. Targeting autophagy peptidase ATG4B with a novel natural product inhibitor Azalomycin F4a for advanced gastric cancer. Cell Death Dis. 2022;13:161 pubmed publisher
Castillo P, Aisagbonhi O, Saenz C, ElShamy W. Novel insights linking BRCA1-IRIS role in mammary gland development to formation of aggressive PABCs: the case for longer breastfeeding. Am J Cancer Res. 2022;12:396-426 pubmed
Hao W, Luo Q, Menger M, Fassbender K, Liu Y. Treatment With CD52 Antibody Protects Neurons in Experimental Autoimmune Encephalomyelitis Mice During the Recovering Phase. Front Immunol. 2021;12:792465 pubmed publisher
Jacquet M, Hervouet E, Baudu T, Herfs M, Parratte C, Feugeas J, et al. GABARAPL1 Inhibits EMT Signaling through SMAD-Tageted Negative Feedback. Biology (Basel). 2021;10: pubmed publisher
Liu W, Feng Q, Liao W, Li E, Wu L. TUG1 promotes the expression of IFITM3 in hepatocellular carcinoma by competitively binding to miR-29a. J Cancer. 2021;12:6905-6920 pubmed publisher
Baeza V, Cifuentes M, Martinez F, Ramírez E, Nualart F, Ferrada L, et al. IIIG9 inhibition in adult ependymal cells changes adherens junctions structure and induces cellular detachment. Sci Rep. 2021;11:18537 pubmed publisher
Li X, Pan F, He B, Fang C. Inhibition of ADAM10 ameliorates doxorubicin-induced cardiac remodeling by suppressing N-cadherin cleavage. Open Life Sci. 2021;16:856-866 pubmed publisher
Wang C, Yang Z, Xu E, Shen X, Wang X, Li Z, et al. Apolipoprotein C-II induces EMT to promote gastric cancer peritoneal metastasis via PI3K/AKT/mTOR pathway. Clin Transl Med. 2021;11:e522 pubmed publisher
da Silva F, Zhang K, Pinson A, Fatti E, Wilsch Bräuninger M, Herbst J, et al. Mitotic WNT signalling orchestrates neurogenesis in the developing neocortex. EMBO J. 2021;40:e108041 pubmed publisher
Wu Q, Zhang W, Liu Y, Huang Y, Wu H, Ma C. Histone deacetylase 1 facilitates aerobic glycolysis and growth of endometrial cancer. Oncol Lett. 2021;22:721 pubmed publisher
Zhao C, Ling X, Xia Y, Yan B, Guan Q. The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis. Cancer Cell Int. 2021;21:441 pubmed publisher
Cho A, Jin Y, An Y, Kim J, Choi Y, Lee J, et al. Microfluidic device with brain extracellular matrix promotes structural and functional maturation of human brain organoids. Nat Commun. 2021;12:4730 pubmed publisher
Mao C, Jiang S, Wang X, Tao S, Jiang B, Mao C, et al. BCAR1 plays critical roles in the formation and immunoevasion of invasive circulating tumor cells in lung adenocarcinoma. Int J Biol Sci. 2021;17:2461-2475 pubmed publisher
Zou J, Zhu X, Xiang D, Zhang Y, Li J, Su Z, et al. LIX1-like protein promotes liver cancer progression via miR-21-3p-mediated inhibition of fructose-1,6-bisphosphatase. Acta Pharm Sin B. 2021;11:1578-1591 pubmed publisher
Lee S, Jung J, Lee Y, Kim S, Kim J, Kim B, et al. Targeting HSF1 as a Therapeutic Strategy for Multiple Mechanisms of EGFR Inhibitor Resistance in EGFR Mutant Non-Small-Cell Lung Cancer. Cancers (Basel). 2021;13: pubmed publisher
Luo C, Xu X, Liu C, He S, Chen J, Feng Y, et al. RBFOX2/GOLIM4 Splicing Axis Activates Vesicular Transport Pathway to Promote Nasopharyngeal Carcinogenesis. Adv Sci (Weinh). 2021;8:e2004852 pubmed publisher
Cheng X, Wang J, Liu C, Jiang T, Yang N, Liu D, et al. Zinc transporter SLC39A13/ZIP13 facilitates the metastasis of human ovarian cancer cells via activating Src/FAK signaling pathway. J Exp Clin Cancer Res. 2021;40:199 pubmed publisher
Wu Y, Guo Q, Ju X, Hu Z, Xia L, Deng Y, et al. HNRNPH1-stabilized LINC00662 promotes ovarian cancer progression by activating the GRP78/p38 pathway. Oncogene. 2021;40:4770-4782 pubmed publisher
Song M, Zhao G, Sun H, Yao S, Zhou Z, Jiang P, et al. circPTPN12/miR-21-5 p/∆Np63α pathway contributes to human endometrial fibrosis. elife. 2021;10: pubmed publisher
Jiang H, Deng W, Zhu K, Zeng Z, Hu B, Zhou Z, et al. LINC00467 Promotes Prostate Cancer Progression via M2 Macrophage Polarization and the miR-494-3p/STAT3 Axis. Front Oncol. 2021;11:661431 pubmed publisher
Urdiciain A, Erausquin E, Zelaya M, Zazpe I, Lanciego J, Melendez B, et al. Silencing of Histone Deacetylase 6 Decreases Cellular Malignancy and Contributes to Primary Cilium Restoration, Epithelial-to-Mesenchymal Transition Reversion, and Autophagy Inhibition in Glioblastoma Cell Lines. Biology (Basel). 2021;10: pubmed publisher
Li X, Lin P, Tao Y, Jiang X, Li T, Wang Y, et al. LECT 2 Antagonizes FOXM1 Signaling via Inhibiting MET to Retard PDAC Progression. Front Cell Dev Biol. 2021;9:661122 pubmed publisher
Nasu M, Esumi S, Hatakeyama J, Tamamaki N, Shimamura K. Two-Phase Lineage Specification of Telencephalon Progenitors Generated From Mouse Embryonic Stem Cells. Front Cell Dev Biol. 2021;9:632381 pubmed publisher
Wang X, Li X, Lin F, Sun H, Lin Y, Wang Z, et al. The lnc-CTSLP8 upregulates CTSL1 as a competitive endogenous RNA and promotes ovarian cancer metastasis. J Exp Clin Cancer Res. 2021;40:151 pubmed publisher
Chen X, Ma W, Yao Y, Zhang Q, Li J, Wu X, et al. Serum deprivation-response protein induces apoptosis in hepatocellular carcinoma through ASK1-JNK/p38 MAPK pathways. Cell Death Dis. 2021;12:425 pubmed publisher
Oh T, Lee M, Lee Y, Kim G, Lee D, You J, et al. PGC1α Loss Promotes Lung Cancer Metastasis through Epithelial-Mesenchymal Transition. Cancers (Basel). 2021;13: pubmed publisher
Loureiro J, Raimundo L, Calheiros J, Carvalho C, Barcherini V, Lima N, et al. Targeting p53 for Melanoma Treatment: Counteracting Tumour Proliferation, Dissemination and Therapeutic Resistance. Cancers (Basel). 2021;13: pubmed publisher
O Hare M, Amarnani D, Whitmore H, An M, Marino C, Ramos L, et al. Targeting Runt-Related Transcription Factor 1 Prevents Pulmonary Fibrosis and Reduces Expression of Severe Acute Respiratory Syndrome Coronavirus 2 Host Mediators. Am J Pathol. 2021;191:1193-1208 pubmed publisher
Kariya Y, Oyama M, Suzuki T, Kariya Y. αvβ3 Integrin induces partial EMT independent of TGF-β signaling. Commun Biol. 2021;4:490 pubmed publisher
Morcom L, Gobius I, Marsh A, Suárez R, Lim J, Bridges C, et al. DCC regulates astroglial development essential for telencephalic morphogenesis and corpus callosum formation. elife. 2021;10: pubmed publisher
Fayad R, Rojas M, Partisani M, Finetti P, Dib S, Abélanet S, et al. EFA6B regulates a stop signal for collective invasion in breast cancer. Nat Commun. 2021;12:2198 pubmed publisher
Gao S, Gao L, Wang S, Shi X, Yue C, Wei S, et al. ATF3 Suppresses Growth and Metastasis of Clear Cell Renal Cell Carcinoma by Deactivating EGFR/AKT/GSK3β/β-Catenin Signaling Pathway. Front Cell Dev Biol. 2021;9:618987 pubmed publisher
Sugita J, Fujiu K, Nakayama Y, Matsubara T, Matsuda J, Oshima T, et al. Cardiac macrophages prevent sudden death during heart stress. Nat Commun. 2021;12:1910 pubmed publisher
Wan L, Wang Y, Zhang Z, Wang J, Niu M, Wu Y, et al. Elevated TEFM expression promotes growth and metastasis through activation of ROS/ERK signaling in hepatocellular carcinoma. Cell Death Dis. 2021;12:325 pubmed publisher
Sun Y, Jing J, Xu H, Xu L, Hu H, Tang C, et al. N-cadherin inhibitor creates a microenvironment that protect TILs from immune checkpoints and Treg cells. J Immunother Cancer. 2021;9: pubmed publisher
Shao G, Fan X, Zhang P, Liu X, Huang L, Ji S. Methylation-dependent MCM6 repression induced by LINC00472 inhibits triple-negative breast cancer metastasis by disturbing the MEK/ERK signaling pathway. Aging (Albany NY). 2021;13:4962-4975 pubmed publisher
Zhang C, Chen L, Liu Y, Huang J, Liu A, Xu Y, et al. Downregulated METTL14 accumulates BPTF that reinforces super-enhancers and distal lung metastasis via glycolytic reprogramming in renal cell carcinoma. Theranostics. 2021;11:3676-3693 pubmed publisher
Galbraith L, Mui E, Nixon C, Hedley A, Strachan D, Mackay G, et al. PPAR-gamma induced AKT3 expression increases levels of mitochondrial biogenesis driving prostate cancer. Oncogene. 2021;40:2355-2366 pubmed publisher
Can xe8 S, Van Snick J, Uyttenhove C, Pilotte L, van den Eynde B. TGFβ1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism. J Immunother Cancer. 2021;9: pubmed publisher
Wan X, Hou J, Liu S, Zhang Y, Li W, Zhang Y, et al. Estrogen Receptor α Mediates Doxorubicin Sensitivity in Breast Cancer Cells by Regulating E-Cadherin. Front Cell Dev Biol. 2021;9:583572 pubmed publisher
Fu C, Zhang Q, Wang A, Yang S, Jiang Y, Bai L, et al. EWI-2 controls nucleocytoplasmic shuttling of EGFR signaling molecules and miRNA sorting in exosomes to inhibit prostate cancer cell metastasis. Mol Oncol. 2021;15:1543-1565 pubmed publisher
Mondal T, Shivange G, Tihagam R, Lyerly E, Battista M, Talwar D, et al. Unexpected PD-L1 immune evasion mechanism in TNBC, ovarian, and other solid tumors by DR5 agonist antibodies. EMBO Mol Med. 2021;13:e12716 pubmed publisher
Grönroos P, Ilmarinen T, Skottman H. Directed Differentiation of Human Pluripotent Stem Cells towards Corneal Endothelial-Like Cells under Defined Conditions. Cells. 2021;10: pubmed publisher
Ding L, Fang Y, Li Y, Hu Q, Ai M, Deng K, et al. AIMP3 inhibits cell growth and metastasis of lung adenocarcinoma through activating a miR-96-5p-AIMP3-p53 axis. J Cell Mol Med. 2021;25:3019-3030 pubmed publisher
Delgado E, Erickson H, Tao J, Monga S, Duncan A, Anakk S. Scaffolding Protein IQGAP1 is Dispensable But Its Overexpression Promotes Hepatocellular Carcinoma via YAP1 Signaling. Mol Cell Biol. 2021;: pubmed publisher
Zhou H, Qin L, Jiang Q, Murray K, Zhang H, Li B, et al. Caveolae-mediated Tie2 signaling contributes to CCM pathogenesis in a brain endothelial cell-specific Pdcd10-deficient mouse model. Nat Commun. 2021;12:504 pubmed publisher
Okawa E, Gupta M, Kahraman S, Goli P, Sakaguchi M, Hu J, et al. Essential roles of insulin and IGF-1 receptors during embryonic lineage development. Mol Metab. 2021;47:101164 pubmed publisher
Hu X, Villodre E, Larson R, Rahal O, Wang X, Gong Y, et al. Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer. Commun Biol. 2021;4:72 pubmed publisher
Dilshat R, Fock V, Kenny C, Gerritsen I, Lasseur R, Travnickova J, et al. MITF reprograms the extracellular matrix and focal adhesion in melanoma. elife. 2021;10: pubmed publisher
Zhang K, Wang D, Cai H, Cao M, Zhang Y, Zhuang P, et al. IL‑6 plays a crucial role in epithelial‑mesenchymal transition and pro‑metastasis induced by sorafenib in liver cancer. Oncol Rep. 2021;45:1105-1117 pubmed publisher
Luo X, Gong H, Gao H, Wu Y, Sun W, Li Z, et al. Oxygenated phosphatidylethanolamine navigates phagocytosis of ferroptotic cells by interacting with TLR2. Cell Death Differ. 2021;: pubmed publisher
Hexiao T, Yuquan B, Lecai X, Yanhong W, Li S, Weidong H, et al. Knockdown of CENPF inhibits the progression of lung adenocarcinoma mediated by ERβ2/5 pathway. Aging (Albany NY). 2021;13:2604-2625 pubmed publisher
Jiang Y, Han Q, Zhao H, Zhang J. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis. J Exp Clin Cancer Res. 2021;40:13 pubmed publisher
Ye D, Wang S, Huang Y, Wang X, Chi P. USP43 directly regulates ZEB1 protein, mediating proliferation and metastasis of colorectal cancer. J Cancer. 2021;12:404-416 pubmed publisher
Jiang X, Xu Y, Ren H, Jiang J, Wudu M, Wang Q, et al. KLHL18 inhibits the proliferation, migration, and invasion of non-small cell lung cancer by inhibiting PI3K/PD-L1 axis activity. Cell Biosci. 2020;10:139 pubmed publisher
van Berkel A, Santos T, Shaweis H, van Weering J, Toonen R, Verhage M. Loss of MUNC18-1 leads to retrograde transport defects in neurons. J Neurochem. 2021;157:450-466 pubmed publisher
Roth J, Muench K, Asokan A, Mallett V, Gai H, Verma Y, et al. 16p11.2 microdeletion imparts transcriptional alterations in human iPSC-derived models of early neural development. elife. 2020;9: pubmed publisher
Hu Q, Masuda T, Kuramitsu S, Tobo T, Sato K, Kidogami S, et al. Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT. PLoS ONE. 2020;15:e0241140 pubmed publisher
Hosseini K, Taubenberger A, Werner C, Fischer Friedrich E. EMT-Induced Cell-Mechanical Changes Enhance Mitotic Rounding Strength. Adv Sci (Weinh). 2020;7:2001276 pubmed publisher
Zhang Y, Zhang L, Lu S, Xiang Y, Zeng C, He T, et al. Long Non-coding RNA CASC15 Promotes Intrahepatic Cholangiocarcinoma Possibly through Inducing PRDX2/PI3K/AKT Axis. Cancer Res Treat. 2021;53:184-198 pubmed publisher
Wang T, Gao X, Zhou K, Jiang T, Gao S, Liu P, et al. Role of ARID1A in epithelial‑mesenchymal transition in breast cancer and its effect on cell sensitivity to 5‑FU. Int J Mol Med. 2020;46:1683-1694 pubmed publisher
Aikin T, Peterson A, Pokrass M, Clark H, Regot S. MAPK activity dynamics regulate non-cell autonomous effects of oncogene expression. elife. 2020;9: pubmed publisher
Wang Y, Gao G, Wu Y, Wang Y, Wu X, Zhou Q. S100A4 Silencing Facilitates Corneal Wound Healing After Alkali Burns by Promoting Autophagy via Blocking the PI3K/Akt/mTOR Signaling Pathway. Invest Ophthalmol Vis Sci. 2020;61:19 pubmed publisher
Oliemuller E, Newman R, Tsang S, Foo S, Muirhead G, Noor F, et al. SOX11 promotes epithelial/mesenchymal hybrid state and alters tropism of invasive breast cancer cells. elife. 2020;9: pubmed publisher
Liu Y, Li L, Liu X, Wang Y, Liu L, Peng L, et al. Arginine methylation of SHANK2 by PRMT7 promotes human breast cancer metastasis through activating endosomal FAK signalling. elife. 2020;9: pubmed publisher
Sun Z, Ji N, Ma Q, Zhu R, Chen Z, Wang Z, et al. Epithelial-Mesenchymal Transition in Asthma Airway Remodeling Is Regulated by the IL-33/CD146 Axis. Front Immunol. 2020;11:1598 pubmed publisher
Cui P, Jing P, Liu X, Xu W. Prognostic Significance of PD-L1 Expression and Its Tumor-Intrinsic Functions in Hypopharyngeal Squamous Cell Carcinoma. Cancer Manag Res. 2020;12:5893-5902 pubmed publisher
Huang F, Zheng C, Huang L, Lin C, Wang J. USP18 directly regulates Snail1 protein through ubiquitination pathway in colorectal cancer. Cancer Cell Int. 2020;20:346 pubmed publisher
Pseftogas A, Xanthopoulos K, Poutahidis T, Ainali C, Dafou D, Panteris E, et al. The Tumor Suppressor CYLD Inhibits Mammary Epithelial to Mesenchymal Transition by the Coordinated Inhibition of YAP/TAZ and TGF Signaling. Cancers (Basel). 2020;12: pubmed publisher
Wang W, Wang H, Xiang L, Ni T, Jin F, Deng J, et al. DJ‑1 is a new prognostic marker and predicts chemotherapy efficacy in colorectal cancer. Oncol Rep. 2020;44:77-90 pubmed publisher
Dias A, Lozovska A, Wymeersch F, Novoa A, Binagui Casas A, Sobral D, et al. A Tgfbr1/Snai1-dependent developmental module at the core of vertebrate axial elongation. elife. 2020;9: pubmed publisher
Christgen M, Bartels S, van Luttikhuizen J, Bublitz J, Rieger L, Christgen H, et al. E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements. Mod Pathol. 2020;33:2483-2498 pubmed publisher
Huang W, Yu D, Wang M, Han Y, Lin J, Wei D, et al. ITGBL1 promotes cell migration and invasion through stimulating the TGF-β signalling pathway in hepatocellular carcinoma. Cell Prolif. 2020;53:e12836 pubmed publisher
Lin Z, Lin X, Zhu L, Huang J, Huang Y. TRIM2 directly deubiquitinates and stabilizes Snail1 protein, mediating proliferation and metastasis of lung adenocarcinoma. Cancer Cell Int. 2020;20:228 pubmed publisher
Wen X, Wan J, He Q, Wang M, Li S, Jiang M, et al. p190A inactivating mutations cause aberrant RhoA activation and promote malignant transformation via the Hippo-YAP pathway in endometrial cancer. Signal Transduct Target Ther. 2020;5:81 pubmed publisher
Qi J, Liu S, Liu W, Cai G, Liao G. Identification of UAP1L1 as tumor promotor in gastric cancer through regulation of CDK6. Aging (Albany NY). 2020;12:6904-6927 pubmed publisher
Tian Q, Yuan P, Quan C, Li M, Xiao J, Zhang L, et al. Phosphorylation of BCKDK of BCAA catabolism at Y246 by Src promotes metastasis of colorectal cancer. Oncogene. 2020;39:3980-3996 pubmed publisher
Liu F, Hu L, Pei Y, Zheng K, Wang W, Li S, et al. Long non-coding RNA AFAP1-AS1 accelerates the progression of melanoma by targeting miR-653-5p/RAI14 axis. BMC Cancer. 2020;20:258 pubmed publisher
Liang W, Gao R, Yang M, Wang X, Cheng K, Shi X, et al. MARCKSL1 promotes the proliferation, migration and invasion of lung adenocarcinoma cells. Oncol Lett. 2020;19:2272-2280 pubmed publisher
Alafate W, Li X, Zuo J, Zhang H, Xiang J, Wu W, et al. Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma. CNS Neurosci Ther. 2020;26:475-485 pubmed publisher
Singh S, Adam M, Matkar P, Bugyei Twum A, Desjardins J, Chen H, et al. Endothelial-specific Loss of IFT88 Promotes Endothelial-to-Mesenchymal Transition and Exacerbates Bleomycin-induced Pulmonary Fibrosis. Sci Rep. 2020;10:4466 pubmed publisher
Moon H, Hippenmeyer S, Luo L, Wynshaw Boris A. LIS1 determines cleavage plane positioning by regulating actomyosin-mediated cell membrane contractility. elife. 2020;9: pubmed publisher
Guo Y, Zhang Z, Wang Z, Liu G, Liu Y, Wang H. Astragalus polysaccharides inhibit ovarian cancer cell growth via microRNA-27a/FBXW7 signaling pathway. Biosci Rep. 2020;40: pubmed publisher
Jin T, Liu M, Liu Y, Li Y, Xu Z, He H, et al. Lcn2-derived Circular RNA (hsa_circ_0088732) Inhibits Cell Apoptosis and Promotes EMT in Glioma via the miR-661/RAB3D Axis. Front Oncol. 2020;10:170 pubmed publisher
Kim K, Shin W, Kang M, Lee S, Kim D, Kang R, et al. Presynaptic PTPσ regulates postsynaptic NMDA receptor function through direct adhesion-independent mechanisms. elife. 2020;9: pubmed publisher
Wang X, Shan Y, Tan Q, Tan C, Zhang H, Liu J, et al. MEX3A knockdown inhibits the development of pancreatic ductal adenocarcinoma. Cancer Cell Int. 2020;20:63 pubmed publisher
Chen Z, Zhang J, Xue H, Qian M, Guo X, Gao X, et al. Nitidine Chloride Is a Potential Alternative Therapy for Glioma Through Inducing Endoplasmic Reticulum Stress and Alleviating Epithelial-Mesenchymal Transition. Integr Cancer Ther. 2020;19:1534735419900927 pubmed publisher
Dong C, Zhang J, Fang S, Liu F. IGFBP5 increases cell invasion and inhibits cell proliferation by EMT and Akt signaling pathway in Glioblastoma multiforme cells. Cell Div. 2020;15:4 pubmed publisher
Wang S, Qi Y, Gao X, Qiu W, Liu Q, Guo X, et al. Hypoxia-induced lncRNA PDIA3P1 promotes mesenchymal transition via sponging of miR-124-3p in glioma. Cell Death Dis. 2020;11:168 pubmed publisher
Wang X, Jian X, Dou J, Wei Z, Zhao F. Decreasing Microtubule Actin Cross-Linking Factor 1 Inhibits Melanoma Metastasis by Decreasing Epithelial to Mesenchymal Transition. Cancer Manag Res. 2020;12:663-673 pubmed publisher
Tian S, Peng P, Li J, Deng H, Zhan N, Zeng Z, et al. SERPINH1 regulates EMT and gastric cancer metastasis via the Wnt/β-catenin signaling pathway. Aging (Albany NY). 2020;12:3574-3593 pubmed publisher
Zhang Y, Du P, Li Y, Zhu Q, Song X, Liu S, et al. TASP1 Promotes Gallbladder Cancer Cell Proliferation and Metastasis by Up-regulating FAM49B via PI3K/AKT Pathway. Int J Biol Sci. 2020;16:739-751 pubmed publisher
Hu D, Chen H, Lou L, Zhang H, Yang G. SKA3 promotes lung adenocarcinoma metastasis through the EGFR-PI3K-Akt axis. Biosci Rep. 2020;40: pubmed publisher
Chandrasekaran B, Dahiya N, Tyagi A, Kolluru V, Saran U, Baby B, et al. Chronic exposure to cadmium induces a malignant transformation of benign prostate epithelial cells. Oncogenesis. 2020;9:23 pubmed publisher
Liu K, Yu Q, Li H, Xie C, Wu Y, Ma D, et al. BIRC7 promotes epithelial-mesenchymal transition and metastasis in papillary thyroid carcinoma through restraining autophagy. Am J Cancer Res. 2020;10:78-94 pubmed
Feng Y, Ji D, Huang Y, Ji B, Zhang Y, Li J, et al. TGM3 functions as a tumor suppressor by repressing epithelial‑to‑mesenchymal transition and the PI3K/AKT signaling pathway in colorectal cancer. Oncol Rep. 2020;43:864-876 pubmed publisher
Guoren Z, Zhaohui F, Wei Z, Mei W, Yuan W, Lin S, et al. TFAP2A Induced ITPKA Serves as an Oncogene and Interacts with DBN1 in Lung Adenocarcinoma. Int J Biol Sci. 2020;16:504-514 pubmed publisher
Xiong G, Chen J, Zhang G, Wang S, Kawasaki K, Zhu J, et al. Hsp47 promotes cancer metastasis by enhancing collagen-dependent cancer cell-platelet interaction. Proc Natl Acad Sci U S A. 2020;117:3748-3758 pubmed publisher
Lin L, Li Y, Liu M, Li Q, Liu Q, Li R. The Interleukin-33/ST2 axis promotes glioma mesenchymal transition, stemness and TMZ resistance via JNK activation. Aging (Albany NY). 2020;12:1685-1703 pubmed publisher
Liao S, Chen H, Liu M, Gan L, Li C, Zhang W, et al. Aquaporin 9 inhibits growth and metastasis of hepatocellular carcinoma cells via Wnt/β-catenin pathway. Aging (Albany NY). 2020;12:1527-1544 pubmed publisher
Yang W, Chen Z, Ma X, Ouyang X, Fang J, Wei H. Co-overexpression of VEGF and GDNF in adipose-derived stem cells optimizes therapeutic effect in neurogenic erectile dysfunction model. Cell Prolif. 2020;53:e12756 pubmed publisher
Li Q, Mao F, Zhou B, Huang Y, Zou Z, Dendekker A, et al. p53 Integrates Temporal WDR5 Inputs during Neuroectoderm and Mesoderm Differentiation of Mouse Embryonic Stem Cells. Cell Rep. 2020;30:465-480.e6 pubmed publisher
Du X, Zhang Z, Zheng X, Zhang H, Dong D, Zhang Z, et al. An electrochemical biosensor for the detection of epithelial-mesenchymal transition. Nat Commun. 2020;11:192 pubmed publisher
Liu Q, Borcherding N, Shao P, Maina P, Zhang W, Qi H. Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance. EBioMedicine. 2020;51:102612 pubmed publisher
Cai H, Li J, Zhang Y, Liao Y, Zhu Y, Wang C, et al. LDHA Promotes Oral Squamous Cell Carcinoma Progression Through Facilitating Glycolysis and Epithelial-Mesenchymal Transition. Front Oncol. 2019;9:1446 pubmed publisher
Dos Santos Carvalho S, Moreau M, Hien Y, Garcia M, Aubailly N, Henderson D, et al. Vangl2 acts at the interface between actin and N-cadherin to modulate mammalian neuronal outgrowth. elife. 2020;9: pubmed publisher
Suzuki D, Flahou C, Yoshikawa N, Stirblyte I, Hayashi Y, Sawaguchi A, et al. iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity. Stem Cell Reports. 2020;14:49-59 pubmed publisher
Wang H, Chen Z, Wang S, Gao X, Qian M, Qiu W, et al. TGFβ1-induced beta-site APP-cleaving enzyme 2 upregulation promotes tumorigenesis through the NF-κB signalling pathway in human gliomas. Mol Oncol. 2020;14:407-425 pubmed publisher
Piprek R, Kolasa M, Podkowa D, Kloc M, Kubiak J. N-Cadherin Is Critical for the Survival of Germ Cells, the Formation of Steroidogenic Cells, and the Architecture of Developing Mouse Gonads. Cells. 2019;8: pubmed publisher
Quach C, Song Y, Guo H, Li S, Maazi H, Fung M, et al. A truncating mutation in the autophagy gene UVRAG drives inflammation and tumorigenesis in mice. Nat Commun. 2019;10:5681 pubmed publisher
Hiepen C, Jatzlau J, Hildebrandt S, Kampfrath B, Goktas M, Murgai A, et al. BMPR2 acts as a gatekeeper to protect endothelial cells from increased TGFβ responses and altered cell mechanics. PLoS Biol. 2019;17:e3000557 pubmed publisher
Jiang K, Zhi X, Ma Y, Zhou L. Long non-coding RNA TOB1-AS1 modulates cell proliferation, apoptosis, migration and invasion through miR-23a/NEU1 axis via Wnt/b-catenin pathway in gastric cancer. Eur Rev Med Pharmacol Sci. 2019;23:9890-9899 pubmed publisher
Hu Y, Ma Y, Liu J, Cai Y, Zhang M, Fang X. LINC01128 expedites cervical cancer progression by regulating miR-383-5p/SFN axis. BMC Cancer. 2019;19:1157 pubmed publisher
Wu X, Chen S, Lu C. Amyloid precursor protein promotes the migration and invasion of breast cancer cells by regulating the MAPK signaling pathway. Int J Mol Med. 2019;: pubmed publisher
Zhang J, Zhang Z, Sun J, Ma Q, Zhao W, Chen X, et al. MiR-942 regulates the function of breast cancer cell by targeting FOXA2. Biosci Rep. 2019;39: pubmed publisher
Zhou S, da Silva S, Siegel P, Philip A. CD109 acts as a gatekeeper of the epithelial trait by suppressing epithelial to mesenchymal transition in squamous cell carcinoma cells in vitro. Sci Rep. 2019;9:16317 pubmed publisher
Chen X, Xiong X, Cui D, Yang F, Wei D, Li H, et al. DEPTOR is an in vivo tumor suppressor that inhibits prostate tumorigenesis via the inactivation of mTORC1/2 signals. Oncogene. 2020;39:1557-1571 pubmed publisher
Valentiner U, Knips J, Pries R, Clauditz T, Münscher A, Sauter G, et al. Selectin Binding Sites Are Involved in Cell Adhesive Properties of Head and Neck Squamous Cell Carcinoma. Cancers (Basel). 2019;11: pubmed publisher
Matsumoto S, Yamamichi T, Shinzawa K, Kasahara Y, Nojima S, Kodama T, et al. GREB1 induced by Wnt signaling promotes development of hepatoblastoma by suppressing TGFβ signaling. Nat Commun. 2019;10:3882 pubmed publisher
Jiang S, Zhang M, Zhang Y, Zhou W, Zhu T, Ruan Q, et al. WNT5B governs the phenotype of basal-like breast cancer by activating WNT signaling. Cell Commun Signal. 2019;17:109 pubmed publisher
Wei C, Zhu M, Zhang P, Yang X, Wang L, Ying J, et al. Elevated kindlin-2 promotes tumour progression and angiogenesis through the mTOR/VEGFA pathway in melanoma. Aging (Albany NY). 2019;11:6273-6285 pubmed publisher
Menon V, Thomas R, Elgueta C, Horl M, Osborn T, Hallett P, et al. Comprehensive Cell Surface Antigen Analysis Identifies Transferrin Receptor Protein-1 (CD71) as a Negative Selection Marker for Human Neuronal Cells. Stem Cells. 2019;37:1293-1306 pubmed publisher
Li Q, Lai Q, He C, Fang Y, Yan Q, Zhang Y, et al. RUNX1 promotes tumour metastasis by activating the Wnt/β-catenin signalling pathway and EMT in colorectal cancer. J Exp Clin Cancer Res. 2019;38:334 pubmed publisher
Sharma S, Carmona A, Skowronek A, Yu F, Collins M, Naik S, et al. Apoptotic signalling targets the post-endocytic sorting machinery of the death receptor Fas/CD95. Nat Commun. 2019;10:3105 pubmed publisher
Wang X, Liu R, Zhu W, Chu H, Yu H, Wei P, et al. UDP-glucose accelerates SNAI1 mRNA decay and impairs lung cancer metastasis. Nature. 2019;571:127-131 pubmed publisher
Adams C, Htwe H, Marsh T, Wang A, Montoya M, Subbaraj L, et al. Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer. elife. 2019;8: pubmed publisher
Roy A, Murphy R, Deng M, MacDonald J, Bammler T, Aldinger K, et al. PI3K-Yap activity drives cortical gyrification and hydrocephalus in mice. elife. 2019;8: pubmed publisher
Slobodnyuk K, Radic N, Ivanova S, Lladó A, Trempolec N, Zorzano A, et al. Autophagy-induced senescence is regulated by p38α signaling. Cell Death Dis. 2019;10:376 pubmed publisher
Lubbers E, Murphy N, Musa H, Huang C, Gupta R, Price M, et al. Defining new mechanistic roles for αII spectrin in cardiac function. J Biol Chem. 2019;294:9576-9591 pubmed publisher
Kim E, Lisby A, Ma C, Lo N, Ehmer U, Hayer K, et al. Promotion of growth factor signaling as a critical function of β-catenin during HCC progression. Nat Commun. 2019;10:1909 pubmed publisher
Tang L, Wen J, Wen P, Li X, Gong M, Li Q. Long non-coding RNA LINC01314 represses cell migration, invasion, and angiogenesis in gastric cancer via the Wnt/β-catenin signaling pathway by down-regulating KLK4. Cancer Cell Int. 2019;19:94 pubmed publisher
Liu Y, Xue M, Du S, Feng W, Zhang K, Zhang L, et al. Competitive endogenous RNA is an intrinsic component of EMT regulatory circuits and modulates EMT. Nat Commun. 2019;10:1637 pubmed publisher
Zhang D, Zhou H, Liu J, Mao J. Long Noncoding RNA ASB16-AS1 Promotes Proliferation, Migration, and Invasion in Glioma Cells. Biomed Res Int. 2019;2019:5437531 pubmed publisher
Hlavac N, VandeVord P. Astrocyte Mechano-Activation by High-Rate Overpressure Involves Alterations in Structural and Junctional Proteins. Front Neurol. 2019;10:99 pubmed publisher
Novielli Kuntz N, Jelen M, Barr K, DeLalio L, Feng Q, Isakson B, et al. Ablation of both Cx40 and Panx1 results in similar cardiovascular phenotypes exhibited in Cx40 knockout mice. Biosci Rep. 2019;39: pubmed publisher
Sharon N, Chawla R, Mueller J, Vanderhooft J, Whitehorn L, Rosenthal B, et al. A Peninsular Structure Coordinates Asynchronous Differentiation with Morphogenesis to Generate Pancreatic Islets. Cell. 2019;176:790-804.e13 pubmed publisher
Liu Z, Liu J, Dong X, Hu X, Jiang Y, Li L, et al. Tn antigen promotes human colorectal cancer metastasis via H-Ras mediated epithelial-mesenchymal transition activation. J Cell Mol Med. 2019;23:2083-2092 pubmed publisher
Li Y, Merkel C, Zeng X, Heier J, Cantrell P, Sun M, et al. The N-cadherin interactome in primary cardiomyocytes as defined using quantitative proximity proteomics. J Cell Sci. 2019;132: pubmed publisher
Aggarwal S, Gabrovsek L, Langeberg L, Golkowski M, Ong S, Smith F, et al. Depletion of dAKAP1-protein kinase A signaling islands from the outer mitochondrial membrane alters breast cancer cell metabolism and motility. J Biol Chem. 2019;294:3152-3168 pubmed publisher
Zhang Z, Chen J, Huang W, Ning D, Liu Q, Wang C, et al. FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma. Mol Oncol. 2019;13:792-810 pubmed publisher
Lee C, Cheng Y, Chang C, Lin C, Chang J. Alpha-tubulin acetyltransferase/MEC-17 regulates cancer cell migration and invasion through epithelial-mesenchymal transition suppression and cell polarity disruption. Sci Rep. 2018;8:17477 pubmed publisher
Song X, Chen H, Zhang C, Yu Y, Chen Z, Liang H, et al. SRC-3 inhibition blocks tumor growth of pancreatic ductal adenocarcinoma. Cancer Lett. 2019;442:310-319 pubmed publisher
Eley L, Alqahtani A, MacGrogan D, Richardson R, Murphy L, Salguero Jimenez A, et al. A novel source of arterial valve cells linked to bicuspid aortic valve without raphe in mice. elife. 2018;7: pubmed publisher
Shimoda Y, Ubukata Y, Handa T, Yokobori T, Watanabe T, Gantumur D, et al. High expression of forkhead box protein C2 is associated with aggressive phenotypes and poor prognosis in clinical hepatocellular carcinoma. BMC Cancer. 2018;18:597 pubmed publisher
Hsu J, Xia W, Hsu Y, Chan L, Yu W, Cha J, et al. STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion. Nat Commun. 2018;9:1908 pubmed publisher
Wang X, Du C, He X, Deng X, He Y, Zhou X. MiR-4463 inhibits the migration of human aortic smooth muscle cells by AMOT. Biosci Rep. 2018;38: pubmed publisher
Park J, Kim I, Choi J, Lim H, Shin J, Kim Y, et al. AHNAK Loss in Mice Promotes Type II Pneumocyte Hyperplasia and Lung Tumor Development. Mol Cancer Res. 2018;16:1287-1298 pubmed publisher
Sakai Takemura F, Narita A, Masuda S, Wakamatsu T, Watanabe N, Nishiyama T, et al. Premyogenic progenitors derived from human pluripotent stem cells expand in floating culture and differentiate into transplantable myogenic progenitors. Sci Rep. 2018;8:6555 pubmed publisher
Zhao X, Peng Z, Long L, Chen N, Zheng H, Deng D, et al. Lentiviral vector delivery of short hairpin RNA to NgR1 promotes nerve regeneration and locomotor recovery in injured rat spinal cord. Sci Rep. 2018;8:5447 pubmed publisher
Zheng C, Wang J, Lin M, Zhang P, Liu L, Lin J, et al. CDK5RAP3 suppresses Wnt/β-catenin signaling by inhibiting AKT phosphorylation in gastric cancer. J Exp Clin Cancer Res. 2018;37:59 pubmed publisher
Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
Hsieh W, Ramadesikan S, FEKETE D, Aguilar R. Kidney-differentiated cells derived from Lowe Syndrome patient's iPSCs show ciliogenesis defects and Six2 retention at the Golgi complex. PLoS ONE. 2018;13:e0192635 pubmed publisher
Zhao H, Klausen C, Li Y, Zhu H, Wang Y, Leung P. Bone morphogenetic protein 2 promotes human trophoblast cell invasion by upregulating N-cadherin via non-canonical SMAD2/3 signaling. Cell Death Dis. 2018;9:174 pubmed publisher
Glaeser K, Urban M, Fenech E, Voloshanenko O, Kranz D, Lari F, et al. ERAD-dependent control of the Wnt secretory factor Evi. EMBO J. 2018;37: pubmed publisher
Vl kov K, Vachtenheim J, R da J, Hor k P, Ondru ov L. Inducibly decreased MITF levels do not affect proliferation and phenotype switching but reduce differentiation of melanoma cells. J Cell Mol Med. 2018;22:2240-2251 pubmed publisher
Hamada N, Iwamoto I, Tabata H, Nagata K. MUNC18-1 gene abnormalities are involved in neurodevelopmental disorders through defective cortical architecture during brain development. Acta Neuropathol Commun. 2017;5:92 pubmed publisher
Cottard F, Madi Berthélémy P, Erdmann E, Schaff Wendling F, Keime C, Ye T, et al. Dual effects of constitutively active androgen receptor and full-length androgen receptor for N-cadherin regulation in prostate cancer. Oncotarget. 2017;8:72008-72020 pubmed publisher
Rong X, Wang B, Palladino E, de Aguiar Vallim T, Ford D, Tontonoz P. ER phospholipid composition modulates lipogenesis during feeding and in obesity. J Clin Invest. 2017;127:3640-3651 pubmed publisher
Wang W, Liu F, Wang C, Wang C, Tang Y, Jiang Z. Glutathione S-transferase A1 mediates nicotine-induced lung cancer cell metastasis by promoting epithelial-mesenchymal transition. Exp Ther Med. 2017;14:1783-1788 pubmed publisher
Roberts S, Dun X, Doddrell R, Mindos T, Drake L, Onaitis M, et al. Sox2 expression in Schwann cells inhibits myelination in vivo and induces influx of macrophages to the nerve. Development. 2017;144:3114-3125 pubmed publisher
Logan C, Rajakaruna S, Bowen C, Radice G, Robinson M, Menko A. N-cadherin regulates signaling mechanisms required for lens fiber cell elongation and lens morphogenesis. Dev Biol. 2017;428:118-134 pubmed publisher
Lu J, Yang Y, Guo G, Liu Y, Zhang Z, Dong S, et al. IKBKE regulates cell proliferation and epithelial-mesenchymal transition of human malignant glioma via the Hippo pathway. Oncotarget. 2017;8:49502-49514 pubmed publisher
Liu S, Cheng C. Akt Signaling Is Sustained by a CD44 Splice Isoform-Mediated Positive Feedback Loop. Cancer Res. 2017;77:3791-3801 pubmed publisher
Sai K, Wang S, Kaito A, Fujiwara T, Maruo T, Itoh Y, et al. Multiple roles of afadin in the ultrastructural morphogenesis of mouse hippocampal mossy fiber synapses. J Comp Neurol. 2017;525:2719-2734 pubmed publisher
Yoon C, Cho S, Chang K, Park D, Ryeom S, Yoon S. Role of Rac1 Pathway in Epithelial-to-Mesenchymal Transition and Cancer Stem-like Cell Phenotypes in Gastric Adenocarcinoma. Mol Cancer Res. 2017;15:1106-1116 pubmed publisher
Samson E, Tsao D, Zimak J, McLaughlin R, Trenton N, Mace E, et al. The coordinating role of IQGAP1 in the regulation of local, endosome-specific actin networks. Biol Open. 2017;6:785-799 pubmed publisher
Wu Y, Jhao Y, Cheng Y, Chen Y. 15-Deoxy-?12,14-prostaglandin J2 inhibits migration of human thyroid carcinoma cells by disrupting focal adhesion complex and adherens junction. Oncol Lett. 2017;13:2569-2576 pubmed publisher
Li P, Wang Y, Mao X, Jiang Y, Liu J, Li J, et al. CRB3 downregulation confers breast cancer stem cell traits through TAZ/?-catenin. Oncogenesis. 2017;6:e322 pubmed publisher
Kim D, Ko H, Park G, Hur D, Kim Y, Yang J. Vandetanib and ADAM inhibitors synergistically attenuate the pathological migration of EBV-infected retinal pigment epithelial cells by regulating the VEGF-mediated MAPK pathway. Exp Ther Med. 2017;13:1415-1425 pubmed publisher
Liao Z, Zhao L, Cai M, Xi M, He L, Yu F, et al. P300 promotes migration, invasion and epithelial-mesenchymal transition in a nasopharyngeal carcinoma cell line. Oncol Lett. 2017;13:763-769 pubmed publisher
Hu X, Zhang Z, Liang Z, Xie D, Zhang T, Yu D, et al. Downregulation of feline sarcoma-related protein inhibits cell migration, invasion and epithelial-mesenchymal transition via the ERK/AP-1 pathway in bladder urothelial cell carcinoma. Oncol Lett. 2017;13:686-694 pubmed publisher
Li P, Zhang R, Wang L, Gan Y, Xu Y, Song L, et al. Long-term load duration induces N-cadherin down-regulation and loss of cell phenotype of nucleus pulposus cells in a disc bioreactor culture. Biosci Rep. 2017;37: pubmed publisher
Huang T, Song J, Zheng F, Pang H, Zhao Y, Gu H, et al. Protection of FK506 against neuronal apoptosis and axonal injury following experimental diffuse axonal injury. Mol Med Rep. 2017;15:3001-3010 pubmed publisher
Shen C, Kuo Y, Chen C, Chen M, Cheng Y. MMP1 expression is activated by Slug and enhances multi-drug resistance (MDR) in breast cancer. PLoS ONE. 2017;12:e0174487 pubmed publisher
Menicacci B, Laurenzana A, Chillà A, Margheri F, Peppicelli S, Tanganelli E, et al. Chronic Resveratrol Treatment Inhibits MRC5 Fibroblast SASP-Related Protumoral Effects on Melanoma Cells. J Gerontol A Biol Sci Med Sci. 2017;72:1187-1195 pubmed publisher
Riascos Bernal D, Chinnasamy P, Gross J, Almonte V, Egaña Gorroño L, Parikh D, et al. Inhibition of Smooth Muscle ?-Catenin Hinders Neointima Formation After Vascular Injury. Arterioscler Thromb Vasc Biol. 2017;37:879-888 pubmed publisher
Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed publisher
Bi Y, Shen W, Min M, Liu Y. MicroRNA-7 functions as a tumor-suppressor gene by regulating ILF2 in pancreatic carcinoma. Int J Mol Med. 2017;39:900-906 pubmed publisher
Chang Y, Lin T, Campbell M, Pan C, Lee S, Lee H, et al. REST is a crucial regulator for acquiring EMT-like and stemness phenotypes in hormone-refractory prostate cancer. Sci Rep. 2017;7:42795 pubmed publisher
Zhai S, Liu C, Zhang L, Zhu J, Guo J, Zhang J, et al. PLCE1 Promotes Esophageal Cancer Cell Progression by Maintaining the Transcriptional Activity of Snail. Neoplasia. 2017;19:154-164 pubmed publisher
Lim E, Nakanishi S, Hoghooghi V, Eaton S, Palmer A, Frederick A, et al. AlphaB-crystallin regulates remyelination after peripheral nerve injury. Proc Natl Acad Sci U S A. 2017;114:E1707-E1716 pubmed publisher
Mindos T, Dun X, North K, Doddrell R, Schulz A, Edwards P, et al. Merlin controls the repair capacity of Schwann cells after injury by regulating Hippo/YAP activity. J Cell Biol. 2017;216:495-510 pubmed publisher
Gemel J, Su Z, Gileles Hillel A, Khalyfa A, Gozal D, Beyer E. Intermittent hypoxia causes NOX2-dependent remodeling of atrial connexins. BMC Cell Biol. 2017;18:7 pubmed publisher
Yu M, Lu B, Liu Y, Me Y, Wang L, Li H. Interference with Tim-3 protein expression attenuates the invasion of clear cell renal cell carcinoma and aggravates anoikis. Mol Med Rep. 2017;15:1103-1108 pubmed publisher
Bershteyn M, Nowakowski T, Pollen A, Di Lullo E, Nene A, Wynshaw Boris A, et al. Human iPSC-Derived Cerebral Organoids Model Cellular Features of Lissencephaly and Reveal Prolonged Mitosis of Outer Radial Glia. Cell Stem Cell. 2017;20:435-449.e4 pubmed publisher
Fang S, Yu L, Mei H, Yang J, Gao T, Cheng A, et al. Cisplatin promotes mesenchymal-like characteristics in osteosarcoma through Snail. Oncol Lett. 2016;12:5007-5014 pubmed publisher
Maltabe V, Barka E, Kontonika M, Florou D, Kouvara Pritsouli M, Roumpi M, et al. Isolation of an ES-Derived Cardiovascular Multipotent Cell Population Based on VE-Cadherin Promoter Activity. Stem Cells Int. 2016;2016:8305624 pubmed publisher
Le Dour C, Macquart C, Sera F, Homma S, Bonne G, Morrow J, et al. Decreased WNT/?-catenin signalling contributes to the pathogenesis of dilated cardiomyopathy caused by mutations in the lamin a/C gene. Hum Mol Genet. 2017;26:333-343 pubmed publisher
Song L, Yu A, Murray K, Cortopassi G. Bipolar cell reduction precedes retinal ganglion neuron loss in a complex 1 knockout mouse model. Brain Res. 2017;1657:232-244 pubmed publisher
Hill S, Nesser N, Johnson Camacho K, Jeffress M, Johnson A, Boniface C, et al. Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling. Cell Syst. 2017;4:73-83.e10 pubmed publisher
Kusumoto H, Shintani Y, Kanzaki R, Kawamura T, Funaki S, Minami M, et al. Podocalyxin influences malignant potential by controlling epithelial-mesenchymal transition in lung adenocarcinoma. Cancer Sci. 2017;108:528-535 pubmed publisher
Yu J, Lei R, Zhuang X, Li X, Li G, Lev S, et al. MicroRNA-182 targets SMAD7 to potentiate TGF?-induced epithelial-mesenchymal transition and metastasis of cancer cells. Nat Commun. 2016;7:13884 pubmed publisher
Han X, Fang Z, Wang H, Jiao R, Zhou J, Fang N. CUL4A functions as an oncogene in ovarian cancer and is directly regulated by miR-494. Biochem Biophys Res Commun. 2016;480:675-681 pubmed publisher
Van Itallie C, Tietgens A, Anderson J. Visualizing the dynamic coupling of claudin strands to the actin cytoskeleton through ZO-1. Mol Biol Cell. 2017;28:524-534 pubmed publisher
Ma H, Wang L, Liu J, Qian L. Direct Cardiac Reprogramming as a Novel Therapeutic Strategy for Treatment of Myocardial Infarction. Methods Mol Biol. 2017;1521:69-88 pubmed
Bosch P, Fuller L, Sleeth C, Weiner J. Akirin2 is essential for the formation of the cerebral cortex. Neural Dev. 2016;11:21 pubmed
Chaudhury A, Cheema S, Fachini J, Kongchan N, Lu G, Simon L, et al. CELF1 is a central node in post-transcriptional regulatory programmes underlying EMT. Nat Commun. 2016;7:13362 pubmed publisher
Gong F, Guo Y, Niu Y, Jin J, Zhang X, Shi X, et al. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma. Oncotarget. 2017;8:315-328 pubmed publisher
Gilbert J, Man H. The X-Linked Autism Protein KIAA2022/KIDLIA Regulates Neurite Outgrowth via N-Cadherin and ?-Catenin Signaling. Eneuro. 2016;3: pubmed
Gao Y, Mruk D, Chen H, Lui W, Lee W, Cheng C. Regulation of the blood-testis barrier by a local axis in the testis: role of laminin ?2 in the basement membrane. FASEB J. 2017;31:584-597 pubmed publisher
Lian G, Dettenhofer M, Lu J, Downing M, Chenn A, Wong T, et al. Filamin A- and formin 2-dependent endocytosis regulates proliferation via the canonical Wnt pathway. Development. 2016;143:4509-4520 pubmed
Cain S, Mularczyk E, Singh M, Massam Wu T, Kielty C. ADAMTS-10 and -6 differentially regulate cell-cell junctions and focal adhesions. Sci Rep. 2016;6:35956 pubmed publisher
Polusani S, Kalmykov E, Chandrasekhar A, Zucker S, Nicholson B. Cell coupling mediated by connexin 26 selectively contributes to reduced adhesivity and increased migration. J Cell Sci. 2016;129:4399-4410 pubmed
Lobato Álvarez J, Roldán M, López Murillo T, González Ramírez R, Bonilla Delgado J, Shoshani L. The Apical Localization of Na+, K+-ATPase in Cultured Human Retinal Pigment Epithelial Cells Depends on Expression of the ?2 Subunit. Front Physiol. 2016;7:450 pubmed
Andrade A, Hope J, Allen A, Yorgan V, Lipscombe D, Pan J. A rare schizophrenia risk variant of CACNA1I disrupts CaV3.3 channel activity. Sci Rep. 2016;6:34233 pubmed publisher
Che D, Zhou T, Lan Y, Xie J, Gong H, Li C, et al. High glucose-induced epithelial-mesenchymal transition contributes to the upregulation of fibrogenic factors in retinal pigment epithelial cells. Int J Mol Med. 2016;38:1815-1822 pubmed publisher
Takeuchi S, Iwama S, Takagi H, Kiyota A, Nakashima K, Izumida H, et al. Tomosyn Negatively Regulates Arginine Vasopressin Secretion in Embryonic Stem Cell-Derived Neurons. PLoS ONE. 2016;11:e0164544 pubmed publisher
Shenoy A, Jin Y, Luo H, Tang M, Pampo C, Shao R, et al. Epithelial-to-mesenchymal transition confers pericyte properties on cancer cells. J Clin Invest. 2016;126:4174-4186 pubmed publisher
Mai H, Xu X, Mei G, Hong T, Huang J, Wang T, et al. The interplay between HPIP and casein kinase 1? promotes renal cell carcinoma growth and metastasis via activation of mTOR pathway. Oncogenesis. 2016;5:e260 pubmed publisher
Dubail J, Vasudevan D, Wang L, Earp S, Jenkins M, Haltiwanger R, et al. Impaired ADAMTS9 secretion: A potential mechanism for eye defects in Peters Plus Syndrome. Sci Rep. 2016;6:33974 pubmed publisher
Matos M, Lapyckyj L, Rosso M, Besso M, Mencucci M, Briggiler C, et al. Identification of a Novel Human E-Cadherin Splice Variant and Assessment of Its Effects Upon EMT-Related Events. J Cell Physiol. 2017;232:1368-1386 pubmed publisher
Cao R, Meng Z, Liu T, Wang G, Qian G, Cao T, et al. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway. Oncotarget. 2016;7:72941-72960 pubmed publisher
Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed publisher
Lee E, Wang J, Yumoto K, Jung Y, Cackowski F, Decker A, et al. DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis. Neoplasia. 2016;18:553-66 pubmed publisher
Kim M, Jeong J, Seo J, Kim H, Kim S, Jin W. Dysregulated JAK2 expression by TrkC promotes metastasis potential, and EMT program of metastatic breast cancer. Sci Rep. 2016;6:33899 pubmed publisher
Kong X, Liu F, Gao J. MiR-155 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells through the activation of PI3K/SGK3/β-catenin signaling pathways. Oncotarget. 2016;7:66051-66060 pubmed publisher
Vardaki I, Ceder S, Rutishauser D, Baltatzis G, Foukakis T, Panaretakis T. Periostin is identified as a putative metastatic marker in breast cancer-derived exosomes. Oncotarget. 2016;7:74966-74978 pubmed publisher
Li N, Lee W, Cheng C. Overexpression of plastin 3 in Sertoli cells disrupts actin microfilament bundle homeostasis and perturbs the tight junction barrier. Spermatogenesis. 2016;6:e1206353 pubmed publisher
Matkar P, Singh K, Rudenko D, Kim Y, Kuliszewski M, Prud homme G, et al. Novel regulatory role of neuropilin-1 in endothelial-to-mesenchymal transition and fibrosis in pancreatic ductal adenocarcinoma. Oncotarget. 2016;7:69489-69506 pubmed publisher
Szewczyk L, Brozko N, Nagalski A, RÃ¶ckle I, Werneburg S, Hildebrandt H, et al. ST8SIA2 promotes oligodendrocyte differentiation and the integrity of myelin and axons. Glia. 2017;65:34-49 pubmed publisher
Liu L, Phua Y, Lee R, Ma X, Jenkins Y, Novy K, et al. Homo- and Heterotypic Association Regulates Signaling by the SgK269/PEAK1 and SgK223 Pseudokinases. J Biol Chem. 2016;291:21571-21583 pubmed
Busse B, Bezrukov L, Blank P, Zimmerberg J. Resin embedded multicycle imaging (REMI): a tool to evaluate protein domains. Sci Rep. 2016;6:30284 pubmed publisher
Kim R, Kaushik N, Suh Y, Yoo K, Cui Y, Kim M, et al. Radiation driven epithelial-mesenchymal transition is mediated by Notch signaling in breast cancer. Oncotarget. 2016;7:53430-53442 pubmed publisher
Ku T, Swaney J, Park J, Albanese A, Murray E, Cho J, et al. Multiplexed and scalable super-resolution imaging of three-dimensional protein localization in size-adjustable tissues. Nat Biotechnol. 2016;34:973-81 pubmed publisher
Zeller P, Legendre A, Jacques S, Fleury M, Gilard F, Tcherkez G, et al. Hepatocytes cocultured with Sertoli cells in bioreactor favors Sertoli barrier tightness in rat. J Appl Toxicol. 2017;37:287-295 pubmed publisher
Li N, Mruk D, Chen H, Wong C, Lee W, Cheng C. Rescue of perfluorooctanesulfonate (PFOS)-mediated Sertoli cell injury by overexpression of gap junction protein connexin 43. Sci Rep. 2016;6:29667 pubmed publisher
Choi S, Kee H, Kurz T, Hansen F, Ryu Y, Kim G, et al. Class I HDACs specifically regulate E-cadherin expression in human renal epithelial cells. J Cell Mol Med. 2016;20:2289-2298 pubmed publisher
Pailler E, Oulhen M, Billiot F, Galland A, Auger N, Faugeroux V, et al. Method for semi-automated microscopy of filtration-enriched circulating tumor cells. BMC Cancer. 2016;16:477 pubmed publisher
Dorland Y, Malinova T, van Stalborch A, Grieve A, van Geemen D, Jansen N, et al. The F-BAR protein pacsin2 inhibits asymmetric VE-cadherin internalization from tensile adherens junctions. Nat Commun. 2016;7:12210 pubmed publisher
Cox A, Barrandon O, Cai E, Rios J, Chavez J, Bonnyman C, et al. Resolving Discrepant Findings on ANGPTL8 in ?-Cell Proliferation: A Collaborative Approach to Resolving the Betatrophin Controversy. PLoS ONE. 2016;11:e0159276 pubmed publisher
Grassi M, Palma C, Thomé C, Lanfredi G, Poersch A, Faça V. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control. J Proteomics. 2017;151:2-11 pubmed publisher
Yang S, Tsai C, Pan Y, Yeh C, Pang J, Takano M, et al. MART-10, a newly synthesized vitamin D analog, represses metastatic potential of head and neck squamous carcinoma cells. Drug Des Devel Ther. 2016;10:1995-2002 pubmed publisher
He Z, Forest F, Gain P, Rageade D, Bernard A, Acquart S, et al. 3D map of the human corneal endothelial cell. Sci Rep. 2016;6:29047 pubmed publisher
Gao Y, Lui W, Lee W, Cheng C. Polarity protein Crumbs homolog-3 (CRB3) regulates ectoplasmic specialization dynamics through its action on F-actin organization in Sertoli cells. Sci Rep. 2016;6:28589 pubmed publisher
Hou H, Chen L, Zha Z, Cai S, Tan M, Guo G, et al. Long form collapsin response mediator protein-1 promotes the migration and invasion of osteosarcoma cells. Oncol Lett. 2016;12:23-28 pubmed
Folmsbee S, Wilcox D, Tyberghein K, De Bleser P, Tourtellotte W, van Hengel J, et al. ?T-catenin in restricted brain cell types and its potential connection to autism. J Mol Psychiatry. 2016;4:2 pubmed publisher
Tisza M, Zhao W, Fuentes J, Prijic S, Chen X, Levental I, et al. Motility and stem cell properties induced by the epithelial-mesenchymal transition require destabilization of lipid rafts. Oncotarget. 2016;7:51553-51568 pubmed publisher
Li Q, Sodroski C, Lowey B, Schweitzer C, Cha H, Zhang F, et al. Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition. Proc Natl Acad Sci U S A. 2016;113:7620-5 pubmed publisher
Qi Y, Yu J, Han W, Fan X, Qian H, Wei H, et al. A splicing isoform of TEAD4 attenuates the Hippo-YAP signalling to inhibit tumour proliferation. Nat Commun. 2016;7:ncomms11840 pubmed publisher
De Cian M, Pauper E, Bandiera R, Vidal V, Sacco S, Gregoire E, et al. Amplification of R-spondin1 signaling induces granulosa cell fate defects and cancers in mouse adult ovary. Oncogene. 2017;36:208-218 pubmed publisher
Clark A, Petty H. Identification of lesion subtypes in biopsies of ductal carcinoma in situ of the breast using biomarker ratio imaging microscopy. Sci Rep. 2016;6:27039 pubmed publisher
Qi J, Li T, Bian H, Li F, Ju Y, Gao S, et al. SNAI1 promotes the development of HCC through the enhancement of proliferation and inhibition of apoptosis. FEBS Open Bio. 2016;6:326-37 pubmed publisher
Hong L, Pan F, Jiang H, Zhang L, Liu Y, Cai C, et al. miR-125b inhibited epithelial-mesenchymal transition of triple-negative breast cancer by targeting MAP2K7. Onco Targets Ther. 2016;9:2639-48 pubmed publisher
Chesnokova V, Zonis S, Zhou C, Recouvreux M, Ben Shlomo A, Araki T, et al. Growth hormone is permissive for neoplastic colon growth. Proc Natl Acad Sci U S A. 2016;113:E3250-9 pubmed publisher
Zhang H, Prado K, Zhang K, Peek E, Lee J, Wang X, et al. Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance. Clin Cancer Res. 2016;22:5349-5361 pubmed
Lee Y, Kim S, Song S, Hong H, Lee Y, Oh B, et al. Crosstalk between CCL7 and CCR3 promotes metastasis of colon cancer cells via ERK-JNK signaling pathways. Oncotarget. 2016;7:36842-36853 pubmed publisher
Bie Q, Sun C, Gong A, Li C, Su Z, Zheng D, et al. Non-tumor tissue derived interleukin-17B activates IL-17RB/AKT/Î²-catenin pathway to enhance the stemness of gastric cancer. Sci Rep. 2016;6:25447 pubmed publisher
Alaee M, Danesh G, Pasdar M. Plakoglobin Reduces the in vitro Growth, Migration and Invasion of Ovarian Cancer Cells Expressing N-Cadherin and Mutant p53. PLoS ONE. 2016;11:e0154323 pubmed publisher
García Bea A, Walker M, Hyde T, Kleinman J, Harrison P, Lane T. Metabotropic glutamate receptor 3 (mGlu3; mGluR3; GRM3) in schizophrenia: Antibody characterisation and a semi-quantitative western blot study. Schizophr Res. 2016;177:18-27 pubmed publisher
Shah B, Lutter D, Bochenek M, Kato K, Tsytsyura Y, Glyvuk N, et al. C3G/Rapgef1 Is Required in Multipolar Neurons for the Transition to a Bipolar Morphology during Cortical Development. PLoS ONE. 2016;11:e0154174 pubmed publisher
Chiang K, Yeh T, Chen S, Pang J, Yeh C, Hsu J, et al. The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic Potential. Int J Mol Sci. 2016;17: pubmed publisher
Liu S, Zhou F, Shen Y, Zhang Y, Yin H, Zeng Y, et al. Fluid shear stress induces epithelial-mesenchymal transition (EMT) in Hep-2 cells. Oncotarget. 2016;7:32876-92 pubmed publisher
Montalbano M, Curcurù G, Shirafkan A, Vento R, Rastellini C, Cicalese L. Modeling of Hepatocytes Proliferation Isolated from Proximal and Distal Zones from Human Hepatocellular Carcinoma Lesion. PLoS ONE. 2016;11:e0153613 pubmed publisher
Wen M, Wang J, Chiu Y, Wang M, Lee S, Tai C. N-Cadherin Regulates Cell Migration Through a Rab5-Dependent Temporal Control of Macropinocytosis. Traffic. 2016;17:769-85 pubmed publisher
Huang M, Liu T, Ma P, Mitteer R, Zhang Z, Kim H, et al. c-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma. J Clin Invest. 2016;126:1801-14 pubmed publisher
Yu J, Berga S, Johnston MacAnanny E, Sidell N, Bagchi I, Bagchi M, et al. Endometrial Stromal Decidualization Responds Reversibly to Hormone Stimulation and Withdrawal. Endocrinology. 2016;157:2432-46 pubmed publisher
Falcão V, Maschio D, de Fontes C, Oliveira R, Santos Silva J, Almeida A, et al. Reduced insulin secretion function is associated with pancreatic islet redistribution of cell adhesion molecules (CAMS) in diabetic mice after prolonged high-fat diet. Histochem Cell Biol. 2016;146:13-31 pubmed publisher
Yin K, Yin W, Wang Y, Zhou L, Liu Y, Yang G, et al. MiR-206 suppresses epithelial mesenchymal transition by targeting TGF-? signaling in estrogen receptor positive breast cancer cells. Oncotarget. 2016;7:24537-48 pubmed publisher
Park S, Kim J, Kim N, Yang K, Shim J, Heo K. Estradiol, TGF-?1 and hypoxia promote breast cancer stemness and EMT-mediated breast cancer migration. Oncol Lett. 2016;11:1895-1902 pubmed
Chen H, Mruk D, Lee W, Cheng C. Planar Cell Polarity (PCP) Protein Vangl2 Regulates Ectoplasmic Specialization Dynamics via Its Effects on Actin Microfilaments in the Testes of Male Rats. Endocrinology. 2016;157:2140-59 pubmed publisher
Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
Thakur A, Nigri J, Lac S, Leca J, Bressy C, Berthezene P, et al. TAp73 loss favors Smad-independent TGF-Î² signaling that drives EMT in pancreatic ductal adenocarcinoma. Cell Death Differ. 2016;23:1358-70 pubmed publisher
Chang H, Liu Y, Xue M, Liu H, Du S, Zhang L, et al. Synergistic action of master transcription factors controls epithelial-to-mesenchymal transition. Nucleic Acids Res. 2016;44:2514-27 pubmed publisher
Chang T, Chen C, Wu Y, Liu J, Kuo Y, Lee K, et al. Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma. PLoS ONE. 2016;11:e0149897 pubmed publisher
Li D, Sinha T, Ajima R, Seo H, Yamaguchi T, Wang J. Spatial regulation of cell cohesion by Wnt5a during second heart field progenitor deployment. Dev Biol. 2016;412:18-31 pubmed publisher
Yang Z, Liu S, Zhu M, Zhang H, Wang J, Xu Q, et al. PS341 inhibits hepatocellular and colorectal cancer cells through the FOXO3/CTNNB1 signaling pathway. Sci Rep. 2016;6:22090 pubmed publisher
Zou M, Zhu W, Wang L, Shi L, Gao R, Ou Y, et al. AEG-1/MTDH-activated autophagy enhances human malignant glioma susceptibility to TGF-Î²1-triggered epithelial-mesenchymal transition. Oncotarget. 2016;7:13122-38 pubmed publisher
Wang X, Ma C, Zong Z, Xiao Y, Li N, Guo C, et al. A20 inhibits the motility of HCC cells induced by TNF-Î±. Oncotarget. 2016;7:14742-54 pubmed publisher
Lee S, Shatadal S, Griep A. Dlg-1 Interacts With and Regulates the Activities of Fibroblast Growth Factor Receptors and EphA2 in the Mouse Lens. Invest Ophthalmol Vis Sci. 2016;57:707-18 pubmed publisher
Jackson S, Olufs Z, Tran K, Zaidan N, Sridharan R. Alternative Routes to Induced Pluripotent Stem Cells Revealed by Reprogramming of the Neural Lineage. Stem Cell Reports. 2016;6:302-11 pubmed publisher
Skardal A, Devarasetty M, Forsythe S, Atala A, Soker S. A reductionist metastasis-on-a-chip platform for in vitro tumor progression modeling and drug screening. Biotechnol Bioeng. 2016;113:2020-32 pubmed publisher
Chojnacka K, Bilinska B, Mruk D. Interleukin 1alpha-induced disruption of the Sertoli cell cytoskeleton affects gap junctional communication. Cell Signal. 2016;28:469-480 pubmed publisher
Kim D, Helfman D. Loss of MLCK leads to disruption of cell-cell adhesion and invasive behavior of breast epithelial cells via increased expression of EGFR and ERK/JNK signaling. Oncogene. 2016;35:4495-508 pubmed publisher
Wang X, Jung Y, Jun S, Lee S, Wang W, Schneider A, et al. PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemness. Nat Commun. 2016;7:10633 pubmed publisher
Sun H, Chen J, Qian W, Kang J, Wang J, Jiang L, et al. Integrated long non-coding RNA analyses identify novel regulators of epithelial-mesenchymal transition in the mouse model of pulmonary fibrosis. J Cell Mol Med. 2016;20:1234-46 pubmed publisher
Bertoldo M, Guibert E, Faure M, Guillou F, RamÃ© C, Nadal Desbarats L, et al. Specific deletion of AMP-activated protein kinase (Î±1AMPK) in mouse Sertoli cells modifies germ cell quality. Mol Cell Endocrinol. 2016;423:96-112 pubmed publisher
Little E, Camp E, Wang C, Watson P, Watson D, Cole D. The CaSm (LSm1) oncogene promotes transformation, chemoresistance and metastasis of pancreatic cancer cells. Oncogenesis. 2016;5:e182 pubmed publisher
Yue X, Zhao Y, Zhang C, Li J, Liu Z, Liu J, et al. Leukemia inhibitory factor promotes EMT through STAT3-dependent miR-21 induction. Oncotarget. 2016;7:3777-90 pubmed publisher
Noh H, Hah Y, Ha J, Kang M, Zada S, Rha S, et al. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity. Oncotarget. 2016;7:4632-46 pubmed publisher
Wang F, Feng Y, Li P, Wang K, Feng L, Liu Y, et al. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma. Oncotarget. 2016;7:4279-97 pubmed publisher
Li N, Mruk D, Mok K, Li M, Wong C, Lee W, et al. Connexin 43 reboots meiosis and reseals blood-testis barrier following toxicant-mediated aspermatogenesis and barrier disruption. FASEB J. 2016;30:1436-52 pubmed publisher
Yan L, Liu Y, Xiang J, Wu Q, Xu L, Luo X, et al. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer. Int J Oncol. 2016;48:471-84 pubmed publisher
Wang G, Yu Y, Sun C, Liu T, Liang T, Zhan L, et al. STAT3 selectively interacts with Smad3 to antagonize TGF-Î² signalling. Oncogene. 2016;35:4388-98 pubmed publisher
Bartscht T, Rosien B, Rades D, Kaufmann R, Biersack H, Lehnert H, et al. Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad signalling: implications for in vivo mode of action. Mol Cancer. 2015;14:199 pubmed publisher
Lyon C, Wadey K, George S. Soluble N-cadherin: A novel inhibitor of VSMC proliferation and intimal thickening. Vascul Pharmacol. 2016;78:53-62 pubmed publisher
Wang J, Lu R, Yang J, Li H, He Z, Jing N, et al. TRPC6 specifically interacts with APP to inhibit its cleavage by Î³-secretase and reduce AÎ² production. Nat Commun. 2015;6:8876 pubmed publisher
Fridriksdottir A, Kim J, Villadsen R, Klitgaard M, Hopkinson B, Petersen O, et al. Propagation of oestrogen receptor-positive and oestrogen-responsive normal human breast cells in culture. Nat Commun. 2015;6:8786 pubmed publisher
Bhate A, Parker D, Bebee T, Ahn J, Arif W, Rashan E, et al. ESRP2 controls an adult splicing programme in hepatocytes to support postnatal liver maturation. Nat Commun. 2015;6:8768 pubmed publisher
Koudelkova P, Weber G, Mikulits W. Liver Sinusoidal Endothelial Cells Escape Senescence by Loss of p19ARF. PLoS ONE. 2015;10:e0142134 pubmed publisher
McCart Reed A, Kutasovic J, Vargas A, Jayanthan J, Al Murrani A, Reid L, et al. An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas. J Pathol. 2016;238:489-94 pubmed publisher
Burns J, Kelly M, Hoa M, Morell R, Kelley M. Single-cell RNA-Seq resolves cellular complexity in sensory organs from the neonatal inner ear. Nat Commun. 2015;6:8557 pubmed publisher
Ou Yang L, Xiao S, Liu P, Yi S, Zhang X, Ou Yang S, et al. Forkhead box C1 induces epithelial‑mesenchymal transition and is a potential therapeutic target in nasopharyngeal carcinoma. Mol Med Rep. 2015;12:8003-9 pubmed publisher
Nassal M, Werdich A, Wan X, Hoshi M, DeschÃªnes I, Rosenbaum D, et al. Phosphorylation at Connexin43 Serine-368 Is Necessary for Myocardial Conduction During Metabolic Stress. J Cardiovasc Electrophysiol. 2016;27:110-9 pubmed publisher
Arya P, Rainey M, Bhattacharyya S, Mohapatra B, George M, Kuracha M, et al. The endocytic recycling regulatory protein EHD1 Is required for ocular lens development. Dev Biol. 2015;408:41-55 pubmed publisher
MartÃnez Revollar G, Garay E, Martín Tapia D, Nava P, Huerta M, Lopez Bayghen E, et al. Heterogeneity between triple negative breast cancer cells due to differential activation of Wnt and PI3K/AKT pathways. Exp Cell Res. 2015;339:67-80 pubmed publisher
Marchi S, Corricelli M, Trapani E, Bravi L, Pittaro A, Delle Monache S, et al. Defective autophagy is a key feature of cerebral cavernous malformations. EMBO Mol Med. 2015;7:1403-17 pubmed publisher
Nagaoka K, Fujii K, Zhang H, Usuda K, Watanabe G, Ivshina M, et al. CPEB1 mediates epithelial-to-mesenchyme transition and breast cancer metastasis. Oncogene. 2016;35:2893-901 pubmed publisher
Yan M, Yao C, Chow J, Chang C, Hwang P, Chuang S, et al. Fucoidan Elevates MicroRNA-29b to Regulate DNMT3B-MTSS1 Axis and Inhibit EMT in Human Hepatocellular Carcinoma Cells. Mar Drugs. 2015;13:6099-116 pubmed publisher
Yokdang N, Hatakeyama J, Wald J, Simion C, Tellez J, Chang D, et al. LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells. Oncogene. 2016;35:2932-47 pubmed publisher
Basheer W, Harris B, Mentrup H, Abreha M, Thames E, Lea J, et al. Cardiomyocyte-specific overexpression of the ubiquitin ligase Wwp1 contributes to reduction in Connexin 43 and arrhythmogenesis. J Mol Cell Cardiol. 2015;88:1-13 pubmed publisher
Poitelon Y, Bogni S, Matafora V, Della Flora Nunes G, Hurley E, Ghidinelli M, et al. Spatial mapping of juxtacrine axo-glial interactions identifies novel molecules in peripheral myelination. Nat Commun. 2015;6:8303 pubmed publisher
Reuther C, Heinzle V, Spampatti M, Vlotides G, de Toni E, Spöttl G, et al. Cabozantinib and Tivantinib, but Not INC280, Induce Antiproliferative and Antimigratory Effects in Human Neuroendocrine Tumor Cells in vitro: Evidence for 'Off-Target' Effects Not Mediated by c-Met Inhibition. Neuroendocrinology. 2016;103:383-401 pubmed publisher
Brigidi G, Santyr B, Shimell J, Jovellar B, Bamji S. Activity-regulated trafficking of the palmitoyl-acyl transferase DHHC5. Nat Commun. 2015;6:8200 pubmed publisher
Noritake K, Aki T, Funakoshi T, Unuma K, Uemura K. Direct Exposure to Ethanol Disrupts Junctional Cell-Cell Contact and Hippo-YAP Signaling in HL-1 Murine Atrial Cardiomyocytes. PLoS ONE. 2015;10:e0136952 pubmed publisher
Gonzalez J, Ramachandran J, Xie L, Contreras J, Fraidenraich D. Selective Connexin43 Inhibition Prevents Isoproterenol-Induced Arrhythmias and Lethality in Muscular Dystrophy Mice. Sci Rep. 2015;5:13490 pubmed publisher
He S, Zhao Z, Yang Y, O Connell D, Zhang X, Oh S, et al. Truncating mutation in the autophagy gene UVRAG confers oncogenic properties and chemosensitivity in colorectal cancers. Nat Commun. 2015;6:7839 pubmed publisher
Russell R, Perkhofer L, Liebau S, Lin Q, Lechel A, Feld F, et al. Loss of ATM accelerates pancreatic cancer formation and epithelial-mesenchymal transition. Nat Commun. 2015;6:7677 pubmed publisher
Xu J, Wan P, Wang M, Zhang J, Gao X, Hu B, et al. AIP1-mediated actin disassembly is required for postnatal germ cell migration and spermatogonial stem cell niche establishment. Cell Death Dis. 2015;6:e1818 pubmed publisher
Nagahara T, Shiraha H, Sawahara H, Uchida D, Takeuchi Y, Iwamuro M, et al. Hepatic stellate cells promote upregulation of epithelial cell adhesion molecule and epithelial-mesenchymal transition in hepatic cancer cells. Oncol Rep. 2015;34:1169-77 pubmed publisher
O Carroll S, Kho D, Wiltshire R, Nelson V, Rotimi O, Johnson R, et al. Pro-inflammatory TNFÎ± and IL-1Î² differentially regulate the inflammatory phenotype of brain microvascular endothelial cells. J Neuroinflammation. 2015;12:131 pubmed publisher
Preuße K, Tveriakhina L, Schuster Gossler K, Gaspar C, Rosa A, Henrique D, et al. Context-Dependent Functional Divergence of the Notch Ligands DLL1 and DLL4 In Vivo. PLoS Genet. 2015;11:e1005328 pubmed publisher
Lee Y, Han M, Baek S, Kim S, Oh S. MED30 Regulates the Proliferation and Motility of Gastric Cancer Cells. PLoS ONE. 2015;10:e0130826 pubmed publisher
Lindskog C, LinnÃ© J, Fagerberg L, HallstrÃ¶m B, Sundberg C, Lindholm M, et al. The human cardiac and skeletal muscle proteomes defined by transcriptomics and antibody-based profiling. BMC Genomics. 2015;16:475 pubmed publisher
Rojas F, Gonzalez D, Cortes N, Ampuero E, HernÃ¡ndez D, Fritz E, et al. Reactive oxygen species trigger motoneuron death in non-cell-autonomous models of ALS through activation of c-Abl signaling. Front Cell Neurosci. 2015;9:203 pubmed publisher
Rode K, Sieme H, Richterich P, Brehm R. Characterization of the equine blood-testis barrier during tubular development in normal and cryptorchid stallions. Theriogenology. 2015;84:763-72 pubmed publisher
Li N, Mruk D, Wong C, Lee W, Han D, Cheng C. Actin-bundling protein plastin 3 is a regulator of ectoplasmic specialization dynamics during spermatogenesis in the rat testis. FASEB J. 2015;29:3788-805 pubmed publisher
Zhang W, Gu Y, Sun Q, Siegel D, Tolias P, Yang Z, et al. Ex Vivo Maintenance of Primary Human Multiple Myeloma Cells through the Optimization of the Osteoblastic Niche. PLoS ONE. 2015;10:e0125995 pubmed publisher
Liu S, Tetzlaff M, Wang T, Yang R, Xie L, Zhang G, et al. miR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment. Pigment Cell Melanoma Res. 2015;28:431-41 pubmed publisher
Giribaldi M, Muñoz A, Halvorsen K, Patel A, Rai P. MTH1 expression is required for effective transformation by oncogenic HRAS. Oncotarget. 2015;6:11519-29 pubmed
ORELLANA R, Kato S, Erices R, Bravo M, Gonzalez P, Oliva B, et al. Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cells. BMC Cancer. 2015;15:290 pubmed publisher
Zarzycka M, Chojnacka K, Mruk D, Górowska E, Hejmej A, Kotula Balak M, et al. Flutamide alters the distribution of c-Src and affects the N-cadherin-Î²-catenin complex in the seminiferous epithelium of adult rat. Andrology. 2015;3:569-81 pubmed publisher
Li Y, Drabsch Y, Pujuguet P, Ren J, van Laar T, Zhang L, et al. Genetic depletion and pharmacological targeting of Î±v integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models. Breast Cancer Res. 2015;17:28 pubmed publisher
Mandara M, Reginato A, Foiani G, Baroni M, Poli F, Gasparinetti N, et al. Papillary meningioma in the dog: A clinicopathological case series study. Res Vet Sci. 2015;100:213-9 pubmed publisher
Yarilin D, Xu K, Turkekul M, Fan N, Romin Y, Fijisawa S, et al. Machine-based method for multiplex in situ molecular characterization of tissues by immunofluorescence detection. Sci Rep. 2015;5:9534 pubmed publisher
Malchenko S, Sredni S, Hashimoto H, Kasai A, Nagayasu K, Xie J, et al. A mouse model of human primitive neuroectodermal tumors resulting from microenvironmentally-driven malignant transformation of orthotopically transplanted radial glial cells. PLoS ONE. 2015;10:e0121707 pubmed publisher
BazelliÃ¨res E, Conte V, Elosegui Artola A, Serra Picamal X, Bintanel Morcillo M, Roca Cusachs P, et al. Control of cell-cell forces and collective cell dynamics by the intercellular adhesome. Nat Cell Biol. 2015;17:409-20 pubmed publisher
Skardal A, Devarasetty M, Rodman C, Atala A, Soker S. Liver-Tumor Hybrid Organoids for Modeling Tumor Growth and Drug Response In Vitro. Ann Biomed Eng. 2015;43:2361-73 pubmed publisher
Tom Dieck S, Kochen L, Hanus C, HeumÃ¼ller M, Bartnik I, Nassim Assir B, et al. Direct visualization of newly synthesized target proteins in situ. Nat Methods. 2015;12:411-4 pubmed publisher
Qiao Y, Shiue C, Zhu J, Zhuang T, Jonsson P, Wright A, et al. AP-1-mediated chromatin looping regulates ZEB2 transcription: new insights into TNFÎ±-induced epithelial-mesenchymal transition in triple-negative breast cancer. Oncotarget. 2015;6:7804-14 pubmed
Tennakoon A, Izawa T, Wijesundera K, Katou Ichikawa C, Tanaka M, Golbar H, et al. Analysis of glial fibrillary acidic protein (GFAP)-expressing ductular cells in a rat liver cirrhosis model induced by repeated injections of thioacetamide (TAA). Exp Mol Pathol. 2015;98:476-85 pubmed publisher
Kageyama T, Hayashi R, Hara S, Yoshikawa K, Ishikawa Y, Yamato M, et al. Spontaneous acquisition of infinite proliferative capacity by a rabbit corneal endothelial cell line with maintenance of phenotypic and physiological characteristics. J Tissue Eng Regen Med. 2017;11:1057-1064 pubmed publisher
Lin Y, Yang Z, Xu A, Dong P, Huang Y, Liu H, et al. PIK3R1 negatively regulates the epithelial-mesenchymal transition and stem-like phenotype of renal cancer cells through the AKT/GSK3Î²/CTNNB1 signaling pathway. Sci Rep. 2015;5:8997 pubmed publisher
Wang G, Liu G, Ye Y, Fu Y, Zhang X. The role of microRNA-1274a in the tumorigenesis of gastric cancer: accelerating cancer cell proliferation and migration via directly targeting FOXO4. Biochem Biophys Res Commun. 2015;459:629-35 pubmed publisher
Yuan L, Seong E, Beuscher J, Arikkath J. Î´-Catenin Regulates Spine Architecture via Cadherin and PDZ-dependent Interactions. J Biol Chem. 2015;290:10947-57 pubmed publisher
Jiang X, Ma T, Zhang Y, Zhang H, Yin S, Zheng W, et al. Specific deletion of Cdh2 in Sertoli cells leads to altered meiotic progression and subfertility of mice. Biol Reprod. 2015;92:79 pubmed publisher
Cai K, Wang Y, Smith E, Smedberg J, Yang D, Yang W, et al. Global deletion of Trp53 reverts ovarian tumor phenotype of the germ cell-deficient white spotting variant (Wv) mice. Neoplasia. 2015;17:89-100 pubmed publisher
Zhang J, Upadhya D, Lu L, Reneker L. Fibroblast growth factor receptor 2 (FGFR2) is required for corneal epithelial cell proliferation and differentiation during embryonic development. PLoS ONE. 2015;10:e0117089 pubmed publisher
Gong X, Yi J, Carmon K, Crumbley C, Xiong W, Thomas A, et al. Aberrant RSPO3-LGR4 signaling in Keap1-deficient lung adenocarcinomas promotes tumor aggressiveness. Oncogene. 2015;34:4692-701 pubmed publisher
Samulitis B, Pond K, Pond E, Cress A, Patel H, Wisner L, et al. Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors. Cancer Biol Ther. 2015;16:43-51 pubmed publisher
Xu M, Zhu C, Zhao X, Chen C, Zhang H, Yuan H, et al. Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors. Oncotarget. 2015;6:979-94 pubmed
Davidson B, Holth A, Hellesylt E, Tan T, Huang R, TropÃ© C, et al. The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions. Hum Pathol. 2015;46:1-8 pubmed publisher
Busskamp V, Lewis N, Guye P, Ng A, Shipman S, Byrne S, et al. Rapid neurogenesis through transcriptional activation in human stem cells. Mol Syst Biol. 2014;10:760 pubmed publisher
Lee Y, Ehninger D, Zhou M, Oh J, Kang M, Kwak C, et al. Mechanism and treatment for learning and memory deficits in mouse models of Noonan syndrome. Nat Neurosci. 2014;17:1736-43 pubmed publisher
Tao W, Moore R, Smith E, Xu X. Hormonal induction and roles of Disabled-2 in lactation and involution. PLoS ONE. 2014;9:e110737 pubmed publisher
Phillips Krawczak C, Singla A, Starokadomskyy P, Deng Z, Osborne D, Li H, et al. COMMD1 is linked to the WASH complex and regulates endosomal trafficking of the copper transporter ATP7A. Mol Biol Cell. 2015;26:91-103 pubmed publisher
Sun Q, Cibas E, Huang H, Hodgson L, Overholtzer M. Induction of entosis by epithelial cadherin expression. Cell Res. 2014;24:1288-98 pubmed publisher
Suh S, Yoo J, Cui R, Kaur B, Huebner K, Lee T, et al. FHIT suppresses epithelial-mesenchymal transition (EMT) and metastasis in lung cancer through modulation of microRNAs. PLoS Genet. 2014;10:e1004652 pubmed publisher
Cai X, Dai Z, Reeves R, Caballero Benítez A, Duran K, Delrow J, et al. Autonomous stimulation of cancer cell plasticity by the human NKG2D lymphocyte receptor coexpressed with its ligands on cancer cells. PLoS ONE. 2014;9:e108942 pubmed publisher
Lu H, Clauser K, Tam W, FrÃ¶se J, Ye X, Eaton E, et al. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages. Nat Cell Biol. 2014;16:1105-17 pubmed publisher
Wei H, Nickoloff J, Chen W, Liu H, Lo W, Chang Y, et al. FOXF1 mediates mesenchymal stem cell fusion-induced reprogramming of lung cancer cells. Oncotarget. 2014;5:9514-29 pubmed
Sun Y, Hu L, Zheng H, Bagnoli M, Guo Y, Rupaimoole R, et al. MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer. J Pathol. 2015;235:25-36 pubmed publisher
Mok K, Mruk D, Cheng C. rpS6 regulates blood-testis barrier dynamics through Akt-mediated effects on MMP-9. J Cell Sci. 2014;127:4870-82 pubmed publisher
Ye T, Ip J, Fu A, Ip N. Cdk5-mediated phosphorylation of RapGEF2 controls neuronal migration in the developing cerebral cortex. Nat Commun. 2014;5:4826 pubmed publisher
Li J, Liu J, Li P, Mao X, Li W, Yang J, et al. Loss of LKB1 disrupts breast epithelial cell polarity and promotes breast cancer metastasis and invasion. J Exp Clin Cancer Res. 2014;33:70 pubmed publisher
Friedman L, Riemslagh F, Sullivan J, Mesias R, Williams F, Huntley G, et al. Cadherin-8 expression, synaptic localization, and molecular control of neuronal form in prefrontal corticostriatal circuits. J Comp Neurol. 2015;523:75-92 pubmed publisher
Chen F, Zhuang M, Peng J, Wang X, Huang T, Li S, et al. Baicalein inhibits migration and invasion of gastric cancer cells through suppression of the TGF-Î² signaling pathway. Mol Med Rep. 2014;10:1999-2003 pubmed publisher
Gou W, Zhao Y, Lu H, Yang X, Xiu Y, Zhao S, et al. The role of RhoC in epithelial-to-mesenchymal transition of ovarian carcinoma cells. BMC Cancer. 2014;14:477 pubmed publisher
Ohkawa T, Satake S, Yokoi N, Miyazaki Y, Ohshita T, Sobue G, et al. Identification and characterization of GABA(A) receptor autoantibodies in autoimmune encephalitis. J Neurosci. 2014;34:8151-63 pubmed publisher
Kudo Sakamoto Y, Akazawa H, Ito K, Takano J, Yano M, Yabumoto C, et al. Calpain-dependent cleavage of N-cadherin is involved in the progression of post-myocardial infarction remodeling. J Biol Chem. 2014;289:19408-19 pubmed publisher
Katanosaka Y, Iwasaki K, Ujihara Y, Takatsu S, Nishitsuji K, Kanagawa M, et al. TRPV2 is critical for the maintenance of cardiac structure and function in mice. Nat Commun. 2014;5:3932 pubmed publisher
Karayannis T, Au E, Patel J, Kruglikov I, Markx S, Delorme R, et al. Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission. Nature. 2014;511:236-40 pubmed
Jung S, Ohk J, Jeong D, Li C, Lee S, Duan J, et al. Distinct regulatory effect of the p34SEI-1 oncoprotein on cancer metastasis in HER2/neu-positive and -negative cells. Int J Oncol. 2014;45:189-96 pubmed publisher
Nikitczuk J, Patil S, Matikainen Ankney B, Scarpa J, Shapiro M, Benson D, et al. N-cadherin regulates molecular organization of excitatory and inhibitory synaptic circuits in adult hippocampus in vivo. Hippocampus. 2014;24:943-962 pubmed publisher
Gong K, Kung L, Magni G, Bhargava A, Jasmin L. Increased response to glutamate in small diameter dorsal root ganglion neurons after sciatic nerve injury. PLoS ONE. 2014;9:e95491 pubmed publisher
Hatakeyama J, Wakamatsu Y, Nagafuchi A, Kageyama R, Shigemoto R, Shimamura K. Cadherin-based adhesions in the apical endfoot are required for active Notch signaling to control neurogenesis in vertebrates. Development. 2014;141:1671-82 pubmed publisher
Mato E, Gonzalez C, Moral A, Pérez J, Bell O, Lerma E, et al. ABCG2/BCRP gene expression is related to epithelial-mesenchymal transition inducer genes in a papillary thyroid carcinoma cell line (TPC-1). J Mol Endocrinol. 2014;52:289-300 pubmed publisher
Reaves D, Fagan Solis K, Dunphy K, Oliver S, Scott D, Fleming J. The role of lipolysis stimulated lipoprotein receptor in breast cancer and directing breast cancer cell behavior. PLoS ONE. 2014;9:e91747 pubmed publisher
Sehgal L, Mukhopadhyay A, Rajan A, Khapare N, Sawant M, Vishal S, et al. 14-3-3?-Mediated transport of plakoglobin to the cell border is required for the initiation of desmosome assembly in vitro and in vivo. J Cell Sci. 2014;127:2174-88 pubmed publisher
Toyoshima D, Mandai K, Maruo T, Supriyanto I, Togashi H, Inoue T, et al. Afadin regulates puncta adherentia junction formation and presynaptic differentiation in hippocampal neurons. PLoS ONE. 2014;9:e89763 pubmed publisher
Yoshida T, Ozawa Y, Kimura T, Sato Y, Kuznetsov G, Xu S, et al. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states. Br J Cancer. 2014;110:1497-505 pubmed publisher
Peitsch W, Doerflinger Y, Fischer Colbrie R, Huck V, Bauer A, Utikal J, et al. Desmoglein 2 depletion leads to increased migration and upregulation of the chemoattractant secretoneurin in melanoma cells. PLoS ONE. 2014;9:e89491 pubmed publisher
Brueggmann D, Templeman C, Starzinski Powitz A, Rao N, Gayther S, Lawrenson K. Novel three-dimensional in vitro models of ovarian endometriosis. J Ovarian Res. 2014;7:17 pubmed publisher
Moore R, Tao W, Meng Y, Smith E, Xu X. Cell adhesion and sorting in embryoid bodies derived from N- or E-cadherin deficient murine embryonic stem cells. Biol Open. 2014;3:121-8 pubmed publisher
Fantozzi A, Gruber D, Pisarsky L, Heck C, Kunita A, Yilmaz M, et al. VEGF-mediated angiogenesis links EMT-induced cancer stemness to tumor initiation. Cancer Res. 2014;74:1566-75 pubmed publisher
Miura S, Hamada S, Masamune A, Satoh K, Shimosegawa T. CUB-domain containing protein 1 represses the epithelial phenotype of pancreatic cancer cells. Exp Cell Res. 2014;321:209-18 pubmed publisher
Zaganjor E, Osborne J, Weil L, Díaz Martínez L, Gonzales J, Singel S, et al. Ras regulates kinesin 13 family members to control cell migration pathways in transformed human bronchial epithelial cells. Oncogene. 2014;33:5457-66 pubmed publisher
Mei H, Nakatsu M, Baclagon E, Deng S. Frizzled 7 maintains the undifferentiated state of human limbal stem/progenitor cells. Stem Cells. 2014;32:938-45 pubmed publisher
Almenar Queralt A, Kim S, Benner C, Herrera C, Kang D, Garcia Bassets I, et al. Presenilins regulate neurotrypsin gene expression and neurotrypsin-dependent agrin cleavage via cyclic AMP response element-binding protein (CREB) modulation. J Biol Chem. 2013;288:35222-36 pubmed publisher
Haisler W, Timm D, Gage J, Tseng H, Killian T, Souza G. Three-dimensional cell culturing by magnetic levitation. Nat Protoc. 2013;8:1940-9 pubmed publisher
Kumar M, Allison D, Baranova N, Wamsley J, Katz A, Bekiranov S, et al. NF-?B regulates mesenchymal transition for the induction of non-small cell lung cancer initiating cells. PLoS ONE. 2013;8:e68597 pubmed publisher
Prox J, Bernreuther C, Altmeppen H, Grendel J, Glatzel M, D Hooge R, et al. Postnatal disruption of the disintegrin/metalloproteinase ADAM10 in brain causes epileptic seizures, learning deficits, altered spine morphology, and defective synaptic functions. J Neurosci. 2013;33:12915-28, 12928a pubmed publisher
Stover A, Brick D, Nethercott H, Banuelos M, Sun L, O Dowd D, et al. Process-based expansion and neural differentiation of human pluripotent stem cells for transplantation and disease modeling. J Neurosci Res. 2013;91:1247-62 pubmed publisher
Sjödahl G, Lövgren K, Lauss M, Patschan O, Gudjonsson S, Chebil G, et al. Toward a molecular pathologic classification of urothelial carcinoma. Am J Pathol. 2013;183:681-91 pubmed publisher
Maddaluno L, Rudini N, Cuttano R, Bravi L, Giampietro C, Corada M, et al. EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature. 2013;498:492-6 pubmed publisher
Sigurdsson V, Ingthorsson S, Hilmarsdottir B, Gustafsdottir S, Franzdóttir S, Arason A, et al. Expression and functional role of sprouty-2 in breast morphogenesis. PLoS ONE. 2013;8:e60798 pubmed publisher
Qian X, Mruk D, Cheng C. Rai14 (retinoic acid induced protein 14) is involved in regulating f-actin dynamics at the ectoplasmic specialization in the rat testis*. PLoS ONE. 2013;8:e60656 pubmed publisher
Lee J, Mhawech Fauceglia P, Lee N, Parsanian L, Lin Y, Gayther S, et al. A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro. Lab Invest. 2013;93:528-42 pubmed publisher
Rakha E, Teoh T, Lee A, Nolan C, Ellis I, Green A. Further evidence that E-cadherin is not a tumour suppressor gene in invasive ductal carcinoma of the breast: an immunohistochemical study. Histopathology. 2013;62:695-701 pubmed publisher
Martiáñez T, Lamarca A, Casals N, Gella A. N-cadherin expression is regulated by UTP in schwannoma cells. Purinergic Signal. 2013;9:259-70 pubmed publisher
Danielson L, Park D, Rotllan N, Chamorro Jorganes A, Guijarro M, Fernandez Hernando C, et al. Cardiovascular dysregulation of miR-17-92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis. FASEB J. 2013;27:1460-7 pubmed publisher
Wang Q, Lin J, Chan S, Lin J. The Xin repeat-containing protein, mXinβ, initiates the maturation of the intercalated discs during postnatal heart development. Dev Biol. 2013;374:264-80 pubmed publisher
Tran M, Choi W, Wszolek M, Navai N, Lee I, Nitti G, et al. The p63 protein isoform ?Np63? inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205. J Biol Chem. 2013;288:3275-88 pubmed publisher
Nagaishi M, Nobusawa S, Tanaka Y, Ikota H, Yokoo H, Nakazato Y. Slug, twist, and E-cadherin as immunohistochemical biomarkers in meningeal tumors. PLoS ONE. 2012;7:e46053 pubmed publisher
Ezponda T, Popovic R, Shah M, Martinez Garcia E, Zheng Y, Min D, et al. The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer. Oncogene. 2013;32:2882-90 pubmed publisher
Tang E, Xiao X, Mruk D, Qian X, Mok K, Jenardhanan P, et al. Microtubule affinity-regulating kinase 4 (MARK4) is a component of the ectoplasmic specialization in the rat testis. Spermatogenesis. 2012;2:117-126 pubmed
Swope D, Li J, Muller E, Radice G. Analysis of a Jup hypomorphic allele reveals a critical threshold for postnatal viability. Genesis. 2012;50:717-27 pubmed publisher
Stoyianni A, Goussia A, Pentheroudakis G, Siozopoulou V, Ioachim E, Krikelis D, et al. Immunohistochemical study of the epithelial-mesenchymal transition phenotype in cancer of unknown primary: incidence, correlations and prognostic utility. Anticancer Res. 2012;32:1273-81 pubmed
Mortillo S, Elste A, Ge Y, Patil S, Hsiao K, Huntley G, et al. Compensatory redistribution of neuroligins and N-cadherin following deletion of synaptic ?1-integrin. J Comp Neurol. 2012;520:2041-52 pubmed publisher
Chkourko H, Guerrero Serna G, Lin X, Darwish N, Pohlmann J, Cook K, et al. Remodeling of mechanical junctions and of microtubule-associated proteins accompany cardiac connexin43 lateralization. Heart Rhythm. 2012;9:1133-1140.e6 pubmed publisher
Swope D, Cheng L, Gao E, Li J, Radice G. Loss of cadherin-binding proteins ?-catenin and plakoglobin in the heart leads to gap junction remodeling and arrhythmogenesis. Mol Cell Biol. 2012;32:1056-67 pubmed publisher
Schneider D, Wu M, Le T, Cho S, Brenner M, Blackburn M, et al. Cadherin-11 contributes to pulmonary fibrosis: potential role in TGF-? production and epithelial to mesenchymal transition. FASEB J. 2012;26:503-12 pubmed publisher
Maddala R, Chauhan B, Walker C, Zheng Y, Robinson M, Lang R, et al. Rac1 GTPase-deficient mouse lens exhibits defects in shape, suture formation, fiber cell migration and survival. Dev Biol. 2011;360:30-43 pubmed publisher
Saghizadeh M, Soleymani S, Harounian A, Bhakta B, Troyanovsky S, Brunken W, et al. Alterations of epithelial stem cell marker patterns in human diabetic corneas and effects of c-met gene therapy. Mol Vis. 2011;17:2177-90 pubmed
Watanabe R, Hayashi R, Kimura Y, Tanaka Y, Kageyama T, Hara S, et al. A novel gelatin hydrogel carrier sheet for corneal endothelial transplantation. Tissue Eng Part A. 2011;17:2213-9 pubmed publisher
Ferro F, Spelat R, Falini G, Gallelli A, D Aurizio F, Puppato E, et al. Adipose tissue-derived stem cell in vitro differentiation in a three-dimensional dental bud structure. Am J Pathol. 2011;178:2299-310 pubmed publisher
Yang Y, Ahn Y, Gibbons D, Zang Y, Lin W, Thilaganathan N, et al. The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice. J Clin Invest. 2011;121:1373-85 pubmed publisher
Li J, Swope D, Raess N, Cheng L, Muller E, Radice G. Cardiac tissue-restricted deletion of plakoglobin results in progressive cardiomyopathy and activation of {beta}-catenin signaling. Mol Cell Biol. 2011;31:1134-44 pubmed publisher
Liu M, Sakamaki T, Casimiro M, Willmarth N, Quong A, Ju X, et al. The canonical NF-kappaB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion. Cancer Res. 2010;70:10464-73 pubmed publisher
Palatinus J, O Quinn M, Barker R, Harris B, Jourdan J, Gourdie R. ZO-1 determines adherens and gap junction localization at intercalated disks. Am J Physiol Heart Circ Physiol. 2011;300:H583-94 pubmed publisher
Schoenauer R, Emmert M, Felley A, Ehler E, Brokopp C, Weber B, et al. EH-myomesin splice isoform is a novel marker for dilated cardiomyopathy. Basic Res Cardiol. 2011;106:233-47 pubmed publisher
Su L, Cheng C, Mruk D. Adjudin-mediated Sertoli-germ cell junction disassembly affects Sertoli cell barrier function in vitro and in vivo. Int J Biochem Cell Biol. 2010;42:1864-75 pubmed publisher
Su L, Mruk D, Lee W, Cheng C. Differential effects of testosterone and TGF-?3 on endocytic vesicle-mediated protein trafficking events at the blood-testis barrier. Exp Cell Res. 2010;316:2945-60 pubmed publisher
Flatmark K, Davidson B, Kristian A, Stavnes H, Førsund M, Reed W. Exploring the peritoneal surface malignancy phenotype--a pilot immunohistochemical study of human pseudomyxoma peritonei and derived animal models. Hum Pathol. 2010;41:1109-19 pubmed publisher
Kaarteenaho R, Sormunen R, Paakko P. Variable expression of tenascin-C, osteopontin and fibronectin in inflammatory myofibroblastic tumour of the lung. APMIS. 2010;118:91-100 pubmed publisher
D Eliseo D, Pisu P, Romano C, Tubaro A, De Nunzio C, Morrone S, et al. Granzyme B is expressed in urothelial carcinoma and promotes cancer cell invasion. Int J Cancer. 2010;127:1283-94 pubmed publisher
Yiin J, Hu B, Jarzynka M, Feng H, Liu K, Wu J, et al. Slit2 inhibits glioma cell invasion in the brain by suppression of Cdc42 activity. Neuro Oncol. 2009;11:779-89 pubmed publisher
Lapyckyj L, Castillo L, Matos M, Gabrielli N, Lüthy I, Vazquez Levin M. Expression analysis of epithelial cadherin and related proteins in IBH-6 and IBH-4 human breast cancer cell lines. J Cell Physiol. 2010;222:596-605 pubmed publisher
Marín Briggiler C, Lapyckyj L, Gonzalez Echeverria M, Rawe V, Alvarez Sedó C, Vazquez Levin M. Neural cadherin is expressed in human gametes and participates in sperm-oocyte interaction events. Int J Androl. 2010;33:e228-39 pubmed publisher
Hwang C, Song K, Kim C, Choi H, Guo X, Law P, et al. Epigenetic programming of mu-opioid receptor gene in mouse brain is regulated by MeCP2 and Brg1 chromatin remodelling factor. J Cell Mol Med. 2009;13:3591-615 pubmed publisher
Walenda T, Bork S, Horn P, Wein F, Saffrich R, Diehlmann A, et al. Co-culture with mesenchymal stromal cells increases proliferation and maintenance of haematopoietic progenitor cells. J Cell Mol Med. 2010;14:337-50 pubmed publisher
Li Z, Zhou Z, Welch D, Donahue H. Expressing connexin 43 in breast cancer cells reduces their metastasis to lungs. Clin Exp Metastasis. 2008;25:893-901 pubmed publisher
Mosnier J, Kandel C, Cazals Hatem D, Bou Hanna C, Gournay J, Jarry A, et al. N-cadherin serves as diagnostic biomarker in intrahepatic and perihilar cholangiocarcinomas. Mod Pathol. 2009;22:182-90 pubmed publisher
Fondrevelle M, Kantelip B, Reiter R, Chopin D, Thiery J, Monnien F, et al. The expression of Twist has an impact on survival in human bladder cancer and is influenced by the smoking status. Urol Oncol. 2009;27:268-76 pubmed publisher
Agarwal S, Lee D, Kiener H, Brenner M. Coexpression of two mesenchymal cadherins, cadherin 11 and N-cadherin, on murine fibroblast-like synoviocytes. Arthritis Rheum. 2008;58:1044-54 pubmed publisher
Li J, Levin M, Xiong Y, Petrenko N, Patel V, Radice G. N-cadherin haploinsufficiency affects cardiac gap junctions and arrhythmic susceptibility. J Mol Cell Cardiol. 2008;44:597-606 pubmed publisher
Lim S, Lim K, Giuliano R, Federoff H. Temporal and spatial localization of nectin-1 and l-afadin during synaptogenesis in hippocampal neurons. J Comp Neurol. 2008;507:1228-44 pubmed publisher
Wu J, Yan H, Chen W, Chen W, Wang C, Chi Y, et al. JNK signaling pathway is required for bFGF-mediated surface cadherin downregulation on HUVEC. Exp Cell Res. 2008;314:421-9 pubmed publisher
Braun A, Xu H, Hu F, Kocherlakota P, Siegel D, Chander P, et al. Paucity of pericytes in germinal matrix vasculature of premature infants. J Neurosci. 2007;27:12012-24 pubmed
Zhang S, Liu Y, Huang G, Liu L. Aconitine alters connexin43 phosphorylation status and [Ca2+] oscillation patterns in cultured ventricular myocytes of neonatal rats. Toxicol In Vitro. 2007;21:1476-85 pubmed
Hwang C, Song K, Kim C, Choi H, Guo X, Law P, et al. Evidence of endogenous mu opioid receptor regulation by epigenetic control of the promoters. Mol Cell Biol. 2007;27:4720-36 pubmed
Wang C, Mruk D, Lee W, Cheng C. Coxsackie and adenovirus receptor (CAR) is a product of Sertoli and germ cells in rat testes which is localized at the Sertoli-Sertoli and Sertoli-germ cell interface. Exp Cell Res. 2007;313:1373-92 pubmed
Sharma M, Henderson B. IQ-domain GTPase-activating protein 1 regulates beta-catenin at membrane ruffles and its role in macropinocytosis of N-cadherin and adenomatous polyposis coli. J Biol Chem. 2007;282:8545-56 pubmed
Chang M, Boulden J, Sutanto Ward E, DuHadaway J, Soler A, Muller A, et al. Bin1 ablation in mammary gland delays tissue remodeling and drives cancer progression. Cancer Res. 2007;67:100-7 pubmed
Akins M, Greer C. Axon behavior in the olfactory nerve reflects the involvement of catenin-cadherin mediated adhesion. J Comp Neurol. 2006;499:979-89 pubmed
Blixt A, Landgren H, Johansson B, Carlsson P. Foxe3 is required for morphogenesis and differentiation of the anterior segment of the eye and is sensitive to Pax6 gene dosage. Dev Biol. 2007;302:218-29 pubmed
Moreno Bueno G, Cubillo E, Sarrio D, Peinado H, Rodriguez Pinilla S, Villa S, et al. Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition. Cancer Res. 2006;66:9543-56 pubmed
Lascombe I, Clairotte A, Fauconnet S, Bernardini S, Wallerand H, Kantelip B, et al. N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors. Clin Cancer Res. 2006;12:2780-7 pubmed
Liu Z, Xiao M, Balint K, Smalley K, Brafford P, Qiu R, et al. Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression. Cancer Res. 2006;66:4182-90 pubmed
Sarkar O, Xia W, Mruk D. Adjudin-mediated junction restructuring in the seminiferous epithelium leads to displacement of soluble guanylate cyclase from adherens junctions. J Cell Physiol. 2006;208:175-87 pubmed
Kim Y, Sauer C, Testa K, Wahl J, Svoboda R, Johnson K, et al. Modulating the strength of cadherin adhesion: evidence for a novel adhesion complex. J Cell Sci. 2005;118:3883-94 pubmed
Sun X, Wei L, Liden J, Hui G, Dahlman Wright K, Hjerpe A, et al. Molecular characterization of tumour heterogeneity and malignant mesothelioma cell differentiation by gene profiling. J Pathol. 2005;207:91-101 pubmed
Bassarova A, Torlakovic E, Sedloev T, Hristova S, Trifonov D, Nesland J. Simultaneous bilateral breast carcinoma: Histopathological characteristics and CD44/catenin-cadherin profile. Histol Histopathol. 2005;20:791-9 pubmed publisher
Xia W, Cheng C. TGF-beta3 regulates anchoring junction dynamics in the seminiferous epithelium of the rat testis via the Ras/ERK signaling pathway: An in vivo study. Dev Biol. 2005;280:321-43 pubmed
Xia W, Wong C, Lee N, Lee W, Cheng C. Disruption of Sertoli-germ cell adhesion function in the seminiferous epithelium of the rat testis can be limited to adherens junctions without affecting the blood-testis barrier integrity: an in vivo study using an androgen suppression model. J Cell Physiol. 2005;205:141-57 pubmed
Knudsen K, Sauer C, Johnson K, Wheelock M. Effect of N-cadherin misexpression by the mammary epithelium in mice. J Cell Biochem. 2005;95:1093-107 pubmed
Marques F, Fonsechi Carvasan G, de Angelo Andrade L, Bottcher Luiz F. Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors. Gynecol Oncol. 2004;94:16-24 pubmed
Kapoor P, Saunders M, Li Z, Zhou Z, Sheaffer N, Kunze E, et al. Breast cancer metastatic potential: correlation with increased heterotypic gap junctional intercellular communication between breast cancer cells and osteoblastic cells. Int J Cancer. 2004;111:693-7 pubmed
Bassarova A, Nesland J, Sedloev T, Danielsen H, Christova S. Pilomatrix carcinoma with lymph node metastases. J Cutan Pathol. 2004;31:330-5 pubmed
Lee N, Mruk D, Conway A, Cheng C. Zyxin, axin, and Wiskott-Aldrich syndrome protein are adaptors that link the cadherin/catenin protein complex to the cytoskeleton at adherens junctions in the seminiferous epithelium of the rat testis. J Androl. 2004;25:200-15 pubmed
Ng J, Han A, Edelson M, Rosenblum N. Oncoprotein profiles of primary peritoneal malignant mixed müllerian tumors. Int J Gynecol Cancer. 2003;13:870-4 pubmed
Siu M, Cheng C. Interactions of proteases, protease inhibitors, and the beta1 integrin/laminin gamma3 protein complex in the regulation of ectoplasmic specialization dynamics in the rat testis. Biol Reprod. 2004;70:945-64 pubmed
Ordonez N. Value of E-cadherin and N-cadherin immunostaining in the diagnosis of mesothelioma. Hum Pathol. 2003;34:749-55 pubmed
Luo Y, Radice G. Cadherin-mediated adhesion is essential for myofibril continuity across the plasma membrane but not for assembly of the contractile apparatus. J Cell Sci. 2003;116:1471-9 pubmed
Lee N, Mruk D, Lee W, Cheng C. Is the cadherin/catenin complex a functional unit of cell-cell actin-based adherens junctions in the rat testis?. Biol Reprod. 2003;68:489-508 pubmed
Rocha A, Soares P, Machado J, Máximo V, Fonseca E, Franssila K, et al. Mucoepidermoid carcinoma of the thyroid: a tumour histotype characterised by P-cadherin neoexpression and marked abnormalities of E-cadherin/catenins complex. Virchows Arch. 2002;440:498-504 pubmed
Ferreira Cornwell M, Luo Y, Narula N, Lenox J, Lieberman M, Radice G. Remodeling the intercalated disc leads to cardiomyopathy in mice misexpressing cadherins in the heart. J Cell Sci. 2002;115:1623-34 pubmed
Paredes J, Milanezi F, Viegas L, Amendoeira I, Schmitt F. P-cadherin expression is associated with high-grade ductal carcinoma in situ of the breast. Virchows Arch. 2002;440:16-21 pubmed
Laskin W, Miettinen M. Epithelial-type and neural-type cadherin expression in malignant noncarcinomatous neoplasms with epithelioid features that involve the soft tissues. Arch Pathol Lab Med. 2002;126:425-31 pubmed
Wheelock M, Soler A, Knudsen K. Cadherin junctions in mammary tumors. J Mammary Gland Biol Neoplasia. 2001;6:275-85 pubmed
Rocha A, Soares P, Seruca R, Máximo V, Matias Guiu X, Cameselle Teijeiro J, et al. Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant. J Pathol. 2001;194:358-66 pubmed
Gottardi C, Wong E, Gumbiner B. E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. J Cell Biol. 2001;153:1049-60 pubmed
Li G, Satyamoorthy K, Herlyn M. N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res. 2001;61:3819-25 pubmed
Luo Y, Ferreira Cornwell M, Baldwin H, Kostetskii I, Lenox J, Lieberman M, et al. Rescuing the N-cadherin knockout by cardiac-specific expression of N- or E-cadherin. Development. 2001;128:459-69 pubmed
van Raamsdonk C, Tilghman S. Dosage requirement and allelic expression of PAX6 during lens placode formation. Development. 2000;127:5439-48 pubmed
Peralta Soler A, Knudsen K, Salazar H, Han A, Keshgegian A. P-cadherin expression in breast carcinoma indicates poor survival. Cancer. 1999;86:1263-72 pubmed

articles

contribute

If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.

related gene review

questions and comments